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SUMMARY
The original purpose of this study was to investigate 
the clinical importance of nutritional deficiency and 
genetic markers in the aetiology and morbidity of 
alcoholic liver disease. Interest in this subject was 
based on the observation that the onset and severity 
of alcoholic liver disease was in part dependent on 
factors other than the period and extent of alcohol 
abuse. As the principal determinant factors, in 
addition to alcohol, were considered to be genetic 
or nutritional a survey of several of these factors 
in alcoholics was carried out. The genetic factors 
assessed were acetylator phenotype and alpha-l-anti~ 
trypsin phenotype. The nutritional factors assessed 
were ascorbate, vitamin B12 and vitamin B6 status.
The early results of this study indicated that the 
value of this approach was limited by the diversity 
of disease states represented by the term alcoholic 
liver disease and by the interdependence of the 
various factors involved. Therefore, it was decided 
to narrow down the field of research, to concentrate 
on one area, directly related to the human situation 
but more amenable to experimentation than the human 
subject. With a suitable system it would be possible 
to investigate the effect of specific perturbations 
under controlled conditions.
The alternative approaches considered included 
investigation of DNA synthesis in liver cell suspensions 
of biopsy samples, characterisation of the effects of
vitamin B6 deficiency in rats fed a vitamin B6 deficient 
diet and use of PHA stimulated lymphocytes. As the liver 
cell suspension and vitamin B6 deficient rat studies 
were unsuccessful it was decided to concentrate on 
PHA stimulated lymphocyte studies. It was considered 
that this was an appropriate model system for 
investigation of cell growth in the alcohol diseased 
liver, development of a functional assay for vitamin 
B6 status and characterisation of the effects of 
vitamin B6 deficiency on DNA synthesis and the effects 
of vitamin B6 antagonists. Two major advantages of the 
use of lymphocytes were that they represented a source 
of cells which under certain conditions might 
demonstrate the same biochemical abnormalities as 
other cell types of the same individual and that 
they would allow assessment of functional vitamin B6 
status.
As vitamin B6 is the coenzyme of a large number of 
enzymes in several areas of metabolism, the effect of 
a vitamin B6 could be expressed in several ways.
However, because of the high DNA synthetic requirement 
in PHA stimulated lymphocytes or in regenerating liver, 
it was considered that one of the most susceptible 
enzyme activities might be that of serine hydroxymethyl- 
transferase, one of several enzymes involved in de novo 
thymidylate synthesis.
Even if a vitamin B6 deficiency did not affect de novo
thymidylate synthesis directly, the effect of such a
deficiency would still be expressed as a reduction in
DNA synthesis. Therefore a principal parameter of
interest in this study was the rate of DNA synthesis
and the principal method of estimation was based
12 5on incorporation of the thymidine analogue ( I)-UdR,
To avoid the possible confounding effect of medium 
pyridoxal on determination of vitamin B6 status, 
pyridoxal deficient medium was used. Because of the 
interest in this study on de novo thymidylate synthesis 
the effects of different medium folate concentrations 
on cellular adaptation to thymidine utilisation was 
assessed. To determine whether or not a vitamin B6 
deficiency results in a specific restriction of de novo 
thymidylate synthesis, experiments using the de novo 
thymidylate synthesis inhibitors MTX and 5-fu were 
carried out. Several methods were used to determine 
whether or not PHA stimulated lymphocytes of alcoholic 
and control subjects differed with respect to functional 
vitamin B6 status. These included determination of 
sensitivity to culture in a pyridoxal deficient medium, 
sensitivity to the effect of the vitamin B6 antagonist 
4-dPN and the effect of addition of UdR on (^^^I)-UdR 
incorporation. The initial results of these studies 
indicated that the alcoholic and control groups were not 
markedly different in vitamin B6 status. This was 
despite the use of 4-dPN in an attempt to increase the
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sensitivity of the test system. However, the sample 
size was small and it was not possible to exclude the 
possibility that a significant difference did exist.
A survey of a much larger sample of the alcoholic 
population would be necessary to assess this.
Because of the lack of availability of greater numbers 
of subjects suitable for inclusion in the study, 
further characterisation of the model and the effects 
of vitamin B6 antagonists was undertaken.
The results of experiments in media of different 
folate concentrations demonstrated that variation of 
the medium folate concentration has a significant 
influence on cellular adaptation to thymidine 
utilisation but no such effect could be demonstrated 
in the case of vitamin B6 deficiency induced by 4-dPN 
or in stimulated lymphocytes of alcoholics. This 
indicates that the primary lesion in 4-dPN induced 
vitamin B6 deficiency is not at the level of de novo 
thymidylate synthesis. Because the extent of UdR 
suppression of thymidine incorporation had been shown 
to differ in cells of different folate status and had 
been described as a diagnostic aid in determination of 
lesions of de novo thymidylate synthesis, its potential 
use in assessment of vitamin B6 status was investigated 
in this study. However, experiments directed at 
characterisation of UdR suppression, using MTX and 5-fu 
to produce a folate deficiency, indicated that the effect 
of UdR on de novo thymidylate synthesis was incompletely
understood and could not be used as a valid indicator
of folate Cor vitamin B6) status. The results of
12 5experiments carried out using ( I)-UdR were 
substantiated by the reciprocal results of experiments
where incorporation of the de novo thymidylate precursors
14 . 143-( C)-serine and ( C)-formate was determined.
The clinical significance of this study was related 
to the possibility that alcoholics or an alcoholic 
subpopulation have a decreased DNA synthetic capacity 
and an increased, hepatic, DNA synthetic requirement.
A vitamin B6 deficiency could reduce cell growth by 
affecting DNA synthesis or other area of metabolism 
and ethanol induced necrosis would increase the DNA 
synthetic requirement. The results reported in this 
study do not suggest that there is a general vitamin B6 
dependent reduced cell growth capacity in the alcoholic 
liver disease population.
CHAPTER 1
INTRODUCTION
Section 1.1
Alcoholic Liver Disease
1.1.1. A Perspective
The three recognised hepatic complications of heavy 
alcohol consumption are alcoholic fatty liver, 
alcoholic hepatitis and cirrhosis (Lieber, 1977). 
Alcoholic fatty liver is an almost invariable finding 
in the early stages of alcohol abuse. It is 
manifested primarily by hepatomegaly, often in the 
absence of clinical symptoms and is reversible with 
abstinence. Alcoholic hepatitis is usually considered 
to be a transitional lesion in development of cirrhosis 
It is probably reversible but with varying degrees of 
residual fibrosis. The essential lesion is focal or 
diffuse liver-cell necrosis with polymorphonuclear- 
leucocyte infiltration. Depending on the extent of 
necrosis it may cause acute liver failure with portal 
hypertension. Repeated episodes of alcoholic hepatitis 
develop into progressive micronodular cirrhosis which 
is usually irreversible (Baptista et al 1981).
The pathogenesis of liver disease in alcoholic patients 
is obscure. Many chronically alcoholic people have 
normal liver morphology and normal liver function 
(Klatskin, 1961). Statistics indicate that the 
prevalence of cirrhosis in patients with alcoholism 
is proportional to alcohol consumption (Smith, 1981). 
Accordingly, in a man of average size who drinks 17 0 g 
of ethanol per day for 25 years, there is 50 per cent 
chance that cirrhosis will develop (Lieber, 1978),
other estimates of the incidence of cirrhosis in 
chronic alcoholics vary from 2 5 to 57 per cent 
(Lelbach, 1975; Brunt et al, 1971) but all agree 
that a substantial proportion of alcoholics do not 
develop cirrhosis. For example, Lelbach (1975) has 
calculated that in a total of over 5000 alcoholics 
analysed in 2 3 liver biopsy series, one-quarter had 
normal livers, one-third had uncomplicated fatty 
liver, one-fifth had alcoholic hepatitis without 
cirrhosis and one-quarter had cirrhosis. From this, 
it can be readily appreciated that the most important 
factors determining the development of alcoholic 
liver disease are the amount of alcohol, the pattern 
of consumption whether daily or intermittent, etc., 
and the period of abuse. However, superimposed on 
these primary factors are age, sex, weight, 
nutritional and other environmental variables as 
well as genetic and immunological determinants 
(Brunt and Mowat, 197 5).
In approaching an understanding of how ethanol causes 
liver disease, it is perhaps most useful to concentrate 
on how the effects of ethanol and ethanol metabolism 
cause lesions at the cellular and intercellular levels, 
and then to consider how such a process, occurring 
repeatedly every day for a number of years, finally 
compromises the function of the liver and sets in chain 
the irreversible process leading to cirrhosis. A 
general model such as this is useful because it breaks 
the process up into a number of stages which can be
examined in turn to determine the role of various 
effectors throughout the course of the disease 
process. For example, the amount of ethanol would 
determine the extent of the local lesions, the 
periodicity would determine whether there was 
intermediate recovery or promulgation of extant lesions, 
and the cumulative effect of the localised lesions. 
Analysis of such variables has confirmed that there is 
no simple correlation between period and extent of 
abuse and incidence of disease (Lelbach, 1975) and 
therefore it may be reasoned that other parameters 
operate to augment or reduce the necrotic process at 
each stage in individual cases. It is the analysis 
and description of such variables that this project 
is concerned with and it is hoped that such an analysis 
will lead to identification of those most at risk to 
the medical consequences of heavy alcohol consumption 
and to the formulation of a more rational approach to 
therapy directed at reduction of morbidity in 
alcoholic liver disease.
By analogy with other diseases where a uniform challenge 
has invoked a disparate response, it is possible that 
genetic differences might account for variation in 
susceptibility to alcoholic liver disease. The common 
association of alcoholism and a reduced food intake has 
prompted many investigators to examine malnutrition as a 
contributory factor in alcoholic liver disease (Patek, 
1979; Lieber, 1978). A more specific consideration of
the various stages of the disease process has directed 
attention on the role of collagen metabolism (Chen 
and Leevy, 1975), immunological processes (Mihas, Bull 
and Davidson, 197 5) and specific nutritional deficiencies 
(Lumeng and Li, 1974).
In order to appreciate certain aspects of the complex 
interplay of factors in alcoholic liver disease, it 
seems appropriate to consider the primary causative agent, 
ethanol, its metabolism, the disease process, approaches 
to the study of the disease and the approach adopted in 
this project. Only the effects of ethanol on the liver 
are considered, other tissues being discussed only in so 
far as they affect the liver.
1.1.2. Ethanol
The ethanol molecule has weak properties of dissociation 
and polarisation and is freely miscible in water and lipids 
One effect of this is that ethanol, in common with other 
pharmacologically active substances such as ether and 
chloroform, appears to have a fluidising effect on cell 
membranes (Chin and Goldstein, 1977a). A practical result 
of this is perhaps the disruption of neuronal membrane 
function, but other, less dramatic effects on cell membrane 
structure and function are probably at least as important 
in determining the overall effect of chronic alcohol 
consumption. This postulated mode of action of ethanol 
also suggests a mechanism for the development of tolerance. 
According to this mechanism, changes in membrane lipid 
composition would occur in order to reduce this fluidising
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effect of ethanol and hence higher concentrations of 
ethanol would be required in order to produce the same 
disruption in physiological membrane function (Chin 
and Goldstein, 1977b). Tolerance to ethanol would 
also develop in other respects, for example, in 
enzyme systems associated with its metabolism.
Development of tolerance to ethanol is a crucial aspect 
of alcoholic liver disease. Lacking tolerance, the 
human body would not be able to withstand, physiologically, 
the onslaught of large quantities of alcohol, but 
as tolerance to the consumption of otherwise immediately 
toxic and incapacitating quantities of alcohol develops, 
the repeated consumption of such amounts over a number 
of years will result in severe functional disruption of 
many body tissues and especially the liver.
1.1.3. Metabolism of Ethanol
Ethanol is rapidly absorbed through the mucosal membranes 
of the gastro-intestinal tract. It is rapidly 
distributed throughout the body, diffusing across 
capillary membranes, tissue membranes and cell membranes.
It has a destabilising effect on membrane structure with 
concomitant effects on the membrane’s permeability and 
transport functions. Due to the lack of any storage 
mechanisms and the limited amount of pulmonary or renal 
excretion, ethanol must be removed by oxidative 
processes in the tissues (Brunt and Mowat, 1975).
Because of its mass, its portal blood supply and its
functional metabolic specialization, the liver is the 
main tissue which metabolises ethanol, and which is 
most deleteriously affected by alcohol metabolism.
The main oxidative process by which ethanol is 
metabolised is via the cystolic enzyme, alcohol 
dehydrogenase (Li, 1977). This reaction requires the 
oxidised nicotinamide coenzyme NAD +, and it is the 
supply of this coenzyme which is the main rate limiting 
factor in ethanol metabolism. In addition, many of 
the disruptive effects of ethanol metabolism in cellular 
metabolism for example, accumulation of fat in the liver, 
hyperlactacidaemia and hyperuricaemia, are believed to 
be mediated through the cells’ attempts to regenerate 
this coenzyme (Lieber, 1967; Lieber, 1975). The 
acetaldehyde produced is further oxidised to acetate 
and these two reactions constitute, quantitatively, 
the most important pathway for the removal of alcohol 
(Lundquist, 1975). The combination of organ specificity, 
the lack of a feedback mechanism to adjust the rate of 
ethanol oxidation to the metabolic state of the liver 
and the inability of ethanol to be stored or metabolised 
to a marked degree in peripheral tissues is seen as the 
main reason why ethanol metabolism, mediated through 
mechanisms aimed to maintenance of redox homeostasis, 
produces metabolic imbalances in the liver (Lieber, 197 5)
It has been suggested that the increased serum lactic 
acid levels resulting from ethanol metabolism may reduce 
uric acid secretion and result in increased serum uric 
acid and that this may precipitate attacks of gout
(Lieber 1962, 1967). Krebs (1968) suggests that 
this is an interesting attempt to find a causal link 
between alcohol and gout. Overall, Krebs (19 68) 
considers that the effect of alcohol on the regulation 
of cytoplasmic and mitochondrial NAD/NADH2 ratios may 
be a major primary factor in the pathogenesis of 
alcoholic liver disease.
1.1.4. Production of Alcoholic Fatty Liver 
Fatty liver, the earliest manifestation of alcoholic 
liver disease is characterised by a variety of changes, 
only one of which, the hepatic accumulation of lipids, 
gives rise to its descriptive name. At the cellular 
level, these include: accumulation of protein and 
swelling and disorientation of mitochondria and 
mitochondrial cristae (Baraona et al, 197 5a; Baraona 
et al, 1975b; Svoboda and Manning, 1964). The effects 
of lipid and protein accumulation include retention of 
water and swelling of the hepatocyte. The main 
mechanisms whereby fatty acids of various sources can 
accumulate in the liver are: increased peripheral fat
mobilisation; decreased hepatic lipoprotein release, 
decreased lipid oxidation in the liver and enhanced 
lipogenesis (Lieber 1975; Lieber, 1977). This disruption 
of hepatic fat metabolism is, at least initially, 
accompanied by hyperlipaemia (Lieber, 1967). A low fat 
diet will reduce the extent of lipid accumulation but 
where ethanol consumption is continued, the abnormality 
will persist (Lieber And Spritz, 1966).
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Fatty liver may also result from protein malnutrition, 
the intestinal bypass operation for obesity, and, in rats, 
feeding of a choline deficient diet. However, the 
abnormality here is not accompanied by the ultrastructural 
changes of mitochondria and rough endoplasmic reticulum 
which occur in ethanol induced fatty liver, nor does this 
lesion in these cases develop into hepatitis or cirrhosis 
(Lieber, De Carli and Rubin, 1975).
1.1.5. Development of Alcoholic Hepatitis and Cirrhosis 
Identification of the link between fatty liver and 
alcoholic hepatitis and between these conditions and 
cirrhosis is of considerable importance. Because 
alcoholic fatty liver is a common accompaniment of 
alcoholism and is usually fully reversible, it has been 
considered benign. However, the fact that it reflects 
a severe metabolic disturbance which is likely to result 
in irreversible damage to the hepatocyte and reduce its 
life span indicates that this lesion may represent a 
necessary precondition for the development of alcoholic 
hepatitis (Lieber, 1977).
Alcoholic hepatitis results when a number of liver cells 
die and this necrosis causes inflammation (Lieber, 1978). 
From the close similarity in the ultrastructural features 
seen in the hepatocytes of fatty liver and alcoholic 
hepatitis, it seems likely that the basic lesion 
precipitating cell death is the same in each condition. 
According to this hypothesis, because the rate of cell 
death is considerably lower in the fatty liver condition
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and is likely to be within the hyperplastic response 
capacity of the liver, the degree of necrosis would 
be insufficient to cause an inflammatory response.
Up to the fatty liver stage of alcoholic liver disease, 
the effect of alcohol has been well described.
After this stage, the process is more complex. In 
humans, the occurrence of fatty liver is almost universal 
but the subsequent onset and severity of alcoholic 
hepatitis, if it occurs at all, is less certain.
The major factor is continuation of alcohol abuse but 
this alone is insufficient explanation for the variation 
in response to alcohol (Lelbach, 1975; Brunt and Mowat,
197 5). As previously indicated, (section 1,1.1.) the 
main host susceptibility factors are believed to be 
genetic, nutritional, differences in immunological 
reactivity or differences in connective tissue 
metabolism. A major problem is the lack of a suitable 
animal model; the full spectrum of alcoholic liver 
disease cannot be reproduced in the rat and in what 
appears to be the most suitable animal, the baboon, the 
full development of alcoholic liver disease, as in humans, 
requires a period of several years (Lieber, 1975).
It is likely that the long incubation period required for 
the development of alcoholic liver disease reflects the 
degree of toxicity of ethanol and partly explains the 
difficulty in determining which factors potentiate or 
reduce the alcoholic liver disease process. It is 
feasible that initially, one of the determinants of the
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disease process may be the balance between cell death 
and cell renewal. A reasonable strategy in an attempt 
to identify the critical determinants in such a multi­
variate disease is to focus attention on one particular 
parameter and determine its relation to the problem as 
a whole. However, after a certain stage, the process 
is self-perpetuating; the secondary changes induced 
by the disease process, in particular the excess of 
fibrous scar tissue, distort the normal architecture 
of the liver and inhibit blood flow and regeneration. 
This latter stage is termed cirrhosis.
Section 1.2.
Approaches to Study of Alcoholic Liver Disease
1.2.1. Nutritional Factors
It is clear from the work of Lieber, De Carli and 
Rubin (1975) that in an animal model of alcoholic 
liver disease, feeding a nutritious diet will not 
prevent development of alcoholic hepatitis and 
cirrhosis when excessive alcohol is chronically 
consumed. However, the relationship between 
malnutrition and the tissue injury seen in chronic 
alcoholics remains controversial. (Patek, 1979).
Evidence of malnutrition in chronic alcoholics is based 
on observation of weight loss and reduced circulating 
levels of vitamins including folic acid (Hines, 1969) 
pyridoxine (Lumeng and Li, 1974) and leucocyte ascorbic 
acid (Beattie and Sherlock, 1976). The causes of 
malnutrition in the alcoholic include reduced dietary 
intake, malabsorption, impaired nutrient metabolism, 
decreased hepatic storage of nutrients and increased 
nutrient requirements (Leevy, Zetterman and Smith, 1975)
However, the effects of reduced nutrient levels on the 
pathogenesis of alcoholic liver disease are difficult to 
establish. Some alcoholic liver disease subjects have 
apparently normal vitamin levels while some alcoholics 
without liver disease have reduced vitamin levels 
(Leevy, Zetterman and Smith, 1975; Lumeng and Li, 1974). 
This illustrates the multifactorial nature of the 
problem and the difficulty of separating the effects 
of alcohol itself from the effects of malnutrition.
There are also the problems of relating nutritional
status at a particular* time with tissue damage which 
develops over a number of years and individual 
susceptibility to tissue damage. Despite these 
difficulties it is clear that nutritional status is 
a major determinant of susceptibility to alcoholic 
liver disease. Therefore, it was decided to determine 
serum levels of several important nutrients in the 
alcoholic study population. The possibility that 
specific nutritional deficiencies enhance the 
susceptibility of certain alcoholics to alcoholic 
liver disease was also of particular interest. If this 
hypothesis could be sustained it would be possible 
to test whether specific nutritional supplements or 
dietary manipulations would have a protective effect.
In order to further characterise the role of ascorbate 
deficiency in alcoholic liver disease, it was also 
intended to investigate the effect of ascorbate status 
on drug metabolism and in particular metabolism of 
antipyrine. Antipyrine is a drug which is metabolised 
predominantly in the liver and whose metabolism and 
therefore elimination from the body has been shown to 
be delayed by liver disease (Branch, Herbert and Read, 
1973). It has been reported (Beattie and Sherlock, 1976) 
that reduced ascorbate levels are associated with 
reduced antipyrine elimination and it was of interest 
both to further investigate this relationship and the 
effect of improved ascorbate status on antipyrine 
elimination.
1.2.2. Genetic Markers
It is suspected that individual susceptibility to 
many diseases including alcoholic liver disease is 
partly genetically determined. Evidence for this is 
based on observed association between certain 
genetically determined traits such as hair and eye 
colour, colour blindness, etc., and liver disease 
(Reid, et al, 1968). Functional association between 
genetic traits and liver disease has also been 
related to genetic determinants of the immune system 
(Bailey et al, 1976), drug metabolism (Rao et al, 1970) 
and protease inhibitor phenotype (Berg and Eriksson, 
1972).
Two ways in which immune associated genetic markers 
could affect alcoholic liver disease are by a direct 
effect on the immune response or by linkage with a 
determinant of the immune response. The prevalence 
of certain histocompatibility locus antigens (HLA) 
in different groups of subjects suggests that these 
genetic markers may be determinants or may be linked 
to determinants of susceptibility to alcoholic liver 
disease (Bailey et al, 1976).
Recognition of genetic variation in drug metabolism 
e.g., of slow and fast acetylators (Rao et al, 1970) 
and of possible clinical implications such as reduced 
response to drug therapy and enhanced drug toxicity 
suggests that such markers could also be related to 
susceptibility to alcoholic liver disease.
Alpha-l-antitrypsin is a serum protein which comprises 
the majority of the alpha-1 globulin fraction and is 
the major protease inhibitor of human serum. Its 
biosynthesis is controlled by two allelic genes and 
homozygous deficiency has been associated with 
severe pulmonary emphysema in adults (Eriksson, 1965; 
Sharp, 1971) as well as liver disease in children 
(Johnson and Alper, 1970) and adults (Berg and Eriksson, 
1972). Partial heterozygous deficiency may be 
associated with chronic lung disease (Kueppers, Fallat 
and Larson, 1969), Alpha-1 antitrypsin is a member of 
a group of proteins, acute phase reactants, which are 
synthesised in the liver and which increase in 
concentration in response to disease states involving 
acute inflammation and, or tissue necrosis.
Although homozygous deficiency of alpha-1 antitrypsin, 
with a United Kingdom frequency of about 1 in 4 00 0 
(Cook, 197 5) is very rare and cannot be considered a 
significant factor in the incidence of alcoholic liver 
disease, it is possible that certain heterozygotes or 
persons with reduced levels of alpha-1 antitrypsin could 
have enhanced susceptibility to alcoholic liver disease. 
For this reason it was decided to determine alpha-1- 
antitrypsin levels in the study population.
One of the difficulties of characterising the genetic 
component of individual susceptibility to alcoholic 
liver disease is the possibility that alcoholism itself 
may have a genetic component and that this might confound
the analysis. However, because of the evidence of 
an association between certain genetic markers and 
alcoholic liver disease, it was decided to investigate 
the relation of several of these, i.e., alpha-1- 
antitrypsin and acetylator phenotype in the present 
study. Originally, it was also intended to determine 
HLA type but this was not possible.
1.2.3. Vitamin B6 Metabolism
Vitamin B6 is the generic name for a number of related 
compounds which all have the basic pyridine ring 
structure (fig. 1). Depending on which (-R) group is 
substituted, pyridoxine, pyridoxal or pyridoxamine 
is formed. The phosphate ester of pyridoxal, 
pyridoxal phosphate, is the active coenzyme.
Pyridoxal phosphate is a coenzyme employed by many 
enzymes in many areas of metabolism and especially 
by those enzymes catalysing amino acid transformations 
Among the enzyme reactions catalysed by pyridoxal 
phosphate are: transamination, decarboxylation, 
phosphorylysis of glycogen, formation of delta- 
aminolaevulinic acid and formation of 5, 10 methylene 
tetrahydrofolate. Thus vitamin B6 is an essential 
factor in such processes, as the maintenance of 
nitrogen balance, porphyrin synthesis and de novo 
thymidylate synthesis and it therefore plays an 
integral role in protein,carbohydrate, lipid, purine, 
pyrimidine and neurotransmitter metabolism. From this 
it can be readily appreciated that a B6 deficiency
would result in anaemia, growth retardation and 
alteration in neuronal function.
As the Bg vitamins occur so widely in nature there 
is unlikely to be a primary Bg deficiency in the 
human. However, there are a number of conditions from 
which a vitamin Eg deficiency could arise. In general, 
malnutrition in chronic liver disease can result from; 
inadequate diet, malabsorption, diminished hepatic 
nutrient storage and disturbed nutrient metabolism.
Thus patients with liver disease may have adequate 
total body levels of nutrient yet because of altered 
transport mechanisms or because of a nutrient 
metabolism block be unable to utilise the nutrient.
A vitamin Bg deficiency might also result from an 
increased metabolic requirement or due to the 
occurrence of a variant enzyme with an abnormally high 
pyridoxal phosphate requirement.
The non specific nature of the effects of Bg deficiency 
and their occurrence only in severe deficiency masks 
marginal Bg deficiency. In infants, vitamin Bg deficiency 
produces convulsions, in the adult the most specific 
clinical manifestation is probably vitamin Bg responsive 
sideroblastic anaemia (Hines and Cowan, 1970). Various 
reports have indicated a significant incidence of this 
abnormality in alcoholics (Hines and Cowan, 197 0;
Pierce, McGuffin and Hillman, 1976). However, the 
development of this abnormality is probably the end 
result of multiple contributing factors and cannot be 
considered a precise or sensitive index of vitamin Bg
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deficiency. For this reason, estimation of the 
incidence of vitamin Bg deficiency in the alcoholic 
has relied either on the determination of the 
functional integrity of vitamin Bg dependent pathways 
or the measurement of vitamin content of serum or 
erythrocytes (Li, 197 6).
No completely satisfactory functional assay has been 
described and most recent studies have depended on 
tyrosine apodecarboxylase determination of pyridoxal 
phosphate (Chabner and Livingstone, 19 70; Lumeng and 
Li, 1974). The range of serum PLP values determined 
using this method vary between 2.4 - 12.4 ng/ml, mean 
7.1 ng/ml (Hamfelt, 1964); 5.0 - 26.3 ng/ml (Lumeng 
and Li, 1974); 18.5 i 5.5 ng/ml (Chabner and Livingstone, 
1970) and 11.3 - 1.0 ng/ml (Rossouw et al, 1977).
In hepatic failure significantly higher serum PLP values 
are observed (Rossouw et al, 1977) which subsequently 
decrease to subnormal levels. It appears that serum 
PLP values are reduced in liver disease, including 
alcoholic liver disease, and that the normal range is 
different for each investigator. Furthermore, the 
presence of hepatic damage could lead to the release of 
PLP into serum and result in a false indication of 
satisfactory vitamin Bg status.
Among the studies which have established that a high 
percentage of chronic alcoholics, whether with or without 
hepatic disease, have low serum pyridoxal phosphate
H- o .
levels are those of Lumeng and Li (1974) and Pierce, 
et al (1976), The cause of these low levels has 
been related to diet but a more likely cause is 
probably the effect of ethanol metabolism (Lumeng,
1978). The main mechanism advanced to account for 
the disruption of vitamin Bg metabolism is that 
acetaldehyde, the immediate product of ethanol 
oxidation, displaces or facilitates the dissociation 
of PLP from protein. This increases the availability 
of PLP for hydrolysis by alkaline phosphatase and 
this increased degradation of PLP results in low 
serum levels of the vitamin.
The functional significance of these low levels is not 
known. The possible effect on cell growth and Y>Y\k 
synthesis, suggested by Leevy (1966, 197 5b) would, if 
confirmed, represent an important consequence. If this 
was further related to a limiting determinant in the 
pathogenesis of alcoholic liver disease, then vitamin 
Bg therapy would have a more rational basis and a 
definite adjunctival role in the prevention and 
management of alcoholic liver disease.
In this study it was decided to determine serum vitamin 
Bg levels in groups of normal, alcoholic and alcoholic 
liver disease subjects. This information would be used 
to investigate the relationship between vitamin Bg levels 
and alcoholic liver disease.
The possibility that vitamin Bg deficiency would result 
in an increase in the amount of apo- relative to holo- 
serum transaminase levels in alcoholic liver disease 
subjects was also investigated. It is possible that a 
relative reduction in holo- enzyme level would result 
in an underestimate of total serum transaminase levels 
in Bg deficient subjects. It has also been suggested 
that the stimulation in serum transaminase activity 
after addition of PLP would provide an estimate of 
vitamin Bg status (Sauberlich et al, 1972).
1.2.4. Vitamin B-^ ^  Metabolism
The liver is the principal storage site for vitamin 
B^2 3.nd assays of liver biopsy material for vitamin 
B-^2 show a diminution in liver disease (Sherlock, 1963 ). 
This is paralleled by an increase in serum 2 levels 
in liver disease, including alcoholic liver disease 
(Hines, 1969). In view of the assumption which is 
often made that serum levels of vitamins reflect cellular 
vitamin status, it is of particular interest that 
elevated serum B^2 levels should be associated with 
reduced hepatic B^g levels.
Neither the cause of elevated serum B12 levels in alcoholic 
liver disease nor the clinical significance of such 
changes have been established. Possible mechanisms 
include: increased absorption of vitamin B^g, an increase 
in serum vitamin B^g binding proteins and consequent 
increase in the availability of binder sites, an increase 
in saturation of the binder sites and abnormal release
of vitamin from the liver. If elevated serum
vitamin  ^levels are associated with reduced cellular 
levels of vitamin B^^? and therefore vitamin B^^ 
deficiency, it is possible that they contribute to the 
neurological, haematopoietic and cell growth defects 
associated with alcoholic liver disease
In this study it was decided to further characterise 
certain aspects of vitamin g metabolism in alcoholic 
liver disease by determination of vitamin B^^ absorption, 
serum vitamin B^2 levels and levels of unsaturated 
vitamin B^2 binding capacity of serum vitamin g 
transport proteins.
1.2.5. Immunological Aspects
A variety of altered immunological parameters have been 
observed in alcoholic liver disease and these have been 
related to development and progression of the disease.
It has been found that serum immunoglobulins are 
usually increased in patients with alcoholic liver 
disease and that they include some autoantibodies 
(Zimmerman and Levi, 19 69). An altered cell mediated 
immunity to liver antigens has been described in 
patients with alcoholic hepatitis using either autologous 
liver, normal human liver or alcoholic hyaline (Sorrel 
and Leevy5 197 2; Mihas, Bull and Davidson, 197 5).
It has been shown that lymphocytes from baboons with 
alcoholic hepatitis are cytotoxic against autologous 
liver cells in tissue culture (Paronetto and Lieber, 1976) 
and that a cell mediated autoimmune reaction may occur 
in patients with alcohol induced liver damage (Cochrane
et al, 1977 ) .
This evidence suggests that necrosis of liver cells is 
accompanied by an inflammatory cell infiltrate which may 
mediate an autoimmune process leading to further liver 
cell damage. Further evidence suggestive of perpetuation 
by abnormal immunoreactivity is the demonstration of 
liver antigen induced migration inhibition in hepatitis 
but not in steatosis or cirrhosis (Mihas et al, 197 5) and 
the increased levels of serum IgA in hepatitis and 
cirrhosis but not steatosis (Steigmann et al, 1974).
It has also been suggested that immunologic reactivity 
to collagen occurs in patients with alcoholic hepatitis 
and that such activity may be important in conversion 
of alcoholic hepatitis to cirrhosis (Zetterman, 
Liusada-Opper and Leevy, 1976). On the basis of a 
decreased lymphocyte response to phytohaemagglutinin 
(Lundy et al, 197 5) and a pronounced decrease in 
peripheral blood lymphocytes in patients with alcoholic 
hepatitis (Bernstein et al, 1974), it was suggested 
that there is a basic impairment in cell-mediated 
immunity in alcoholic liver disease (Leevy et al, 1975).
These observations suggest that immunological mechanisms 
may be involved in the perpetuation of hepatic damage 
in alcoholic patients but they do not distinguish 
between immunological factors causing cell death and 
fibrosis and changes in immunological parameters resulting 
from the disease process.
1.2.6. The Role of Collagen Metabolism 
It has been suggested that ethanol can trigger the 
development of cirrhosis not only through the scarring 
that results from necrosis and inflammation but also 
through a direct effect of ethanol on the metabolism of 
collagen (Feinman and Lieber, 1972). This possibility 
is suggested by the observation that after alcohol 
administration, in rats or baboons, an increase in liver 
collagen can be detected chemically at the fatty liver 
stage before necrosis, inflammation or fibrosis is 
present. It is questionable, however, if this observation 
can be extrapolated to man. For example, the relative 
amount of collagen in the adult rat is one-third that of 
man and in fully developed rat cirrhosis, hepatic collagen 
is about equal to that of the normal human liver (Popper 
and Fiez, 1978).
Increases in hepatic collagen have been associated with 
increases in peptidyl proline hydroxylase activity 
(Chen and Leevy, 197 5) and decreased degradation and 
accumulation of variant forms of collagen (Hutterer, 
Eisenstadt and Rubin, 1970). Hutterer et al (1970) have 
also suggested a decreased rate of collagen catabolism 
rather than increased rate of synthesis distinguishes 
the irreversible phase of fibrosis from the reversible 
phase. An immunological mechanism has also been advanced 
(Zetterman et al, 197 6).
However, it is generally recognised that liver cell 
necrosis is the most important stimulus for hepatic 
fibrosis and that this stimulation is due to the release
of substances from the necrotic cell which stimulate 
fibrosis (Popper and Piez, 1978).
1.2.7. Use of Animal Models
Human studies are limited by the genetic and environmental 
heterogeneity of the human population and by ethical 
considerations of human experimentation. However, the 
advantages of animal studies such as uniform population, 
standard conditions and wider range of permissible 
experiments do not necessarily out-weigh the disadvantages 
of human studies. This is of particular importance in 
studies of alcoholic liver disease which has a long 
development period, is accompanied by many biochemical 
changes and is associated with numerous other variables.
In such cases, the usual limitations of animal studies 
of human disease, e.g., the extent to which the human 
disease can be reproduced in animals and the validity 
of extrapolation from the animal to the human, assume 
greater significance.
This point can be illustrated with reference to the rat.
In human alcoholic liver disease, an early manifestation 
is the 'fatty liver', a term used to describe a variety 
of biochemical abnormalities including altered fat 
metabolism. These abnormalities are believed to be 
progenitors of more serious lesions which would eventually 
result in alcoholic hepatitis and altered fat metabolism 
is central to these changes. However, under normal 
conditions there is a wide difference in the dependence 
of man and rat on fat in their diet and consequently in
their metabolic adaption to the metabolism of this 
substance (Stanko, Mendelow , Shinozuka & Adibi, 1978 ).
Other important considerations are differences in 
collagen metabolism (1.2.6.) and period of development 
of the disease. Human alcoholic liver disease takes 
at least four years and usually much longer to develop 
and this development period cannot be reproduced in 
the rat. Therefore, in several crucial respects, there 
is a wide species difference between man and rat which 
means the rat cannot be considered an appropriate 
animal model for study of alcoholic liver disease.
One animal which does appear to have some of the important 
attributes required for an animal model of alcoholic 
liver disease is the baboon. This species is longer 
lived, phylogenetically closer to man than the rat and 
on feeding with a nutritionally adequate diet containing 
alcohol, the entire spectrum of alcoholic liver injury 
is produced (Rubin and Lieber, 1974). However, the use 
of this model in the present study is not feasible for 
a variety of reasons, one of which is that a four year 
period is required for development of the full spectrum 
of disease. The lack of a suitable animal model of 
alcoholic liver disease does not however preclude the 
use of animals to study specific aspects of the disease 
process.
Section 1.3.
An Alternative Approach
1.3.1. The Need for an Alternative Approach 
The original impetus for this project arose from the 
observation that the onset and severity of alcoholic 
liver disease was in part dependent on factors other 
than the period and extent of alcohol abuse. The prime 
consideration then was to determine the relationship of 
two major such factors: nutritional deficiency and 
genetic predisposition, to the aetiology and morbidity 
of the disease. Therefore, it was decided to investigate 
the frequency of various genetic markers and certain 
aspects of nutritional status in alcoholic liver disease 
and alcoholic non-liver disease populations. The 
rationale, methods and results of these studies are 
described in sections 1.2., 2.2. and 3.1. However, from 
an analysis of the preliminary results of this study and 
from a greater appreciation of the practical difficulties 
associated with such a study, it became apparent that a 
comprehensive, single-centre and short-term study was 
unlikely to produce significant results. Among the 
difficulties associated with this study were the general 
problems of research studies involving human subjects, 
the diversity of the disease states represented by the 
term alcoholic liver disease, the multiplicity and 
interaction of incident factors, the heterogeneity of 
the alcoholic liver disease population in respect of age, 
sex, social class, living conditions, smoking, co­
operativeness, etc., and the more specific problems of 
integrating such a complex study into a clinical environ­
ment .
Such considerations determined that it would be more 
useful to narrow down the field of research to 
concentrate on one area directly related to the human 
situation but much more amenable to experimental 
manipulation than the human subject. With a suitable 
system it would be possible to investigate the effect 
of specific perturbations under controlled conditions.
Such an approach would be concerned with elucidation 
of critical determinants in the development and 
progression of the disease rather than attempt to 
resolve the precise significance of major effector 
variables to the overall course of the disease.
Therefore, it was decided to choose one established 
variable observed in the alcoholic population, e.g., 
vitamin Bg status, and study this intensively in order 
to determine cause and effect of variation in this 
parameter on a potentially crucial determinant of 
alcoholic liver disease. It was realised that the 
adoption of this fresh approach would limit the scope 
of the project but it was considered that this dis­
advantage would be outweighed by an increase in the 
power of the results.
1.3.2. A Simple Model of Alcoholic Liver Disease 
In order to facilitate appraisal of alcoholic liver disease 
and determination of a suitable area for investigation, 
a simple model of the disease process was constructed.
This is illustrated in fig. 2 and shows the progression 
from a normal liver which, on exposure to alcohol, 
develops into the fatty liver, a condition characterised
Fig. 2. A Simple Model of Alcoholic Liver Disease
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at the cellular level by deposition of fat, retention 
of protein, disruption of microtubules and disruption 
of mitochondria.
The fatty liver thus represents a fairly serious state of 
cellular abnormality but it is a reversible condition, 
in contrast to the condition which develops on continued 
exposure to alcohol; alcoholic hepatitis or cirrhosis, 
which is irreversible. At some stage in the process, 
the reversible phase progresses into the irreversible 
phase and since this transition is crucial to the 
development of the disease, further attention was 
focused on the factors which might determine the 
transition. If we expand the 'fatty liver' stage of 
the model, fig. 3, and consider the factors which might 
govern, recovery, stability or progression of the disease 
process, it is apparent that the cellular disturbances 
present at this stage will result in increased cell 
death. Subsequent recovery or progression will depend 
on the response to this; either a normal increase in cell 
growth and regeneration, leading to recovery/stability, 
or an inadequate response leading to further necrosis and 
development of the disease process. Cell growth then, 
and in turn DNA synthesis is likely to be a key determinant 
in alcoholic liver disease.
1.3.3. DNA Synthesis in Alcoholic Liver Disease 
Determination of DNA synthesis in alcoholic liver disease 
has been investigated using liver biopsy samples (Leevy, 
1963, 1966), but the methods used limit interpretation of 
the results. With recent advances in techniques of primary
short term culture of hépatocytes (Demoise, Galambos 
and Falek, 1971; Gebhardt, Belleman and Mecke, 1978) it 
was hoped some of these limitations could be overcome. 
Accordingly, exploratory experiments were carried out to 
determine the feasibility of using such methods to 
determine parameters of cell growth in liver biopsy 
samples. The methods used in these experiments are 
described in section 2.2.9.Essentially, a suspension of 
isolated hepatic cells was prepared by disaggregation 
of finely chopped liver tissue of freshly sacrificed rats 
in medium containing collagenase and EDTA. Estimation 
of parameters of DNA synthesis in these freshly isolated 
cells was carried out by determination of acid-insoluble 
incorporation of the DNA precursor (H)-TdR using auto­
radiography of cytocentrifuge slide preparations.
However, it was not possible from these experiments to 
determine appropriate conditions for obtaining or 
maintaining an adequate viable cell suspension which 
could be satisfactorily transferred to use of biopsy 
material.
As it was not possible to satisfactorily study cell growth 
and regeneration in the alcohol diseased liver directly, 
an indirect method was sought. This method was suggested 
by consideration of folate deficiency.
The main effect of folate deficiency is suppression of 
DNA synthesis. In the adult, the tissue most seriously 
affected is bone marrow and the most important clinical 
lesion is megaloblastic anaemia (Blakley, 1969).
In folate deficient individuals the effects of deficiency
can be directly observed by examination of bone 
marrow tissue. However, Das and Hoffbrand (1970) 
have also demonstrated the effects of folate deficiency 
using a more accessible tissue, peripheral blood 
lymphocytes. The principle inherent in this 
observation, of using one cell type to investigate the 
effects of vitamin deficiency on DNA synthesis in 
another cell type was adopted and extended in the 
present study. This was to use peripheral blood 
lymphocytes as an indirect means of studying the 
effects of vitamin deficiency on cell growth and DNA 
synthesis in the alcohol diseased liver.
1.3.4. The Effect of Vitamin Bg Deficiency on DNA
Synthesis
The ubiquity of vitamin Bg in cellular metabolism as 
well as the numerous manifestations of a Bg deficiency 
has been mentioned previously (1.2.3.). If the limiting 
effect of a Bg deficiency depends to a large extent on 
the Bg requirement of a particular enzyme system in a 
specific tissue, then under different conditions the 
primary effect of a Bg deficiency will be realised in 
different ways, reflecting the tissue and enzyme system 
most affected. Hence under different conditions the 
limiting effect of a Bg deficiency might be; reduced 
activity of delta-aminolevulinic acid with reduced 
formation of protoporphyrin and the occurrence of 
sideroblastic anaemia or, reduced activity of serine 
hydroxymethyltransferase and consequent disruption of 
folate metabolism.
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In the particular circumstances of alcoholic liver 
disease it is possible that the principal effect of 
a Bg deficiency would be to reduce serine hydroxymethyl- 
transferase activity and consequently, DNA synthesis 
and cell growth, Leevy (1966) has previously reported 
that chronic alcoholics rendered folate or pyridoxine 
deficient show defective incorporation of nucleic acid 
precursors into RNA and significantly impaired DNA 
synthesis and cell replication. This work utilized 
liver biopsy samples which are subject to sampling error 
and difficulties of obtaining even distribution of 
oxygen throughout the sampled tissue. In addition, 
it is not usually possible to carry out repeated biopsy 
sampling to assess progress of treatment. Therefore, 
development of a method which utilized peripheral blood 
lymphocytes to assess the effect of alcohol and vitamin 
deficiency on cell growth and DNA synthesis in the 
liver would offer significant advantages in investigation 
of alcoholic liver disease. As well as investigation 
of the role of reduced DNA synthesis in alcoholic 
liver disease, such a method would permit a more precise 
determination of the effect of Bg deficiency on 
cellular metabolism.
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Section 1.4.
Studies Utilizing the Phytohaemagglutinin Stimulated
Lymphocyte
1.4.1. Perspective
In 1960 Nowell demonstrated that an aqueous extract of 
the kidney bean, phytohemagglutinin (PHA) was able to 
produce large, dividing blast like cells in cultures 
of human peripheral blood. It was found that the 
particular cells stimulated were the small lymphocytes 
and that the morphological changes were preceded or 
accompanied by the induction of DNA synthesis and 
increased RNA and protein synthesis. Since then, a 
great deal of research has centred on the early events 
of lymphocyte activation with the aim of elucidating the 
physiological and biochemical mechanisms whereby the 
quiescent small lymphocyte is derepressed to become a 
metabolically active, dividing cell. Several of these 
early events are in fact not unique to lymphocytes but 
are known to occur in other systems in which gene 
derepression is taking place, e.g., regenerating liver 
cells .
The proliferative response of small lymphocytes to mitogens, 
such as PHA, or to foreign lymphocytes, as in the mixed 
lymphocyte reaction (MLR) has also been used as an in vitro 
model of the cell-mediated immune response (Bach, Segall 
and Zier, 1973). A further use has been to investigate 
the role of vitamin g folate deficiency in the
development of pernicious anaemia and megaloblastic 
anaemia (Das and Hoffbrand, 1970; Hooton and Hoffbrand,
1977) .
These and other properties combine to make this system 
particularly attractive for studying certain aspects of 
alcoholic liver disease. Previously, the main 
application in this area has been to investigate immunol­
ogical factors, the main finding being the identification 
of a depressed immunocapacity in alcoholic liver disease 
(Lundy et al, 197 5), This deficiency has been related 
to the immunosuppressive effect of a Bg deficiency 
(Robson and Schwarz, 1975; Axelrod, 1971). This work and 
a novel approach to alcoholic liver disease utilising 
the PHA stimulated lymphocyte are discussed in later 
sections. Essentially the novel approach involves the 
concept of a systemic, marginal, Bg deficiency resulting 
in an acute or chronic Bg deficiency in a particularly 
stressed organ. In this case, the lymphocyte subjected 
to PHA is considered as a model for the liver subjected 
to alcohol. The main distinction between this and 
previous work is that here, the lymphocyte is employed 
as an in vitro model of the dividing liver cell, rather 
than of the immune response, and the effect of a Bg 
deficiency is related to a specific cellular function,
DNA synthesis, rather than to overall blastogenesis.
1.4.2. Advantages and Disadvantages
As previously indicated, (section 1.3.3.), the main reason 
for using the PHA stimulated lymphocyte to study the 
relationship between vitamin Bg deficiency and DNA 
synthesis in alcoholic liver disease is that the value of 
this system has previously been demonstrated in studying 
the relationship of folate and vitamin B^g deficiency to 
haematosuppression. The principal objection to the use of
lymphocytes as a means of investigating the alcohol 
diseased liver is the wide disparity in differentiation 
and function of these tissues. Therefore, there is no 
direct reason why changes in hepatic tissue should be 
reflected in the small lymphocyte cell population.
However, the changes which accompany growth stimulation 
in lymphocytes are similar to those which occur during 
a switch to a more rapid rate of growth in other cell 
types, e.g., in the remaining hepatocytes after partial 
hepatectomy, in kidney cells after the removal of the 
opposite kidney or in confluent fibroblasts after 
subculture from a confluent monolayer (Ling and Kay, 197 5). 
This suggests that although there are significant 
differences between hepatic tissue and lymphocytes, there 
are sufficient common characteristics to support the use 
of PHA stimulated lymphocytes as a valid model system.
Further advantages of this PHA stimulated lymphocyte cell 
culture system include the facility to control the culture 
medium concentration of serum and specific nutrients, etc., 
and therefore investigate the effect of specific perturba­
tions under controlled conditions, and, the possibility of 
obtaining serial samples from an individual either to 
monitor a course of treatment or to compare pre- and post­
treatment responses. These advantages, allied to the 
reproducibility of PHA stimulation of lymphocytes and the 
availability of autologous serum extends the range of 
investigations that it is possible to carry out. In 
particular, the use of autologous serum provides the 
opportunity to investigate the effect of cytotoxic or
immunogenic factors in alcoholic liver disease 
(Lieber, 1977).
One limitation of the PHA stimulated lymphocyte as a 
model of alcohol diseased liver regenerative capacity 
and DNA synthesis is that it excludes the effect of 
the immediate cellular and intercellular environment 
as it affects regeneration. For instance, it does not 
preclude the possibility that a vitamin Bg deficiency 
might arise and be expressed only in the liver due to 
the local effect of a metabolite of ethanol such as 
acetaldehyde. Experiments could be designed to determine 
the effect of such a factor but control of other extra­
cellular factors is more intractable. In the presence 
of active liver cell damage where the proliferative 
response is impaired, instead of formation of new tissue 
there is deposition of fibrous, collagen scar tissue 
which disrupts the normal vascular architecture and 
reduces hepatic blood flow (Lieber, 1977), Even if 
alcohol assault ceases and nutritional deficiency 
corrected, any subsequent regenerative response is 
necessarily inhibited by the enveloping fibrous tissue 
and reduced blood supply. The same limitation, however, 
strengthens the model as it relates to a systemic 
vitamin sufficiency being expressed as a local deficiency 
in a stressed organ.
This study is primarily concerned with investigation of 
the effect of vitamin Bg deficiency on DNA synthesis 
and thus on hepatic regenerative capacity. However, the 
association of vitamin Bg deficiency and impairment
of the immune response (Robson and Schwarz, 1975) 
has also been linked to restriction of nucleic acid 
synthesis (Axelrod, 1971). Thus use of the PHA 
stimulated lymphocyte system in this study may be 
considered a means of investigating both hepatic and 
immune response aspects of alcoholic liver disease. 
Overall, it is clear that with certain qualifications, 
in particular an appreciation of the limitations, the 
model system imposes on interpretation of results and 
given that more direct methods such as use of biopsy 
material are not available, the indirect approach adopted 
in this study is justifiable.
1.4.3. Use of Vitamin Deficient Rats    b---------------
As the reported vitamin Eg deficiency of alcoholics is 
relative rather than absolute, as there are no clearly 
defined symptoms which can be specifically attributed 
to vitamin Bg deficiency and since the alcoholic 
population is so heterogeneous with respect to period 
and extent of alcohol abuse, diet and other effector 
variables, a test system was sought where an unequivocal 
vitamin Bg deficiency could be investigated. As a number 
of reports suggested that such a deficiency state could 
be produced in rats by feeding a diet deficient in 
pyridoxine HCL (Reynolds, 197 8; Sloger, Scholfield and 
Reynolds, 1978; Lumeng, Ryan and Li, 1978) and since rat 
lymphocytes are also responsive to PHA (Ling and Kay,
197 5) it was decided to carry out parallel experiments 
using vitamin Bg deficient rat lymphocytes.
It was hoped to use such experiments to test the 
validity of certain aspects of the PHA stimulated 
lymphocyte model. In the rat. the effect of Bg 
deficiency could be assessed in both lymphocytes 
and liver, perhaps by use of a double-labelling 
technique, and this information could be used to 
assess the validity of the lymphocyte model in man. 
Stressing the vitamin Bg deficient rat liver by 
drug induced hepatic regeneration was also considered 
as a closer approximation to the alcohol stressed 
human liver. While it was realised that experimental 
manipulation of the whole animal to study parameters 
of growth in a specific cell population introduces 
uncontrolled variables such as alteration in blood 
chemistry and hormonal balance (Ling and Kay, 1975), 
which may interfere with or confound the effects of 
vitamin or other nutritional deficiency on the system, 
it was considered that such studies would still provide 
valuable information. For this reason, a group of rats 
were fed a vitamin Bg deficient diet for a period of 
six weeks.
Unfortunately, for a number of reasons, it was not possible 
to satisfactorily complete these experiments. These 
reasons included the difficulty of obtaining serial 
aseptic blood samples from the rat and the problem of 
establishing the most appropriate culture conditions 
to obtain a satisfactory response of rat lymphocytes 
to PHA. When blood samples were collected from the 
cervical blood vessels, or from the rat tail vein, it 
was not possible to obtain a satisfactory culture due
to bacteriological contamination. This problem was
not solved by washing the lymphocyte suspension in a
balanced salt solution containing high concentrations
of antibiotic. Therefore, microculture of rat
lymphocytes from whole blood was unsuccessful and it
was not possible to obtain a sufficient number of
lymphocytes from a small blood volume for successful
culture of a lymphocyte preparation. In addition to
these problems, it became apparent that, probably due
to gastrointestinal bacteria (Sumi, et al, 1977), the
pyridoxine HCL deficient diet failed to produce a
vitamin Bg deficiency state. It is possible that a
more successful approach to the production of an
absolute vitamin Bg deficiency state might involve the
1use of a vitamin Bg inhibitor such as 4 -deoxypyridoxine.
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1.4.4. Determination of DNA Synthesis
A scheme illustrating known reactions in the biosynthetic 
pathway of DNA thymine is given in fig. 4. Two pathways 
are shown; the de novo pathway and the salvage pathway. 
Also shown is the site of action of the inhibitors Am,
MTX and 5-fu and the involvement of folate and vitamin 
Bg coenzymes. Although all four deoxyribose nucleoside 
triphosphates must be available for the synthesis of DNA 
chains to proceed, thymidylate is a unique component of 
DNA and therefore the formation of thymidine phosphates 
is a strategically important part of the complex 
metabolic system which provides nucleotide building 
blocks for DNA replication. In most systems studied, 
the activity of thymidine kinase is low in non-growing 
cells but increases just before the onset of DNA 
synthesis. Although the physiological significance 
of thymidine kinase and the salvage pathway has not been 
absolutely defined, thymidine kinase has many of the 
attributes of a rate-determining enzyme for DNA 
biosynthesis (Adams et al, 197 6) including sensitivity 
to feedback inhibition by dTTP, and this has led to the 
idea that thymidine kinase is involved in the control 
of initiation of DNA synthesis. However, it is more 
likely that these controls are concerned with regulation 
of DNA precursor synthesis rather than DNA synthesis 
itself.
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In animal cells TdR is specifically incorporated into 
DNA thymidylate contributing neither to DNA deoxy- 
cytidylate nor to pyrimidine ribonucleotides.
Since incorporation into DNA is the only major anabolic 
fate of labelled thymidine, DNA synthesis can be 
measured without isolation of DNA; only the removal of 
unused substrate and acid-soluble metabolites being 
necessary. Thymidine is incorporated into DNA via the 
salvage pathway which employs the enzyme thymidine 
kinase. Although the rise in activity of this enzyme 
prior to DNA synthesis and its sensitivity to allosteric 
controls indicates that thymidine kinase is important in 
the deoxyribonucleotide economy of cells (Taylor- 
Papadimitriou and Rozengurt, 1979), thymidine is not an 
obligatory intermediate in the biosynthesis of the 
thymidine phosphates and, under certain circumstances, 
the mutational loss of this enzyme is not lethal.
Despite this apparent redundancy, in certain tissue 
culture conditions, the ubiquity of thymidine kinase in 
proliferating cells, mitochondria, and in viral 
infection suggest that the role of thymidine kinase is 
not solely that of an enzyme which enables the cells in 
the body to synthesise DNA more economically by maximising 
efficient utilisation of endogenous nucleotides which 
arise from nucleic acid degradation or from the diet.
Some indication of a more extensive role may be derived 
from the observation that exogenous thymidine is required
in certain cell lines and in some freshly explanted 
cells when the medium folate concentration is 
comparable to that of serum (Taylor-Papadimitriou 
and Rozengurt, 1979), It was also demonstrated that 
the growth stimulating effect of 'feeder cells' is 
partly due to their supplying exogenous thymidine.
The culture medium used in these experiments was 
medium 199 which has a folate concentration of 0.01 mg/1 
compared with MEM which has a folate concentration of 
1.0 mg/1.
The importance of thymidine kinase, other than as a means
for the incorporation of ( H)-thymidine to measure DNA
synthesis, has been considered because it is realised
that salvage thymidylate synthesis competes with de
novo thymidylate synthesis and therefore that the
relative contribution of each pathway to total
thymidylate synthesis must be considered in experiments
q
in which the incorporation of ( H)-thymidine is used 
to measure DNA synthesis. This is particularly relevant 
when the possible effect of a folate or vitamin Bg 
deficiency on the de novo pathway of thymidylate 
synthesis is considered.
In bacteria and higher organisms de novo synthesis of 
DNA thymine proceeds by méthylation of the uracil 
derivative, dUMP. This reaction requires the enzyme 
thymidylate synthetase and the methyl group is supplied 
by the folate coenzyme (5, 10) methylene tetrahydrofolate 
(5, 10 MeH^F). The methyl group of this folate
compound is derived from precursors such as formate,
formaldehyde or the hydroxymethyl group of serine.
The relative contribution of each of these precursors
is not known either under normal conditions or under
vitamin Bg deficient conditions. However, certain
observations noted by Blakley (1969) are relevant.
He reports that cells of E Coll growing exponentially
in a simple synthetic medium derive the methyl group
of thymine exclusively from carbon-3 of serine when
this compound is supplied in the absence of other
14extracellular supplements. When 3-( C)-serine or 
2-(^^C)-serine or 2-(^^C)-glycine is administered to 
rats, there is extensive incorporation of labelled 
carbon into the methyl group of DNA thymine and this 
incorporation does not involve formate or formyl 
derivatives as obligatory intermediates, Formate and 
formaldehyde have also been shown to be precursors of 
thymine methyl in rats, rabbit bone marrow in vitro 
and Ehrlich ascites cell in culture.
Although formaldehyde is formed by the oxidation of 
sarcosine and dimethylglycine in liver preparations 
and formate can arise from the thioclastic fission of 
pyruvate (Blakley, 1969), neither can be regarded as 
major metabolites and so it is likely that the major 
physiological source of the thymine methyl group is 
the 3-C of serine. As the formation of 5, 10 methylene 
H^F from serine requires the pyridoxal phosphate 
dependent enzyme serine hydroxymethyltransferase and the 
formation of 5, 10 methylene H^F is crucial to de novo
thymidylate synthesis, it is possible that the activity 
of this enzyme and hence DNA synthesis would be 
specifically reduced by vitamin Bg deficiency.
The significance of the enzyme serine hydroxymethyl- 
transferase is further illustrated by the observation 
that during the log phase of growth of human fibroblast 
cells in culture it was shown that the specific activity 
of each of the enzymes dihydrofolate reductase, serine 
hydroxymethyltransferase and thymidylate synthetase 
rose by a factor of 20, 4 and 2 (Rosenblatt and Erbe, 
1973). The implication being that these enzymes form 
a cycle supplying methyl groups for de novo thymidylate 
synthesis. Serine hydroxymethyltransferase was also 
found to be present in non stimulated human lymphocytes 
and its activity in these cells rose several fold
following PHA stimulation (Haurani and Masse, 1977),
14 . 14and, when 3-( C)-serine and ( C) formate were used as
precursors for DNA thymine in PHA stimulated human
lymphocytes it was found that changes in the uptake of
each label were similar in magnitude and occurred at
the same time (Wolberg, 1971).
1.4.5. Effects of Vitamin Deficiency
In stimulated lymphocytes, or bone marrow cells, of
patients with megaloblastic anaemia due to folate or
3vitamin B^^ deficiency, there is an increase in ( H) TdR 
incorporation into DNA compared with corresponding cells 
of these patients treated with the appropriate vitamins 
either in vivo or in vitro (Das and Hoffbrand, 1970).
From experiments carried out on isolated nuclei, 
it was shown that this increase was not just the result 
of an increased specific radioactivity of the dTTP pool 
due to inhibition of de novo thymidylate synthesis 
and an increase in thymidine kinase activity but was 
also partly due to a real increase in DNA synthesis 
(Hooton and Hoffbrand, 1977),
When deoxyuridine is added to normal PHA stimulated
3lymphocyte cultures prior to incubation with ( H)-TdR
3it is found that incorporation of ( H)-TdR into DNA
is reduced, or suppressed, to less than 10% of that in
comparable control experiments. However, when UdR
is added to PHA stimulated lymphocyte cultures dervied
from patients with folate or vitamin B12 deficiency,
3this UdR suppression of ( H)-TdR incorporation is less 
marked (Das and Hoffbrand, 1970).
Although a precise biochemical basis for this phenomenon 
has not been described, it has been utilised as the 
basis of a clinical test for determination of vitamin 
B^2 folate deficiency (Herbert et al, 1973).
The most commonly cited explanation of this UdR
suppression effect is that, under normal conditions,
addition of UdR stimulates synthesis of dTMP and hence
dTDP and dTTP. The consequent increase in dTTP levels
resulting in allosteric inhibition of thymidine kinase,
the enzyme responsible for salvage synthesis of
3thymidylate and hence incorporation of ( H)-TdR 
(Herbert and Das, 1976). However, in the presence of 
a folate deficiency, or a vitamin B^^ deficiency leading 
to a folate deficiency, it is believed that the 
efficiency of the de novo pathway is reduced such that 
addition of UdR fails to stimulate dTMP synthesis to 
the same extent as in normal circumstances and consequently 
allosteric inhibition of thymidine kinase is reduced 
and ( H)-TdR incorporation is suppressed to a lesser 
extent (Herbert and Das, 1976). Thus a difference in the 
UdR suppression effect was related to differences in the 
efficiency of the de novo pathway caused by variation 
in folate coenzyme status.
Despite the uncertainty surrounding the biochemical basis 
of this test its use was justified on the basis that it 
did discriminate between vitamin sufficiency/deficiency 
on a functional basis and gave similar results to other 
tests which were more invasive, more indirect and less
convenient (Wickramasinghe and Longland, 1974). 
Interest in the possible occurrence of a vitamin 6
deficiency in alcoholic liver disease and in the 
hypothesis that such a deficiency would be expressed 
primarily through an effect on cellular DNA synthesis 
led to an examination of how such an effect might be 
mediated. From a consideration of known metabolic 
pathways of deoxyribonucleotide synthesis and 
particularly of thymidylate synthesis it was apparent 
that the pyridoxal phosphate dependent enzyme, 
serine hydroxymethyltransferase might represent 
a limiting metabolic block in a vitamin Bg deficiency 
state. The central role of this enzyme in the supply 
of active folate coenzymes for the de novo thymidylate 
pathway is apparent from fig. 4.
If a vitamin Bg deficiency did occur and was mediated 
through an effect on serine hydroxymethyltransferase 
it would most likely be expressed as a folate 
deficiency and would result in alteration of UdR 
suppression characteristics similar to that of an a 
priori folate deficiency. Thus it was hoped to be 
able to extend the use of the UdR suppression test for 
determination of folate and vitamin B^^ deficiency 
to the study of vitamin Bg deficiency.
Acceptance of the validity of the UdR suppression test 
has been restricted by several observations which do 
not appear to be compatible with the concept of a 
stimulus in de novo thymidylate synthesis leading to
allosteric inhibition of thymidine kinase. For example,
no consistent rise in dTTP concentration was observed
in normal cells after exposure to deoxyuridine
(Ganeshaguru and Hoffbrand, 1978) and, the addition of
non radioactive TdR failed to decrease the incorporation 
3of ( H)-UdR into DNA of normal bone marrow cells (Beck,
197 5). However, in other experiments, non radioactive
3TdR decreased the incorporation of ( H)-UdR into DNA
of PHA stimulated lymphocytes by more than 98% and it
has been suggested that this discrepancy reflects the
minor role of the salvage pathway in normal cells (Herbert
and Das, 1976; Herbert and Das, 1979). It has also been
shown that radioactive deoxyuridine is actively
incorporated into DNA by normal bone marrow cells and
that this process is inhibited in megaloblastic bone
marrow cells (Metz et al, 1968; Ganeshaguru and Hoffbrand,
1978). The observation that increasing concentrations
of added thymidine caused progressive inhibition of
3subsequently added ( H)-UdR incorporation into DNA
(Herbert and Das, 1979 )( without inhibition of DNA
3synthesis, because decreasing ( H)-UdR incorporation
14was paralleled by increasing incorporation of ( C)-TdR 
into DNA) was considered to demonstrate reciprocity of 
the salvage and de novo pathways of DNA-thymine synthesis 
with control being mediated by dTTP, the common end 
product of both pathways, via feedback inhibition 
(Herbert and Das, 1976).
The fact that no consistent hypothesis has been 
established indicates that there has been a lack 
of full appreciation of the factors involved, e.g., 
cell type, medium folate concentration and the 
absolute rate of DNA synthesis. In addition, other 
possibilities such as increased degradation of 
thymidine and competitive substrate inhibition of 
thymidine kinase by deoxyuridine do not appear to 
have been fully considered.
The effects of a folate deficiency can also be produced 
using the inhibitors methotrexate and 5-fluorouracil.
As in the case of folate deficiency, interruption of 
the flow of thymidylate by methotrexate (see fig. 4)
Q
has been shown to cause an increase in ( H)-TdR
q
incorporation and of ( H)-TTP incorporation in isolated 
nuclei (Hooton and Hoffbrand, 1977) and radioactive 
deoxyuridine incorporation into DNA is inhibited by 
methotrexate in PHA stimulated normal human lymphocytes 
(Hoffbrand et al, 1973), In human tumour tissue in 
vitro, 5-fluorouracil was shown to cause a decrease in 
formate incorporation which was associated with a 
reciprocal increase in thymidine incorporation (Wolberg 
1969) .
The identification of a functional folate deficiency 
in various disease states has also been investigated, 
using non stimulated human lymphocytes, by measurement 
of the incorporation of (^^C)-formate label into 
serine in the presence of excess glycine (Ellegaard 
and Esmann, 1972; Ellegaard and Esmann, 1973).
A functional folate deficiency being diagnosed by a
14decreased rate of ( C)-serine synthesis according
to the following scheme.
PLP
Hj^ P ^ methylene H,,P— —  .. » H^F
+
14 14( C)-formate glycine 3~( ' C)serine
Conceivably this assay system could equally well be 
adapted to investigate the possibility of a functional 
vitamin Bg deficiency. However, in two major respects, 
the stimulated lymphocyte is a more appropriate model. 
Like the normal adult liver, lymphocytes normally 
represent a quiescent cell population (Norman, et al,
1968) hence a vitamin deficiency affecting DNA synthesis 
would not be expressed in such a cell population. 
However, in cells actively synthesising DNA such as 
regenerating liver cells or stimulated lymphocytes a 
vitamin deficiency affecting DNA synthesis could be 
more readily identified. Similarly, the stimulated 
folate deficient lymphocyte has been shown to manifest 
the same biochemical abnormalities as the megaloblastic 
cell (Das and Hoffbrand, 1970) and therefore seems a 
more appropriate cell system for investigation of a 
possible vitamin deficiency in the stressed alcohol 
diseased liver. Furthermore, determination of a 
functional parameter of such strategic significance 
as DNA synthesis seems a more valid indicator of vitamin
status than determination of a parameter of more 
limited significance such as amino acid inter­
conversion .
In folate deficient, DNA synthesising, cells, the 
inhibition of the de novo pathway due to the reduced 
supply of active folate coenzyme for thymidylate 
synthetase is likely to result in an adaptive shift 
in the relative utilisation of de novo and salvage 
pathways for dTMP synthesis. Therefore, when (3H)~
TdR incorporation is used to assess the rate of DNA 
synthesis, the apparent rate will be higher than an 
equivalent rate of DNA synthesis under folate sufficient 
conditions. If a vitamin Bg deficiency affected DNA 
synthesis at the level of serine hydroxymethyltrans- 
ferase similar considerations regarding the assessment
Q
of the rate of DNA synthesis using ( H)-TdR under 
vitamin Bg deficient conditions would apply.
A possible approach to determination of the respective 
contributions of the de novo and salvage pathways to 
thymidylate synthesis and hence to determination of the 
actual effect of a Bg or other vitamin deficiency on 
DNA synthesis is to uncouple the de novo contribution 
using aminopterin, methotrexate or 5-fluorouracil or to 
suppress the salvage contribution using deoxyuridine. 
Aminopterin and methotrexate are folate analogues 
which effectively block all reactions involving the 
enzyme dihydrofolate reductase (Blakley, 1969 ; Paul,
197 5). This enzyme is involved in the regeneration
of H^F and hence 5, 10 methylene H^F which is the 
coenzyme employed by thymidylate synthetase in the 
méthylation of dUMP to form dTMP. The concerted 
operation of dihydrofolate reductase, serine hydroxy­
methyltransf erase and thymidylate synthetase as a cycle 
producing folates for pyrimidine synthesis is indicated 
by the co-increase of these enzymes in the log phase 
of the culture cycle of human fibroblasts (Rossenblatt 
and Erbe, 1973). It may also be deduced from the 
observation that whereas dTMP synthesis in the 
presence of excess H|^ F is unaffected by aminopterin, 
synthesis in the presence of a catalytic amount of 
H^F and a supply of NADH is greatly decreased by 
aminopterin due to inhibition of the aminopterin 
sensitive enzyme dihydrofolate reductase (Blakely,
1969) .
In the presence of this block the cells are made 
dependent on exogenous thymidine and its phosphoryla­
tion by thymidine kinase. Since this enzyme is thought 
to be involved in the control of DNA synthesis 
(Herbert and Das, 1979) and since its activity is 
usually associated with the rate of growth of an 
organism or organ, it is conceivable that thymidine 
incorporation in the presence of aminopterin would 
be a more appropriate index of growth than thymidine 
incorporation alone, where the efficiency of the 
de novo pathway for thymidylate synthesis is affected 
by a Bg or other vitamin deficiency, or excess.
1.4.6. Other Uses of the PHA Stimulated Lymphocyte 
The majority of studies using either PHA stimulated 
peripheral blood lymphocytes or the mixed lymphocyte 
reaction have focused on their immunological 
significance (Leevy et al, 1975 a, b; Robson and 
Schwarz, 1975). Very often these studies have relied 
on the acid insoluble incorporation of labelled 
thymidine to arrive at a stimulation index or an 
index of DNA synthesis (Ling and Kay, 197 5) and the 
possibility that such studies have a widerapplication 
or that the assay system is sometimes inappropriate 
is not always realised. From studies of the 
incorporation of various precursors into DNA-thymine 
or stimulated lymphocytes it has been found that the 
incorporation of labelled thymidine does provide an 
adequate assessment of total precursor incorporation 
(Wolberg, 1971). However, consideration of the 
alternative pathways of DNA thymine synthesis and their 
respective dependence on folate,  ^ and Bg coenzymes 
indicates that the thymidine incorporation index might 
not reflect total DNA synthesis in cells deficient 
in one or more of these coenzymes. Another factor not 
sufficiently appreciated in most studies is that standard 
cell culture medium contains pyridoxine HCl or pyridoxal 
HCl and hence would be expected to correct any pre­
existing Bg deficiency and so confound observations 
based on Bg status.
When previous work relating to vitamin Bg deficiency 
and lymphocyte stimulation was surveyed, certain 
inconsistent observations and anomalous results 
became apparent. Herbert et al (1973) detailed the 
analysis of an alcoholic patient (representative of 
a particular group of such patients) whose serum 
levels of vitamin B^^ folate were not unequivocally
low yet whose bone marrow showed megaloblastic change 
and whose UdR suppression test was abnormal. In 
addition this test was markedly corrected by in vitro 
addition of vitamin B^2* These observations indicated 
that the patient had true tissue vitamin B^2 deficiency 
despite normal serum B^2 folate levels. The authors 
suggested that the serum vitamin elevation in the face 
of tissue deficit was brought about by release into 
the serum of abnormal vitamin binding proteins from 
the damaged liver and that this abnormal binding reduced 
the availability of vitamin for normal cellular 
metabolism (Herbert and Tisman, 1975). While this 
hypothesis may be correct, the data is also consistent 
with a vitamin Bg deficiency in these patients. The 
fact that an abnormal UdR suppression test was corrected 
by in vitro addition of vitamin B^g Is not necessarily 
in conflict with this latter hypothesis as additional 
vitamin B^2 might well be expected to cryptically 
correct a vitamin Bg deficiency.
The effect of vitamin Bg deficiency on cellular immunity 
has been investigated in rats (Robson and Schwarz, 197 5)
The method used was to measure the incorporation of 
3( H)“TdR in the mixed lymphocyte reaction. The
reduced incorporation in the reaction between thoracic
duct lymphocytes of Bg deficient rats compared with
that of normal rats indicated that B„ deficient ratsb
had a reduced cell-mediated immune response. While
the overall conclusion may be correct, and is
consistent with in vivo correlates of lymphocyte
function, consideration of the known involvement
of PLP in de novo thymidylate synthesis indicates
that it would be inappropriate to rely solely on 
3 .( H)-TdR incorporation via the salvage pathway to 
assess the immune response. Axelrod (1971), also 
from animal studies, concluded that a vitamin Eg 
deficiency resulted in a marked reduction in the 
production of antibody-forming cells following 
antigenic stimulation and that this was secondary to 
a restriction of nucleic acid synthesis due to a 
reduced supply of units from serine.
In studies of alcoholic liver disease patients, Leevy 
et al (1975), assessed cell mediated lymphocyte 
reactivity at different stages of the disease process 
and found only slight differences. However, Lundy 
et al (197 5), reported an impaired immunologic status 
in alcoholic patients which was reflected in a reduced 
response of lymphocytes of alcoholics to PHA stimulation
q
Both studies used ( H)-TdR incorporation to determine 
reactivity or stimulation and the possible effect of 
specific vitamin deficiencies on this test method do
not appear to have been considered.
1.4.7. Principal Objectives of Study 
From a consideration of alcoholic liver disease, the 
metabolism of ethanol, other contributory factors and 
of possible approaches to a more precise elucidation 
of the role of these factors, it was decided to adopt 
a novel approach. This novel approach utilised the 
phenomenon of PHA stimulation of lymphocytes and it was 
hoped that lymphocytes of alcoholic liver disease 
subjects, thus stressed, might reflect, to a certain 
extent, changes in the alcoholic liver. The role of 
one possibly significant factor, vitamin Bg deficiency, 
was of particular interest because of its potentially 
crucial role in nucleic acid biosynthesis. The occurrence 
of a relative Bg deficiency in the alcoholic liver disease 
population had been determined from measurement of serum 
levels of Bg coenzymes but such methods were not completely 
reliable and it was not possible to attribute a functional 
defect to this postulated Bg deficiency.
Because lymphocyte PHA responsiveness is reduced in 
disease and in alcoholic liver disease and is also very 
variable between individuals, experiments were carried 
out with an internal control, where lymphocyte response 
to culture in different conditions, essentially Bg 
sufficient or Bg deficient, was assessed. Although 
vitamin Bg is important in a number of areas of metabolism, 
by analogy with the effect of a folate deficiency, it 
was thought that a particularly susceptible enzyme would 
be serine hydroxymethyltransferase ; a reduction in the
activity of which would result in a cryptic folate 
deficiency. Therefore, various experiments were 
designed to determine such an effect.
As the reported Bg deficiency of alcoholics is relative
rather than absolute, as there are no clearly defined
symptoms which can be specifically attributed to
vitamin Bg deficiency and since the alcoholic population
is so heterogeneous with respect to period and extent of
alcohol abuse, diet and other effector variables,
a test system was also sought whereby an unequivocal
absolute vitamin Bg deficiency could be investigated.
Two methods were used to achieve such a result, one
was to feed rats a vitamin B„ deficient diet and theb
other was to use the vitamin Bg inhibitor 4-deoxypyri- 
doxine.
The final objective of this study was to determine the 
effect of vitamin Bg deficiency on aspects of cellular 
metabolism other than thymidylate synthesis. For 
example, vitamin Bg coenzymes are essential for the 
interconversion of and the biosynthesis of certain amino 
acids and it is possible that limitation of growth and 
regeneration could occur at the level of protein synthesis 
rather than nucleic acid synthesis, though one might 
expect this only to occur as a result of combined vitamin 
and protein malnutrition. Similar considerations could 
apply to a vitamin Bg deficiency affecting purine 
synthesis, porphyrin synthesis or lipid synthesis.
The principal objectives of this study then were to 
determine the occurrence and the effect of vitamin 
Bg deficiency in alcoholic liver disease and to 
determine the effect of vitamin Bg deficiency on 
certain aspects of cellular metabolism.
CHAPTER 2
MATERIALS AND METHODS
Section 2.1.
Materials
2.1.1. Experimental Subjects
Three groups of subjects were investigated in this
study. The clinical, biochemical and histological
characteristics of each of these groups were as follows.
Alcoholic Liver Disease Group
1. Several years' history of excessive alcohol 
consumption. Histories of alcoholics' alcohol 
consumption are known to be unreliable (Brunt et al, 
1974) . This means that it is impossible to obtain 
accurate estimates of alcohol consumption. Neverthe­
less, it is usually possible to establish an 
approximate history of excessive consumption, e.g., 
more than 8 0g of ethanol per day for a period of 
four years.
2. Marked hepatomegaly.
3. Histological evidence of fatty change, alcoholic 
hepatitis or cirrhosis.
4. Abnormally high serum transaminase levels, i.e., AST 
and ALT levels greater than 40 Î.U. per litre.
Alcoholic Non-Liver Disease Group
1. Several years' history of excessive alcohol consumption
2. Where a liver biopsy was carried out, no evidence 
of fatty change, alcoholic hepatitis or cirrhosis.
3. None or only slight hepatomegaly.
4. Normal or only slightly raised serum transaminase 
levels, i.e., AST and ALT levels less than 40 I.U. 
per litre.
Control Group
Members of this group included both hospital patient 
and hospital staff volunteers with no evidence of 
excessive alcohol consumption or vitamin deficiency 
associated disease. The clinical diagnoses of the 
patients in this group included: chronic obstructive 
airways disease, nervous dyspepsia, abdominal pain, 
gastric ulcer, nephrotic syndrome, hiatus hernia and 
irritable bowel syndrome.
General exclusion criteria for all groups were: prior 
treatment with vitamin supplements, evidence of recent 
myocardial infarction, primary biliary cirrhosis, 
cryptogenic cirrhosis, gastric or bronchial carcinoma 
and age less than 21 years. The clinical decisions 
concerning diagnosis of alcoholic liver disease, 
requirement for liver biopsy and diagnosis of alcoholic 
non-liver disease, etc., were made by Dr. A.D. Beattie, 
or other member of the hospital medical staff.
2.1.2. Cell Culture Media, Materials
Gibco Bio-Cult Ltd., Paisley
a) Modified MEM (1)
Minimal Essential Medium, with Hanks’ Salts 
with L-Glutamine without Pyridoxal HCl.
b) Modified MEM (2)
Minimal Essential Medium, with Hanks' Salts, with 
L-Glutamine without Pyridoxal HCl and with a 
folate concentration of 0.01 mg/1.
G) Complete Medium
MEM - Minimal Essential Medium with Hanks' Salts, 
with L-Glutamine.
d) Balanced Salt Solution
HBSS, Hanks' Balanced Salt Solution (lOX)
e) Amino Acid Concentrates
MEM Amino acids solution (BOX) with L-Glutamine 
MEM Non essential amino acids (lOOX)
f) Vitamin Concentrates
MEM Vitamins Solution (lOOX)
g) Antibiotic-antimycotic Solution (lOOX)
h) Sodium Bicarbonate Solution (NaHCOg) 7.5%
i) Folic Acid
j) Pyridoxal HCl
k) Phytohemagglutinin (M Form) Lyophilised 
1) Tubes for Lymphocyte Culture (38 x 12.5 mm)
Evans Medical Ltd., Speke, Liverpool 
Heparin, preservative free (1000 units/ml)
2.1.3. Chemicals, Biochemicals and Miscellaneous Items
Sigma Chemical Co. Ltd., Poole, Dorset, U.K.
Aminopterin (4-aminofolic acid; 4 aminopteroyl 
glutamic acid)
Bovine Serum Albumin
2 - deoxyuridine
4 - deoxypyridoxine HCl
5-fluorouracil
formic acid
histopaque
trypan blue
tyrosine apodecarboxylase 
isonicotinic acid hydrazide (ISONIAZID) 
hemin (Bovine, Type 1)
deoxyribonucleic acid, sodium salt Type III from 
Salmon testis
Vestric, Alma Street, Glasgow 
Sodium Metrizoate Sol'n (3 2,8% w/v)
Pharmacia Fine Chemicals, AB - Uppsala, Sweden 
Ficoll 400
Millipore U.K. Ltd., London 
Swinnex filters (0.22 um)
Millex sterile disposable filter units. (0.22 um)
BP Nutrition (UK) Limited, Stepfield, Witham, Essex 
Pyridoxine deficient rat diet
Sterilin Ltd., Teddington, Middlesex 
Universal containers (30 ml)
disposable test tubes (10 ml) round base with stoppers
disposable test tubes (12 ml) conical base with stoppers 
(sterile)
plastic insert vials 
Boehringer Mannheim GMBH
UV text kits for GOT (aspartate aminotransferase) and 
GPT (alanine aminotransferase)
Lederle Laboratories, Gosport, Hampshire 
methotrexate sodium
BDH Chemicals Ltd., Poole, Dorset
toluene (scintillation grade)
POPOP-2, 5-diphenyloxazole
Glaxo Laboratories Limited, Greenford, Middlesex 
streptomycin sulphate 
benzyl-penicillin
Packard Instrument Ltd., Caversham, Berks.
Insta-gel
Polyethylene Scintillation Counting Vials 
hyamine hydroxide
Miles Laboratories Ltd., Slough, England 
Alpha-l-antitrypsin test kit
All other materials and reagents used were of the 
appropriate grade as supplied by BDH Chemicals Ltd., 
Sigma Chemical Co. Ltd., the Department of Haematology,
S.G.H., or the Pharmacy, S.G.H.
2.1.4. Radiochemicals
All radiochemicals used in the present study were obtained 
from the Radiochemical Centre, Amersham, Bucks.
5_^125^) - 2 - deoxyuridine 5Ci/mg, 0. 5-1. OrnCi/ml
1 4L-(3- C) serine 56mCi/m mol 50Ci/ml
14( C) formic acid, sodium salt 60.3mCi/m mol solid
14L-(U- C) leucine 339mCi/m mol 50Cx/ml
(methyl- H) thymidine 24Ci/m mol l.OmCi/ml
57Cyano( Co) cobalamin 180-300 uCi/ng lOuCi/ml
14L-(carboxyl- C)-tyrosine 59mCi/mmol solid
3 / .
Section 2.2
Methods
2.2.1. Determination of Leucocyte and Serum
Ascorbic Acid
The method used was based on that deseribed by Denson 
and Bowers (1961).
Sample Preparation
a) Leucocytes
4 ml venous blood was added to 12.5 ml of diluent (0.9% 
NaCl5 6% dextran, 10% EDTA; 100: 25 : 1). The diluent 
blood was left to stand for 3 0 min., during which time 
the majority of the red cells sedimented by gravity.
The supernatant, containing the leucocytes was then 
removed by pasteur pipette and mixed. A 0.0 8 ml sample 
was removed and added to 2 0 ml Isoton. After addition 
of 8 drops dilute Zaponin (1:9, Isoton) the leucocyte 
cell concentration of the supernatant was determined 
using a Coulter, model D, electronic cell counter.
10 ml supernatant was then centrifuged (800 g , 15 min).
The resulting supernatant was then discarded and the 
leucocyte cell pellet ground with 1.3 ml 5% TCA.
After centrifuging (800 g , 10 min), 1 ml of the acid 
supernatant was retained for ascorbic acid assay.
b) Serum
2 ml of 5% TCA was added to 1 ml of serum and centrifuged 
(800 g , 10 min). Two 1 ml samples of the acid supernatant 
were retained for ascorbic acid assay.
Ascorbic Acid Assay
0.3 ml of reagent dye (2.2% 2, 4 di-nitro phenyl 
hydrazine in 10 N H^SOj^, 5% thiourea and 6% cupric 
sulphate (Cu SO^. SHgO), 100:5:5) was added to 1 ml of 
sample and incubated in a water bath at 36°C for 4 
hours. After cooling in ice water and addition of
1.5 ml 65% HgSO^ in ice water, each reagent sample 
was read against a similarly treated reagent blank 
(1 ml 5% TCA) at 520 nm on an S P 600 spectrophotometer.
A standard curve was drawn using the spectrophotometer 
readings from similarly treated 0.5, 1.0, 2.0, 5.0,
10.0, 15.0 and 20.0 ug/ml ascorbic acid standard 
solutions in 5% TCA. The ascorbic acid concentrations 
in the leucocyte and serum samples were determined from 
the standard curve. The leucocyte ascorbic acid (LAA) 
was expressed as ug/10^ WBC and the serum ascorbic acid 
as ug/ml serum.
2.2.2. Determination of Serum Pyridoxal-5 -phosphate
The method use was based on that described by Chabner
and Livingstone (1970) and involved determination of
14enzymatic, PLP dependent decarboxylation of l-( C)- 
tyrosine using tyrosine apodecarboxylase.
Preparation of Apoenzyme Solution (Based on method 
described by Lumeng and Li (1974) )
Tyrosine apodecarboxylase solution, 2 50 ml, was 
prepared by mixing:
60 ml (24%) glycerol 
3 5 ul 2mM mercaptoethanol
6 2.5 mg tyrosine apodecarboxylase
and 0.3 M sodium citrate buffer pH 6.0 to 250 ml.
7 ml samples were stored at -20°C.
Sample Preparation
Deproteinised serum samples were prepared by mixing 
0.1 ml 5 0% TCA with 1.0 ml serum and centrifuging 
(800 g, 15 min). The deproteinised serum supernatant 
was neutralized (pH 6-7) with 4.5 N NaOH (0.02 ~
0.025 ml).
Assay
The PLP dependent decarboxylation was carried out in
a 30 ml glass universal vial in a shaking water bath
at 32°C. Reactions were initiated by injection of 
14200 ul of l-( C)-tyrosine solution (final concentration,
5 mM sp.act 2 0 uCi/mmol) to a 15 min. pre-incubated
vial containing 1.0 ml sodium citrate buffer pH 6.0,
200 ul apoenzyme solution and 200 ul deproteinised
serum or standard PLP solution. Eaeh vial also contained
a scintillation counter minivial holding 0.2 ml Hyamine OH
Reactions were terminated after 15 min. by injection of
1 ml 5 M HCl. After a further 15 min. incubation,
5 ml of toluene scintillant was added to each minivial 
14and C activity counted.
Specimens and reactants were protected from exposure 
to light in order to avoid photolysis of PLP. All
assays were performed in duplicate. Recovery of
added PLP was 9 0 - 8.5%. Reproducibility was - 4.7%.
The concentration of standard pyridoxal phosphate 
solutions was determined by absorbance at 38 8 nm
(Peterson and Sober, 1954).
2.2.3. Determination of Serum AST and ALT Activity 
in the Presence and Absence of Added PLP
Two 0.5 ml serum samples from alcoholic liver disease 
subjects were prepared. To one 0.5 ml sample, 0.5 ml 
phosphate buffer (100 mmol/1, pH 7.4) was added and to 
the second 0.5 ml sample, 0.5 ml phosphate buffer 
(100 mmol/1, pH 7.4) containing PLP (5 mg/1) was added. 
The serum samples were then incubated in the dark at 
room temperature for 3 0 min. prior to duplicate 
determination of AST or ALT activity according to the 
test kit manufacturer's recommended method (Boehringer 
Mannheim UV Test Kits for GOT and GPT).
2.2.4. Determination of Acetylator Status
The method used was based on that described by Rao 
et al (197 0) and involved administration of a 1.0 g 
oral dose of sulphadimidine to each subject followed 
by assay of free and total sulphonamide in a 5 ~ 6 hour 
post-dose urine sample. Sulphadimidine was supplied 
by the hospital pharmacy. The method of estimation of 
free and total sulphadimidine was based on the Bratton 
and Marshall technique (Varley, 1962) and the acetylated 
sulphadimidine (total-free) was expressed as a 
percentage of the total sulphadimidine. Classification
of acetylator status was based on Rao's finding
that in slow acetylators, the proportion of acetylated
sulphadimidine in urine samples was less than 7 0%.
The sulphadimidine estimation technique was based on 
diazotisation of sulphadimidine in urine followed by 
coupling with N-(1-napthyl) ethylene-diamine dihydro­
chloride and spectrophotometric estimation of the 
product.
Determination of Total Sulphonamide
2 5 ul of the 5 - 6  hour urine sample was mixed with
3 ml HgO, 1 ml 20% TCA and 0.5 ml 5 M HCl. After 
heating (lOO^C, 1 h), cooling, mixing with 0.1 ml
0.2% sodium nitrite, leaving to stand for 3 min., 
mixing with 0.1 ml 0.5 M ammonium sulphamate leaving to 
stand for 2 min., mixing with 0.5 ml 0.0 5% N(1-napthyl) 
ethylenediamine dihydrochloride, and leaving to stand 
for 10 min., the optical density of the solution at 
540 nm was determined. For determination of free 
sulphonamide, heating with HCl (lOO^C, 1 hour) was 
omitted. The sulphonamide concentration was calculated 
by comparison with a similarly treated, standard 
sulphadiazine solution. Estimations were carried out 
in duplicate.and the mean value was used to calculate 
results.
2.2.5. Determination of Serum Alpha-1-Antitrypsin 
The method used, radial immunodiffusion, was based 
on that described by Mancini, Carbonara and Heremans 
(1965) as modified in the commercial kit supplied 
by Miles Labs.
The principle of radial immunodiffusion is that a 
soluble antigen, when placed into a round cylindrical 
well cut into an agar gel, will radially diffuse into 
the gel at a speed which is determined by many factors 
including the size of the molecule, the concentration 
of agar in the gel and the temperature of incubation.
If monospecific, high titred antibody has been incorpor­
ated uniformly into the gel, immune precipitation will 
occur as the antigen and antibody reach equilibrium.
The end point is reached when all of the antigen has 
reacted with the available antibody. The result is 
the formation of a precipitation ring around the antigen 
well which can be visualised and whose diameter can 
be easily measured. Since the diameter of this ring 
is directly proportional to the antigen concentration, 
a standard curve of diameter versus antigen concentration 
can be plotted using a series of reference standards of 
known antigen concentration. Measurement of the ring 
diameter produced by an unknown serum sample will allow 
the direct determination of antigen, and hence alpha-1- 
antitrypsin concentration, from the standard curve.
The immunodiffusion plates used in this method consisted 
of plastic dishes containing a monospecific alpha 1- 
antitrypsin antiserum incorporated into a layer of agar. 
The serum alpha 1-antitrypsin assay involved pipetting 
5.0 ul of each serum sample or alpha 1-antitrypsin 
reference standards into wells cut in the agar layer.
After incubating at room temperature for 18 hours the 
ring diameter of each of the serum samples and reference 
standards was measured. The ring diameters of the 
five reference standards ranging from 27 to 330 mg/100 ml 
were then plotted on semilogarithmic graph paper and 
the alpha 1-antitrypsin concentration of each serum sample 
determined from the standard curve. Although measurement 
of alpha-1 antitrypsin may be accomplished by functional
i.e., anti-protease assays, immunochemical measurement 
such as radial immunodiffusion is the most specific 
approach.
2.2.6. Determination of Unsaturated Serum Vitamin
Binding Capacity 
The method used was that described by Gottlieb et al 
(1965) and is based on the finding that charcoal 
pre-coated with a large molecule can adsorb only free 
^12’ whereas uncoated charcoal can adsorb both free B^^ 
and B^2 bound to a large molecule.
Assay of unsaturated binding capacity of serum
(UBBC) involved sequential addition of 0.5 ml unknown 
serum sample and 2.5 ng (^^Q ) labelled B^g to a 10 ml 
plastic test tube containing 2 ml 0.9% NaCl, mixing 
for 10 sec and adding 2 ml albumin coated charcoal
for 10 sec and adding 2 ml albumin coated charcoal 
suspension. This was prepared by mixing equal volumes 
of 5% aqueous suspension of Norit ’A ’ charcoal and a 
1% aqueous solution of bovine serum albumin (BSA).
The short incubation period of serum and  ^ alone 
reduces equilibrium between native and added B^^'
After centrifugation of the charcoal mixture the radio­
activity of the supernatant was counted in a gamma 
scintillation counter.
This procedure was repeated once with omission of serum 
and once with the omission of albumin coated charcoal.
The minus serum control determined the background 
radioactivity count and this was subtracted from all 
other determinations. The minus coated charcoal control 
determined the radioactivity equivalent to 2.5 ng B^2 
and allowed calculation of the UBBC of the unknown serum 
sample (pg/ml)i.e., that quantity of B^g prevented from 
adsorbing to charcoal by the serum. All determinations 
were carried out in duplicate.
2.2.7. Determination of Serum Transcobalamin Levels 
The method used; differential precipitation of serum 
transcobalamins by ammonium sulphate, is based on that 
described by Carmel (1974). Serum (0.5 ml), was 
incubated with 0.1 ml ( ^ "^Co)-labelled-B^ 2 (20 ng/ml) 
and 1.4 ml potassium phosphate buffer (0.4M, pH 6.3) 
for 3 0 min., prior to addition to the pellet of 1 ml 
albumin coated charcoal. After mixing and centrifugation 
(15 min., 800 g) the supernatant was added to tubes
containing 4 ml, 3M ammonium sulphate. After a second 
incubation (30 min) and centrifugation (15 min., 800g) 
the supernatant was decanted into a separate tube.
The radioactivity in the supernatant and precipitate 
was then determined in a gamma scintillation counter. 
Background adsorption was determined by repeating 
this procedure with omission of serum and, after the 
appropriate correction, the radioactive counts were 
converted to pg/ml by comparison to a known standard, 
tubes to which no coated charcoal was added. All 
determinations were carried out in duplicate. The 
precipitated transcobalamin was transcobalamin II and 
the supernatant contained the R, B^2 binders, 
transcobalamins I and III.
2.2.8. Determination of Antipyrine tg
The method used was based on that described by Beattie 
and Sherlock (1976). Each subject received 1.2 g 
antipyrine orally and blood samples were taken at 0, 
0.5, 2, 5, 8, 12 and 24 hours. Serum antipyrine 
concentration was measured by the method of Brodie 
et al (1949). From these estimations, the tj was 
determined by regression analysis.
2.2.9 Preparation of Liver Cell Suspension 
Preparation and Incubation
Healthy young male rats killed by a blow to the head 
were used. Sections of liver (50 mg) were removed 
and placed in dissection medium (balanced salt 
solution with added penicillin 1000 units/ml and 
streptomycin 1000 ug/ml). In sterile conditions, 
the liver sections were cut into fine, 1 mm cubes. 
After rinsing three times with dissection medium 
the pieces of liver were resuspended in 5 ml Hams 
FI0 medium containing 1000 units/ml collagenase and 
incubated with gentle shaking for 3 0 min., 37°C in 
a universal container. After centrifugation (100 g , 
2 min) the pellet was resuspended in 10 ml Hams FIO 
medium with added fetal calf serum (20%), glutamine 
(1%), penicillin (100 units/ml) and streptomycin 
(100 ug/ml). Fragments were allowed to settle, 6 ml 
supernatant was collected, placed in a separate glass
3
universal vial containing 30 ul ( H)-TdR (5 uCi/ml)
and incubated with gentle shaking for up to 2 hours 
at 37°C. Samples 2 x 1 ml were collected at 30 min 
6 0 min and 2 hours and placed in ice.
Processing of Samples
0.2 ml volumes of the incubated samples and 0.2 ml 
volumes of 1:1, 1:2, 1:4 and 1:8 diluted samples were 
cytocentrifuged, and the slide preparations were dried 
rapidly in air and fixed in methanol for 10 min. After 
further fan assisted drying, the slides were examined 
using phase contrast microscopy to determine the most
appropriate dilution. These slides were then washed, 
three times with 10% ice-cold TCA and with ice cold 
water, rinsed with methanol, dried and stored dry at 
4°C.
2.2.10. Autoradiography
The principle of this technique is that radioactive 
precursors which have been incorporated into cellular 
nucleic acid may be detected in slide cell preparations 
by overlaying the preparation with a radiosensitive 
emulsion. Beta-particles from radioactive decay of the
3
( H) penetrate the emulsion and when stopped ( 1 um)
give up their energy to form a 'latent image' in the 
silver halide of the emulsion. Subsequent development 
reduces the silver halide to metallic silver where 
latent images have been formed. This produces a black 
dot in transmitted light microscopy, 01 - 0.5 um in 
diameter. The technique therefore involves coating 
with emulsion, exposure, development, fixing, staining, 
and, examination.
In red safelight, the prepared slides were dipped into 
melted emulsion, (prepared by incubation in a water 
bath, (30 min, 45°C), the excess emulsion was drained 
off and the slides allowed to dry. The slides were then 
placed in a light tight box with dessicant and exposed 
for one week at 4°C.
Again in red safelight, the slides were allowed to 
come to room temperature and humidity, then placed 
in Kodak D19, developed for 10 min, washed briefly, 
placed in hypo for 4 min, rinsed and washed for 2 min 
in clearing agent, washed in tap water for 5 min, 
then rinsed in distilled water and allowed to dry.
The slides were stained to 10 min with dilute Giemsa 
stain (1:10), then rinsed in tap water, then distilled 
water, allowed to dry and then examined.
The experiments described in section 2.2.9. and 2.2.10. 
were carried out at the Beatson Institute for Cancer 
Research, Garscube Estate, Glasgow.
2.2.11. Vitamin B  ^ Deficient Rat Studies
Six adult standard laboratory rats (Charles River strain),
three male and three female, were fed the following
pyridoxine deficient diet for a period of six weeks.
Vitamin, fat free casein 22.0%
Sucrose 69.5%
Beef tallow 2.0%
Cod liver oil 2.0%
Salt mix 4 . 0%
Vitamin supplement (Bg free) 0.5%
A further six rats from the same colony, three male and 
three female, were housed in identical conditions and 
were fed a standard laboratory diet. Use of a pyridoxine 
deficient diet to induce a vitamin Bg deficiency state 
was suggested by the work of Ribaya and Gershoff,
(1977); Hunter and Harper, (1977); and Reynolds, (1978).
The animals used in this study were supplied by 
and housed in the animal house of the Institute of 
Neurological Science, Southern General Hospital,
Glasgow.
2.2.12. Collection of Blood Samples for Lymphocyte
Studies
From each subject, 20 ml of venous blood was collected 
aseptically by venepuncture, in a sterile syringe, by 
a member of the medical staff of the Southern General 
Hospital. Of the 20 mis, 10 ml was added to 6 ml ESS 
containing 60 units preservative free heparin and mixed. 
The remaining 10 ml was placed in a sterile glass 
container, allowed to clot, centrifuged (800 g, 15 min) 
and the serum, collected by sterile pasteur pipette, 
retained.
2.2.13. Preparation of a Lymphocyte Suspension 
The isolation method is essentially that of Boyum 
(1968, 1976), who described methods for isolation of 
mononuclear cells from circulating blood and bone marrow 
In general, these procedures employed mixtures of 
polysaccharide (ficoll) and a radiopaque contrast medium 
(sodium metrizoate, adjusted to a density of 1.077 - 
0.001 g/1. This medium allowed the rapid recovery of 
viable lymphocytes from small volumes of blood.
The method involved layering dilute, anticoagulinated 
blood onto the ficoll/sodium metrizoate mixture.
During centrifugation erythrocytes and granulocytes 
are aggregated by ficoll and rapidly sediment; whereas, 
lymphocytes remain at the dilute plasma-ficoll/sodium
diatrizoate interface.
In this study an equivalent ficoll/sodium metrizoate 
solution was used. The composition of this mixture 
was: per 10 0ml; 3 0 ml 3 2.8% w/v sodium metrizoate +
5.6g Ficoll 400 + sterile distilled H^O, and this 
medium was then sterilised by filtration prior to use.
To prepare a lymphocyte suspension, aliquots (8 ml) 
of the whole blood/BSS/heparin mixture were carefully 
layered onto 2 ml of the ficoll/sodium metrizoate 
solution in a sterile centrifuge tube. After 
centrifugation (4 00 g , 30') the upper layer was 
removed and discarded, and the opaque interphase 
layer collected. After pooling the separated lymphocytes 
of individual subjects, the cells were washed twice 
by resuspension in BSS and centrifugation at 8 00 g 
for 15min. After the final wash the cells were re­
suspended in 1.5 ml BSS. This cell suspension was then 
counted using an electronic cell counter (the Coulter 
Counter, Model 4D). This method of cell counting is 
more reproducible and more convenient than the manual 
method using a haemocytometer. A differential white 
cell count, using Leishmans stain, showed that over 
9 5% of this cell suspension consisted of small lymphocytes 
and viability, using trypan blue exclusion, was also 
shown to be over 95%. The method of preparation of 
the lymphocyte suspension is illustrated in fig. 5.
Fig. 5. Preparation of Lymphocyte Suspension
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2.2.1M-. Preparation of Cell culture Media 
Complete MEM (minimal essential medium), with Hanks' 
salts 5 with L-glutamine, was supplied by Gibco.
Prior to initiation of PHA stimulated lymphocyte 
culture, the following additions were made; per 
100 ml medium.
2 ml rehydrated PHA-M (Gibco)
2 ml preservative free heparin, 2000 units (Evans) 
0.1 ml streptomycin sulphate, 10 0 0 jj. g (Glaxo)
0.1 ml benzyl penicillin, 1000 units (Glaxo)
Two types of modified MEM, with Hanks' salts, with 
L-glutamine, were also used (Gibco). The modifications 
to these media from complete MEM, were as follows.
In modified MEM (1) pyridoxal HCl was omitted.
In modified MEM (2) pyridoxal HCl was omitted and 
the folic acid concentration was reduced from 1.0 mg/1 
to 0,01 mg/1. Further modifications to these media 
were as specified in the results section. Prior to 
use in PHA stimulated lymphocyte culture, PHA, heparin, 
streptomycin and penicillin were added, as for 
complete MEM.
Where appropriate for the requirements of particular 
experiments, folate, pyridoxal HCl, H-dPN, INH, non- 
essential amino acids and hemin were added at this stage; 
to complete or modified MEM, to the specified 
concentration. Hemin was dissolved in NaOH and 
sterilised by filtration prior to addition to the 
culture medium. (Freedman, Geraghty and Rosman, 1974).
2.2.15. PHA Stimulated Lymphocyte Culture 
PHA stimulated lymphocyte cultures were initiated as 
follows; to (38 x 12.5 mm) lymphocyte culture tubes 
the following additions were made:
0.8 5 ml MEM: complete, modified or as specified, 
containing PHA, heparin, streptomycin and penicillin
0.1 ml autologous serum
0.02 “ 0.05 ml lymphocyte suspension, containing
2.5 X  10^ cells.
Where variations to this procedure were used, the 
changes are specified in the appropriate results section.
Up to 3 0 PHA stimulated lymphocyte cultures were prepared 
from individual 2 0 ml blood samples, allowing up to 15 
determinations to be made on lymphocyte cultures from 
each subject.
The choice of conditions used in preparation of these PHA 
stimulated lymphocyte cell cultures was partly determined 
by the size of the culture tube, i.e., a total volume 
of 1 ml was required in order to leave a sufficient 
gas phase and the experience of other authors determined 
the most appropriate cell concentration (Dupont, et al, 
1977), The amount of PHA used was based on the supplier's 
recommendation and the use of heparin, streptomycin, 
penicillin and 10% autologous serum was based on the 
recommendations of Ling and Kay (197 5). The preparation
of cell culture media and lymphocyte cultures are 
illustrated in fig. 6.
2.2.16. Determination of Acid-insoluble 
(^^^l)-UdR Incorporation 
In this study, estimates of the rate of DNA synthesis 
in PHA stimulated lymphocyte cultures were required 
both as a measure of the rate of cell growth and in 
order to further characterise aspects of DNA metabolism. 
The use of labelled thymidine as a means of quantitating 
DNA synthesis has been mentioned previously (1.4.4.).
The principle of the use of a labelled precursor to 
follow the synthesis of a macromolecule is that the 
measured radioactivity incorporated into the macro­
molecule is proportional to the rate of synthesis of 
the macromolecule. Since thymidine is a specific 
precursor for DNA synthesis, the rate of incorporation 
of radioactively labelled thymidine has been used as 
an index of the rate of DNA synthesis in growing cells 
(Cleaver, 1967) .
There are, however, several limitations inherent in 
methods which use labelled thymidine incorporation into 
PHA stimulated lymphocytes to quantitate the rate of 
DNA synthesis or degree of stimulation. Even if 
culture conditions are standardised with respect to 
medium, stimulant, duration of culture, temperature, 
pH and 02 tension, and even if the proportion of viable 
cells and cells undergoing stimulation is comparable, 
the fact that incorporation of exogenous labelled 
thymidine is dependent on a variety of factors including
Fig. 6. PHA Stimulated Lymphocyte Culture
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competition between de novo and salvage thymidylate 
pathways, the size of endogenous pools of thymidylate 
precursors as well as the absolute rate of DNA synthesis, 
requires that results of experiments dependent on 
determination of such incorporation be carefully inter­
related.
Ling and Kay (197 5) discuss two factors which affect the 
validity of the assumption that changes in the rates of 
incorporation of precursor into a macromolecule reflect 
changes in the rate of synthesis of that macromolecule.
The first of these is that the amount of unlabelled 
material present in the culture medium competing with 
the labelled precursor for uptake into the cell and 
incorporation into the macromolecule must be constant, 
or any changes in it brought about by stimulation must 
be known. The second is that the rate at which the 
added precursor saturates the pool of nucleotide tri­
phosphates from which nucleic acid is synthesised must 
also be independent of stimulation.
Ideally, the time required for saturation of the 
nucleoside triphosphate pool should be short relative 
to the period of the radioactive pulse and the specific 
activity of the pool should remain constant throughout 
the pulse. Should stimulation prove to affect the rate 
of saturation of the nucleoside triphosphate pool 
significantly, it is extremely difficult to make the 
requisite corrections. These require accurate déterminât' 
ions of the specific activities of the pool throughout
the labelling period, an extremely difficult procedure 
when dealing with the amount of material available 
from lymphocyte cultures. Simple determinations of 
the rate of uptake of the precursor into the pool of 
triphosphates are not adequate. Furthermore, in all 
conditions which deviate from the ideal, the assumption 
that the nucleotide triphosphate pools of all the cells 
in the culture can be treated as non-compartmentalised 
becomes critical. Taheri, Wickremasinghe and 
Hoffbrand (1981) have in fact presented evidence that 
nucleotide pools in PHA stimulated lymphocytes are 
compartmentalised.
In considering the effect of the endogenous pool size 
on the validity of thymidine labelling experiments, 
the pre-existing pool is generally regarded as an 
expandable pool such that addition of a small amount 
of high specific activity precursor will not fully 
expand the pool (Cleaver, 1967). Under these 
conditions most of the thymidine nucleotides entering 
DNA are derived from the endogenous pathway and the 
relative rates of incorporation into DNA by different 
cultures will only indicate the relative rate of DNA 
synthesis if the proportion of nucleotides entering 
DNA derived from the labelled thymidine is constant.
With a long pulse, one can offset the effect of changing 
pool size but the effect of a variable pool size 
complicates interpretation of data based on the changes 
in the incorporation of labelled thymidine and thus 
it is necessary that experiments based on such 
incorporation should include an internal control.
It is relevant to note that Ganeshaguru and Hoffbrand 
(197 8) have presented evidence that the thymidine 
triphosphate pool in PHA stimulated lymphocyte cultures 
derived from folate deficient subjects is not 
significantly different from that observed in normal 
cells.
While there are limitations in the use of radio­
labelled thymidine to assess DNA synthesis, there is 
considerable empirical evidence that the rate of 
thymidine incorporation does correlate quite well 
with other parameters of lymphocyte stimulation, and 
in practice several different methods, e.g.. Ling and 
Kay (1975), Hirschhorn, Hirschhorn and Waithe (1974) 
and Bain (1970), appear to provide a relatively 
reproducible measure of DNA synthesis.
Certain other variables must be considered in the 
interpretation of experiments using PHA stimulated 
lymphocytes and labelled thymidine. It is known that 
the small lymphocyte population is functionally hetero­
genous and that responsiveness to activators may be 
restricted to one or another of functionally defined 
cell types. The interaction of lymphocytes in culture 
and the kinetics of the reaction of activators with 
lymphocyte membranes is complex and poorly understood. 
The degree of reaction of cultures varies with the area 
of the culture surface, the cell concentration, the 
volume of medium and with both the concentration of 
activator and the ratio of activator molecules to cells,
The time of peak response, or of detectable response, 
varies not only with cell type but also with the 
particular activator. In cultures incubated for more 
than two days simultaneous cell death and cell division 
also complicate analysis of the response. Radiation 
effects, réutilisation, low thymidine kinase activity, 
the amount of radioactive label added, the specific 
activity, the presence of cold thymine, exposure time, 
effect of contaminating cells and the fact that 
different cell populations contain different levels 
of thymidine phosphorylase activity which may 
profoundly affect their uptake of labelled thymidine 
(Marsh and Perry, 1964), These considerations emphasise 
the requirement for standardised conditions and the use 
of an internal control.
12 5The use of ( DUdR as an analogue of TdR is discussed
by Cleaver (1967), and its use in PHA stimulated
lymphocyte studies has been validated by Herbert et al
(1973). The TdR analogue properties of (^^^I)-UdR are
attributable to the steric similarity of the iodine
12 5atom and the methyl group of thymidine, ( l)-UdR 
therefore competes with thymidine for uptake and
incorporation into DNA. In tracer studies, the serious
12 5toxicity of internuclear radiation from ( 1) (Hofer
and Hughes, 1971) is a considerable disadvantage, but
this problem is less critical in short-term labelling
of activated lymphocytes (Ford, 1978). The principal
12 5advantages of using a gamma-emitter, ( D-UdR,
rather than a beta-emitting nuclide are that radioactivity
counting characteristics are improved, sample prepa­
ration is simplified and hence determination of 
incorporation much more convenient. An additional
advantage is that because it is released from dead 
12 5cells as ( I), réutilisation is minimal (Ford, 1978)
The method used in this study was based on the work of 
Herbert et al (1973).
At a specified time after initiation of the PHA
12 5Stimulated lymphocyte cell culture, 0.5 uCi of ( I)- 
UdR was added to the appropriate cell culture tubes. 
Following a 3h incubation at 37°C cultures were terminated 
by addition of 1 ml cold saline. After centrifugation 
(800 g, 15'), removal of supernatant, two washes with 
cold 10% TCA and one rinse in HgO, the radioactivity 
of the acid-insoluble residue was determined directly 
by placing the cell culture tubes in a Packard automatic 
gamma scintillation spectrometer. An outline plan of a 
PHA stimulated lymphocyte experiment is illustrated in 
fig. 7., and the details of the cell culture analysis 
are illustrated in fig. 8.
The principal labelling control employed in order to
determine background contamination or the degree of
non-specific incorporation of label was to determine
the radioactivity retained in cell cultures to which
cold saline was added, immediately prior to addition of 
12 5( I)-UdR label. Zero time controls and analysis of 
cultures maintained at 5^C were also carried out.
The radioactivity in these control tubes was found to
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be 5% or less than that of comparable untreated cultures. 
This background activity was subtracted from the 
activity determination of each culture tube. Results 
were calculated from the mean cpm of at least duplicate 
analyses. The standard error of the mean for duplicate 
analyses was usually between 1 and 5%.
2.2.17. Determination of the Effect of UdR, MTX,
5-fu, Formate and 4-dPN on Acid-insoluble (^^^I)-UdR 
Incorporation
In order to determine the effect of prior treatment with 
UdR, MTX 5-fu, formate and 4-dPN on subsequent DNA 
synthesis in PHA stimulated lymphocyte cultures, 
specified amounts of these compounds were added to 
cultures 1 h prior to incubation with radioactive label. 
In control cultures, BSS (50 ul) was added and after 
this preincubation period, determination of DNA synthesis 
was carried out as described for each radioactive label.
2.2.18. Determination of the Effect of Pre-incubation
with MTX and 5-fu on the Subsequent Effect of UdR on
12 5Acid-insoluble ( I)-UdR Incorporation 
In order to determine the effect of addition of MTX 
and 5-fu to PHA stimulated lymphocyte cultures on the 
subsequent effect of preincubation with UdR on DNA 
synthesis, specified amounts of MTX and 5-fu were 
added to cultures 15 min. prior to preincubation 
with UdR. In control cultures, BSS (50 ul) was added 
and after this pre-preincubation period, preincubation 
with UdR and determination of radioactive label
incorporation was carried out as appropriate.
2.2.19. Determination of DNA Synthesis Using
14 1 4 .3-( C)-Serine of ( c)-Formate
There are two pathways for the synthesis of thymidylate 
DNA precursor; the de novo pathway and the salvage 
pathway (fig. 4). It is convenient to make use of 
TdR to label DNA because it is a specific precursor 
of DNA and is not incorporated into either RNA or 
protein. However, it is incorporated via the salvage 
pathway which is probably of lesser physiological 
significance than the de novo pathway. There are a 
number of possible approaches to labelling DNA other 
than making use of TdR but all require some degree of 
separation of DNA from other cellular macromolecules 
before determination of incorporation.
The method chosen in this study of labelling DNA
independently of the salvage pathway, was to use 3-
14 • 14( C)-serine or ( C)-formate. Use of either of these
radioactive precursors is likely to result in labelling
of a wide variety of cellular constituents including:
protein DNA, RNA and lipid. Therefore, determination
of incorporation of radioactive label into DNA requires
preliminary purification of harvested cell cultures.
14The principal route of incorporation of 3-( C)-serine,
and (^^C)-serine and (^^C)-formate label into DNA is via
1 4the carbon-1 (C-l) pool. Entry of 3-( C)-serine label 
into this pool is largely dependent on PLP and the 
serine hydroxymethyltransferase reaction and hence might
be expected to be susceptible to a vitamin Bg
14deficiency. Entry of ( C)-formate label into the 
C-l pool is usually independent of vitamin Bg.
Labelling of the C-l pool results in labelled DNA 
via de novo thymidylate synthesis, via labelling 
of the purine ring at carbons 2 and 8, and also via 
post-synthetic méthylation of specific sites.
The labelling procedure adopted in this study paralleled
that of (^^^I)-UdR labelling. At a specified time after
initiation of the PHA stimulated lymphocyte culture,
14 .0.25uCi L-( 3- C)-serine, specific activity SGm'Ci/mi mol 
14or l.OuCi ( C)-formic acid, specific activity 60.3mCi/
mol, was added to the appropriate cell culture tubes. 
Following a 3 hour incubation at 37^C, cultures were 
terminated by addition of 1 ml cold saline.
After centrifugation (800 g , 15 min.) and removal of 
supernatant, the following DNA purification procedure, 
based on that described by Turnbull and Adams (1976), 
was adopted. The cell pellet was resuspended by mixing 
with 1 ml of a solution containing sodium dodecyl 
sulphate (1%), EDTA (2mM), 4-amino salicyclic acid (3%), 
n-butanol (5%), NaCl (0.5M) and salmon testis DNA 
(0.5mg/ml) to act as a carrier. Protein was removed 
by extraction with phenol 8 8% m-cresol 12%/8-hydroxy- 
quinoline (0.1%). After centrifugation (800 g, 15 min.) 
the upper aqueous layer was removed and DNA spooled out 
after overlayering with 2 volumes of absolute ethanol.
The DNA was then digested in 0.2 ml of 0.5N NaOH (3 hours,
37*^ C) to remove RNA. After two washes with cold 10%
TCA and drying, the acid-insoluble material was 
solubilised by addition of 0.2 ml hyamine hydroxide 
and heating at 50°C for 15 min. This DNA extract 
sample was then transferred, with scintillant cocktail 
and rinsing, to a scintillation counter insert vial 
prior to counting in a Packard liquid scintillation 
spectrometer.
The purpose of treatment with phenol/m-cresol and 
alkaline hydrolysis was to exclude measuring incorporation 
into protein or RNA.
2.2.20. Determination of Protein Synthesis 
1 4Using ( C)-leucine.
An increase of protein synthesis is one of the major 
metabolic changes caused by PHA stimulation of lymphocytes. 
The rate of amino acid incorporation has been shown to 
be a reasonably accurate index of the rate of lymphocyte 
protein synthesis (Ling and Kay, 1975) and because 
1-leucine is one of the most specific amino acid precursors 
of protein, use of this amino acid is particularly 
convenient in experimental determination of protein 
synthesis. L-leucine however, cannot be considered an 
absolutely protein specific label because in its metabolism 
it is converted to acetyl coenzyme A and acetoacetate.
A major advantage of this specificity is that if a 
radioactive metabolite is a precursor of a particular 
class of macromolecule then the incorporation of that
metabolite is likely to give a more accurate estimate 
of the synthesis of the particular macromolecule.
A further advantage is that the determination of 
incorporation of radioactive label does not require 
prior removal of other cellular macromolecules.
The method used in this study was based on that
described by Hirschhorn et al (1974). At a specified
time after initiation of the PHA stimulated lymphocyte
1 4cell culture, 1.OuCi of uniformly labelled ( 0-1-
leucine, specific activity 33 9mCi/mol, was added to 
the appropriate cell culture tubes. Following a 3 hour 
incubation at 37^C cultures were terminated by addition 
of 1 ml cold saline. After centrifugation (800 g ,
15 min.) removal of supernatant, one wash with cold 
10% TCA, addition of 0.2 ml IM NaOH, heating at 50°C 
for 15 min, a second wash, with cold 10% TCA the acid- 
insoluble material was finally solubilised by addition 
of 0.2 ml hyamine hydroxide and heating at 50^C for 
15 min. prior to transfer, with scintillant cocktail 
and rinsing to a scintillation counter insert vial.
Controls for the labelling of protein included addition 
of saline prior to addition of label and preincubation 
with puromycin (20ug/ml, 30 min.) before addition of 
the label. The radioactivity of these controls was 5% 
or less than that of comparable untreated cultures.
2.2.21. Sterilisation of Solutions and Equipment 
All materials and equipment used in lymphocyte cell 
culture studies were either sterile, e.g., lymphocyte 
cell culture tubes, centrifuge tubes, sterile water 
or were sterilised using one of a variety of methods.
For example, glass pipettes were sterilised in a 
hot-air oven, plastic pipette tips and test-tubes were 
sterilised by ethylene oxide and solutions to be added 
to cell cultures were sterilised using sterile 
disposable Millex filter units (0.22 urn).
Preparative work and cell culture manipulations were 
performed using aseptic technique on a bench, swabbed 
with 7 0% alcohol, in a room separate from the main 
laboratory.
2.2.22. Radioisotope Counting
12 5Counting of gamma ray emitting nuclides, i.e., ( I)
5 7and ( Co) was performed using a Packard automatic gamma 
scintillation spectrometer with a Nal crystal. Samples 
were counted directly by placing the processed cell 
culture tubes or test-tubes in scintillation counter 
vials.
14 3Counting of beta-emitting nuclides, i.e., ( C) and ( H) 
was performed using a Packard model 33 20 liquid
1 • 1 U-scintillation spectrometer. In determination of ( COg) 
(2.2.2.), the scintillant mixture was added to the hyamine
14hydroxide, containing absorbed ( COg), in the 
scintillation counter insert vial. In determination 
of radioactive incorporation into acid-insoluble 
precipitates, the samples were solubilised with 
hyamine hydroxide prior to transfer, with scintillant 
and rinsing, to scintillation counter insert vials.
Two scintillation fluids were used, each of which 
gave similar results. One was based on the use of 
diphenyloxazole (PPG) as primary phosphor and bis- 
phenyloxazolylbenezene (POPOP) as secondary phosphor. 
This was made by dissolving 12.5 g PPG and 0.7 5 g 
POPGP in 2.5 1 of scintillation grade toluene (Packard 
Technical Bulletin no. 1.). The second system used 
was Insta-gel (Packard). The channels ratio method was 
to estimate the degree of quenching and hence efficiency
of counting of radioactive samples. This was between
14 q
70 - 85% for ( C) and 15 - 30% for ( H). As the
degree of quenching was constant, within experiments, it
was not necessary to convert from cpm to dpm.
2.2.23. Treatment of Results of PHA Stimulated 
Lymphocyte Experiments
For each determination of acid-insoluble incorporation
12 5 14of ( I)-UdR, cpm, and ( C)-leucine, cpm, into
harvested cells, or of acid-insoluble incorporation of
3-(^^C)-serine, cpm, and (^^C)-formate, cpm, into a
DNA extract of harvested cells, the mean value, derived
from replicate cultures, less background incorporation 
in control cultures, was calculated. These are the 
results of experiments on cells of individual subjects 
which are presented in tables of results. In analysis 
of group results, presented in figures, the mean and 
standard error of the mean of individual results was 
frequently used. However, as there was often 
considerable variation in incorporation into cultures 
of different subjects, individual results were, where 
appropriate, calculated as a percentage of incorporation 
in a control culture. For example, incorporation into 
cultures preincubated with UdR was compared with and 
expressed as a percentage of incorporation in replicate 
cultures to which no UdR was added. Similarly, incorporat­
ion into cultures at 4 8 hours was expressed as a 
percentage of incorporation into comparable cultures 
at 72 hours. This approach provides an internal control 
in each experiment and allows a valid comparison to be 
made of results of different groups of subjects. Use of 
this approach was suggested by the work of Herbert et al 
(1973).
In determining the significance or otherwise of group 
differences, the two sample student t-test or equivalent 
non-parametric test for testing equality of means of 
two random samples was used. The arithmetical mean, x 
is defined as: The sample standard deviation.
dk (n - 1) is defined as: /n
n - 1
The standard error of the mean is defined as 
cK ( n - 1 ) / k/ u '.
CHAPTER 3
RESULTS
Section 3.1.
Preliminary Studies
3.1.1. Ascorbic Acid Levels
Results of determinations of leucocyte and serum 
ascorbic acid levels of control and alcoholic liver 
disease subjects are summarized in Table 1. The 
leucocyte ascorbic acid level in the alcoholic liver 
disease group is statistically significantly lower than 
that observed in the control group (p < 0.05, two sample 
t-test). The mean serum ascorbic acid level in the 
alcoholic liver disease group is also statistically 
significantly lower (at the 5% level) than that 
observed in the control group.
The entry criteria for the study required the exclusion 
of subjects who had recently received vitamin supplements 
In practice it was found that in the alcoholism 
treatment unit at the Southern General Hospital, which 
was the main source of subjects for the alcoholic non­
liver disease group, treatment often included vitamin 
supplements and this precluded their entry to the study. 
The leucocyte and serum ascorbic acid levels in a sample 
of these alcoholic non-liver disease subjects were:
LAA (umol/10^ WBC), 204.2 ± 13.4; SAA (umol/1),
74.9 ± 10.4; (n = 13, xis.e.). The leucocyte ascorbic 
acid level but not the serum ascorbic acid level is 
statistically significantly higher (p < 0.05) than that 
observed in control subjects.
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3.1.2. Serum Pyridoxal-Phosphate Levels
Results of determinations of serum PLP levels of control 
and alcoholic liver disease subjects are summarized in 
Table 2. The mean serum PLP level in the alcoholic 
liver disease group is not statistically significantly 
lower (at the 5% level) than that observed in the 
control group.
3.1.3. Effect of Added PLP on Serum Transaminase Activity 
AST and ALT activities were determined in the presence 
and absence of added PLP. It was found that AST 
activity was stimulated to a greater degree than ALT 
activity. The results of determinations of AST 
activity in the presence and absence of added PLP in 
serum samples from alcoholic liver disease subjects
are illustrated in Table 3. Using these values the 
percentage stimulation in AST activity due to added 
PLP was calculated and compared with the measured serum 
PLP levels. Product moment correlation analysis suggests 
there is no significant association between serum PLP 
and stimulation of AST activity due to added PLP.
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3.1.4. Acetylator Phenotype
The results of determinations of acetylator phenotype 
in alcoholic liver disease and control subjects are 
given in Table 4, Also included in this table are the 
results of determinations of acetylator phenotype in 
alcoholic non-liver disease subjects, some of whom had 
received vitamin supplements. In each of the groups, 
the distribution of fast and slow acetylators was not 
significantly different, at the 5% level, test, from 
that expected in a normal Caucasian population, i.e,,
40% fast, 60% slow.
3.1.5. Alpha-1-Antitrypsin Phenotype
The number of alcoholic liver disease subjects in which 
alpha-l-antitrypsin phenotype was assessed was 32, 
comprising 24 males and 8 females. Alpha-l-antitrypsin 
phenotype was also assessed in 6 control subjects 
(3 males, 3 females) and 7 alcoholic non-liver disease 
subjects (5 males, 2 females). In each case the alpha- 
l-antitrypsin level was within the normal range (200 - 400 
mg/100 ml serum). There were no subjects with an 
abnormally low level which might indicate alpha-l- 
antitrypsin deficiency due to a homozygous or heterozygous 
alpha-l-antitrypsin genotype. In addition, there were 
no subjects with an abnormally high level of alpha-l- 
antitrypsin which might indicate acute inflammation.
The results do not exclude the possibility that a 
heterozygous alpha-l-antitrypsin genotype is masked by 
raised levels due to disease.
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3.1.6. Unsaturated Vitamin B12 Binding Capacity and 
Serum Transcobalamin Levels
Results of determinations of serum levels of vitamin
B12 (carried out by the Department of Haematology,
Southern General Hospital) , serum UBBC and transcobalamin
levels of alcoholic liver disease and control subjects
are summarized in Table 5. The apparently higher level
of serum B12 observed in alcoholic liver disease subjects
compared with control subjects, though not statistically
significantly different, is consistent with several
reports reviewed by Bonjour (1979). Product moment
correlation analysis suggests that serum B12 levels are
not statistically significantly correlated with UBBC in
either the alcoholic liver disease or control group.
Although there is no significant difference between
the alcoholic liver disease and control group in either
the transcobalamin II component of UBBC or total UBBC,
the transcobalamin I and III component of UBBC in the
alcoholic liver disease group is significantly higher
than that observed in the control group.
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3.1.7. Antipyrine Clearance
The results of determination of antipyrine ti and SAA in 
alcoholic liver disease and control subjects are given 
in Table 6. The results of two-sample student t-tests 
indicate that antipyrine ti and SAA values are 
statistically significantly different in the alcoholic 
liver disease and control groups (p < 0.001 and p < 0.01) 
Product moment correlation analysis suggests there is 
no statistically significant correlation between anti­
pyrine ti and SAA values in either the alcoholic liver 
disease or control group. Also there is no statistically 
significant correlation between antipyrine ti and serum 
AST activity or LAA values in the alcoholic liver disease 
group. However, seven of the eleven alcoholic liver 
disease subjects with an antipyrine tj greater than 23 h 
had histological evidence of cirrhosis.
3.1.8. Preparation and Autoradiography of a Liver Cell 
Suspension and Vitamin B6 Deficient Rat Studies
The preliminary experiments to assess DNA synthesis in
a suspension of finely divided rat liver tissue using
(3H)-TdR and autoradiography were unsuccessful. The
main difficulty was obtaining and maintaining a viable
suspension of undamaged cells. Various approaches were
used to try and overcome this problem, e.g., reduction
of processing time, gentler processing of cells, etc.,
which were also unsuccessful. Use of a liver tissue
slice technique was considered but this would have
introduced further difficulties in interpretation of
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results and would not have been suitable for use in 
studies of human liver biopsy material.
The experimental feeding of a vitamin B6 deficient diet 
to rats was also unsuccessful. After a period of 6 weeks 
feeding of the deficient diet, none of the rats showed 
signs of vitamin B6 deficiency symptoms or a reduction 
in serum PLP values. In contrast, Reynolds (1978) 
reports the occurrence of vitamin B6 deficiency after 
four weeks' feeding with a vitamin B6 deficient diet.
The most likely explanation for the failure to produce 
a vitamin B6 deficient state in the present study is 
the presence of a bacterial flora in these rats which 
provided an alternative source of vitamin B6. This 
explanation is suggested by Sumi et al (19 77) whose 
study of germ-free and conventional rats suggested 
that the presence of gut microflora made some 
contribution to the conventional rats' vitamin B6 
nutrition.
Section 3.2.
Preliminary PHA Stimulated Lymphocyte Studies
3.2.1. Acid-insoluble (^^^I)-UdR Incorporation During
PHA Stimulated Lymphocyte Culture
12 5The results of determination of acid-insoluble ( I)- 
UdR incorporation during PHA stimulated culture are 
illustrated in Fig. 9. The lymphocytes used were 
from control subjects and the culture medium was 
complete MEM.
3.2.2. Effect of Variation of Cell and Serum
12 5Concentration on Acid-insoluble ( I)-UdR Incorporation 
into PHA Stimulated Lymphocyte Cultures
The results of determination of the effect of variation
of cell and serum concentration on acid-insoluble
incorporation into PHA stimulated lymphocyte cultures
are given in Table 7. The results suggest that acid- 
125insoluble ( I)-UdR incorporation into PHA stimulated 
lymphocyte cultures is sensitive to increases in serum 
and cell concentration and that this sensitivity may 
be used to assess the effect of different sera on PHA 
stimulation. Table 7 also illustrates the use of 
calculating results as a percentage of incorporation 
in a standard culture for each subject. This reduces 
inter-individual variability and allows between subject 
comparisons to be made.
Fig. 9. Acid-insoluble (^^^I)-UdR Incorporation at k,
21, 48, 72 and 96 hours PHA Stimulated Lymphocyte
Culture
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5
stimulated lymphocytes (2.5 x 10 cells) was determined 
at the times indicated after;
(I) culture in-^complete MEM
(II) pre-incubation addition BSS (50 ul), 1 h prior to
(III) incubation 3 h (^^^I)-UdR, 0.5 uCi
Results are given as mean (cpm) ± s.e. of lymphocyte 
cultures of 5 control subjects.
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3.2.3. Inter-individual Variation in Acid-insoluble
12 5( I)-UdR Incorporation into PHA Stimulated Lymphocyte 
Cultures of Control Subjects
12 5The results of determination of acid-insoluble ( I)-
UdR incorporation into PHA stimulated lymphocyte
cultures derived from control subjects are given in
Table 8. These results demonstrate the wide variation
12 5in acid-insoluble ( I)-UdR incorporation into PHA 
stimulated lymphocyte cultures derived from a control 
group. The results are from analyses of cultures carried 
out over a period of several weeks using the same 
conditions and complete MEM in each case.
3.2.4. Inter-individual Variation in Acid-insoluble 
12 5( I)“UdR Incorporation into PHA Stimulated Lymphocyte 
Cultures of Alcoholic Liver Disease Subjects
12 5The results of determination of acid-insoluble ( I)-UdR
incorporation into PHA stimulated lymphocytes derived
from alcoholic liver disease subjects are given in
Table 9. Also included in this table are the results
of clinical laboratory investigation of these subjects.
The results demonstrate the wide variation in acid- 
125insoluble ( I)-UdR incorporation into PHA stimulated
lymphocyte cultures of alcoholic liver disease subjects.
Examination of Table 9 strongly suggests that there
is no simple relationship between acid-insoluble 
12 5 .( I)-UdR incorporation and the extent of liver damage 
as assessed by enzyme content of serum or histology 
of liver biopsies. This is confirmed by statistical.
Table 8
12 5Inter-individual Variation in Acid-insoluble ( I)- 
UdR Incorporation into PHA Stimulated Lymphocyte 
Cultures of Control Subjects
Subject
-1 9 q
Acid-insoluble ( I)-UdR 
Incorporation (cpm)
1 17147
2 50027
3 36291
4 12496
5 6443
6 14695
7 12393
8 7958
9 6566
10 9564
11 9543
12 16059
Mean 16599
s.e. 3820
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into 
PHA stimulated lymphocyte cultures derived from 12 
control subjects was determined at 72 h after;
(I) culture in complete MEM (2.5 x lO^Cells, 15%
autologous serum)
(II) pre-incubation addition of BSS (50 ul) 1 h prior to;
(III) incubation 3 h, (^^^I)-UdR, 0.5 pCi
Results given are the mean of duplicate analyses
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product moment correlation analysis.
3.2.5. Relationship Between Serum PLP Concentration 
and Acid-insoluble (^^^I)-UdR Incorporation into PHA 
Stimulated Lymphocyte Cultures of Alcoholic Liver 
Disease Subjects
12 5The results of determination of acid insoluble ( I)-
UdR incorporation into PHA stimulated lymphocyte
cultures and serum PLP levels of alcoholic liver
disease subjects are given in Table 10. Product moment
correlation analysis suggests there is no statistically
12 5significant association between acid-insoluble C I)- 
UdR incorporation into PHA stimulated lymphocyte 
cultures and serum PLP Levels of these subjects.
3.2.6. Absence of PHA Stimulated Lymphocyte Response 
in Advanced Alcoholic Cirrhosis
In one subject with advanced alcoholic cirrhosis, a PHA 
stimulated lymphocyte response was absent when auto­
logous serum was used in the culture medium. When 
homologous control serum was used however, a normal
PHA stimulated lymphocyte response, as assessed by
12 5acid-insoluble ( I)-UdR incorporation at 7 2 hours 
was observed. The results of Southern General 
Hospital clinical laboratory investigation of this 
subject were;
AST 389 I Units/1
ALT 10 4 I Units/I
AP 165 I Units/1
bilirubin 400 umol/1
Table 10
12 5Serum PLP Concentration and Acid-insoluble ( I)- 
UdR Incorporation into PHA Stimulated Lymphocyte 
Cultures of Alcoholic Liver Disease Subjects
Subj ect Serum PLP (ng/ml)
(125i)_udR 
incorporation (cpm)
1 0.4 11524
2 0.4 30506
3 0 . 8 32758
4 1.7 7958
5 3.1 13687
6 4.3 6566
7 4.8 11496
8 5.0 14695
9 5.4 5427
Mean 2.9 14957
s.e. 0.7 3321
Serum PLP determinations were carried out using the 
method described in Section 2.2.2.
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into 
PHA stimulated lymphocyte cultures derived from 
alcoholic liver disease subjects was determined at 
72 h after;
(I) culture in complete MEM (2.5 x 10 cells,
10% autologous serum)
(II) pre-incubation addition of BSS (50 ul)
1 h prior to ;
(III) incubation 3 h (
Results given are the mean of duplicate analyses.
Subjects 1,2 and 3 are subjects 10, 12 and 13
in Table 9.
The observation of a normal PHA stimulated lymphocyte 
response in control serum suggests normal cellular 
function and abnormal serum. The most likely serum 
factor causing the inhibition of a PHA stimulated 
lymphocyte response is the high bilirubin content.
3.2.7. Effect of Culture in a Pyridoxine Deficient 
Culture Medium on Acid-insoluble (^^^I)-UdR 
Incorporation into PHA Stimulated Lymphocytes
Initial experiments with a pyridoxine deficient medium,
modified MEM (1), suggested that the absence of
pyridoxine from MEM resulted in a significant
12 5reduction in acid-insoluble ( I)-UdR incorporation
into PHA stimulated lymphocyte cultures. The results
12 5of determination of acid-insoluble ( I)-UdR incorpor­
ation into PHA stimulated lymphocytes of three different 
groups of subjects cultured in both complete MEM and 
modified MEM 1 (without pyridoxine) are summarised 
in Table 11, The three groups of subjects were; 
control subjects, alcoholic liver disease subjects 
and alcoholic liver disease subjects whose recent 
treatment included vitamin supplements containing
pyridoxine. In each subject group, acid-insoluble 
12 5( I)-UdR incorporation in modified MEM (1) cultures
was statistically significantly lower than in complete
MEM cultures (p < 0.05; p < 0.001; p < 0.01 respectively)
12 5Acid-insoluble ( I)-UdR incorporation in complete
MEM cultures was not statistically significantly 
different between the control and alcoholic liver
ID / .
disease groups (p > 0.05). The mean acid-insoluble 
12 5( I)-UdR incorporation in modified MEM (1) cultures, 
expressed as a percentage of incorporation in complete 
MEM cultures, was statistically significantly lower 
in both alcoholic liver disease groups compared to 
the control group (p < 0.05) and was also lower in the 
vitamin treated alcoholic liver disease group compared 
to the non-vitamin treated alcoholic liver disease 
group (p < 0.05).
Several experiments were conducted to characterise this
observed effect of culture in pyridoxine deficient modified
MEM (1) on acid-insoluble incorporation of (^^^I)-UdR
into PHA stimulated lymphocyte cultures. These
included changing the culture medium from complete MEM
to modified MEM (1) at different times during culture,
the effect of addition of pyridoxine and other forms of
vitamin B6 to modified MEM (1) and the effect of varying
the proportion of complete MEM and modified MEM (1)
in the PHA stimulated lymphocyte culture medium.
The results of these experiments suggested that the
12 5observed reduction in acid-insoluble ( I)-UdR
incorporation in PHA stimulated lymphocytes cultured
in modified MEM (1) was not solely due to the absence
of pyridoxine. This was confirmed by later experiments
12 5in which acid-insoluble ( )-UdR incorporation into 
PHA stimulated lymphocytes cultured in modified MEM
(2), without pyridoxine and with a folate concentration
of 1.0 mg/1 was not significantly different from that 
in lymphocytes cultured in complete MEM. It was 
concluded that the observed differences between 
modified MEM (1) and complete MEM could not be wholly 
attributed to an effect of the pyridoxine concentration 
and therefore that the results summarised in Table 11 
could not be interpreted on this basis.
19 5
3.2.8. Effect of Ethanol on Acid-insoluble ( I)- 
UdR Incorporation into PHA Stimulated Lymphocyte Culture
Results of determinations of the effect of different
amounts of ethanol added either at initiation of
12 5culture or 1 hour prior to addition of ( I)-UdR on
12 5acid-insoluble ( I)-UdR incorporation into PHA 
stimulated lymphocyte cultures are shown in Fig. 10. 
The results suggest that the presence in lymphocyte 
cultures of progressively larger amounts of ethanol 
has a significant inhibitory effect on PHA stimulation 
of lymphocytes. When ethanol is added 1 hour prior 
to addition of radioactive label, a marked inhibitory 
effect is only apparent at the 5% concentration level.
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Acid-insoluble ('“"^_)-'Udn incorporation (cpm) into ?HA stimulated 
lymphocyte cultures (2.5 x 10" cells, 10% serum) was determined at 
?2h after;
(i) GGttxon or 
% or 5 i
culture in complete MZK with spécifié 
ethanol to a concentration of 0/5%,
pre-incubation addition of specified amounts o 
ethanol, Ih orior to;
(ii)
(iii) incubation, 3h ( :)-jc 0 .
Results are given as the mean ± s.e. of incorporation into 
duplicate cultures of 3 conrrcl subjects, expressed as a 
oercentage of incorporation into cultures without added ethanol.
Section 3.3.
Development of a Functional Assay for 
Determination of Vitamin B6 Status
In Alcoholic Subjects
3.3.1. Effect of Pre-incubation with Aminopterin on
12 5Acid-insoluble Incorporation of ( I)-UdR into 
PHA Stimulated Lymphocytes
Acid-insoluble incorporation of (^^^I)-UdR into PHA
stimulated lymphocyte cultures was determined at
21, 18, 72 and 96 h after initiation. In experimental
cultures, aminopterin, to a final concentration of
12 5111 u M was added 1 h prior to incubation with ( I)-
UdR. In control cultures, 50 pi of BSS was added.
The culture medium used was complete MEM and the 
results are shown in Fig. 11. Group results as 
illustrated here, are expressed as mean + standard error 
of individual results.
As previously indicated (section 1.1.1.) the effect of 
pre-incubation with aminopterin is to inhibit dihydro­
folate reductase activity such that the de novo 
contribution to thymidylate synthesis is substantially 
reduced. Subsequent incorporation of thymidylate 
precursor via the salvage pathway is then largely free 
of competition with the de novo contribution. This use 
of aminopterin allows an assessment to be made of the 
relative contribution of the de novo and salvage pathways 
to thymidylate synthesis. Longer term use of aminopterin 
would, in the absence of an exogenous supply of salvage 
pathway substrate, result in cessation of DNA synthesis.
12 5In Fig. 11, acid-insoluble incorporation of ( I)-UdR 
is shown as various times during the course of PHA 
stimulated human lymphocyte culture, after prior 
addition of either aminopterin or BSS. The results show

Fig. 11 Effect of Pre-incubation with Am on
12 5Subsequent Acid-insoluble Incorporation of ( I) 
UdR into PHA Stimulated Lymphocytes Cultured in 
Complete MEM
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5stimulated lymphocytes (2.5 x 10 cells) was determined 
at the times indicated, after;
(i) culture in complete MEM
(ii) pre-incubation addition of BSS (#), or Am, lllpM 
( ■ I  ) , Ih prior to
(iii) incubation 3h, (^^^l)-UdR, O.SpCi
Results are given as mean (cpm) ± s.e. of lymphocyte 
cultures of 6 control subjects.
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that in complete MEM, which has a folate concentration 
of 1.0 mg/1, the salvage contribution to thymidylate 
synthesis is low relative to that of the de novo 
contribution. Furthermore, it appears from these 
results that the contribution of each of these pathways 
to total thymidylate synthesis varies during the course 
of stimulated lymphocyte culture such that, while the 
salvage contribution increases through 9 6 h, the de 
novo contribution is maximal at 48 h and declines 
slowly thereafter. The significance of the folate 
concentration in complete MEM is related to its likely 
effect on the de novo contribution to thymidylate 
synthesis and this relationship is examined in the 
following experiment.
3.3.2. Effect of Variation of the Medium Folate
12 5Concentration on Acid-insoluble Incorporation of ( !)■
UdR into PHA Stimulated Lymphocytes
Modified MEM (2) was used to prepare two media
identical in component specification to complete MEM
except that one had a folate concentration of 0.01 mg/1
and the other a folate concentration of 2 mg/1. Acid-
125insoluble incorporation of ( I)-UdR was determined 
at 72 h, in PHA stimulated lymphocytes cultured in 
each of these media, after pre-incubation with BSS or 
aminopterin (114pM). Individual results, the mean 
of incorporation into duplicate cultures, were used to 
calculate the group results, shown in Fig. 12, which 
are given as the mean ± standard error of individual 
results.

Fig. 12. Effect of Variation of the Medium Folate 
Concentration on Acid-insoluble Incorporation 
(^^^I)-UdR into PHA Stimulated Lymphocytes
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into 
PHA stimulated lymphocytes (2.5 x 10  ^ cells) was 
determined at 7 2h, after;
(i) culture in modified MEM (2) of high folate 
concentration (2.0mg/l), PI (O.Olmg/1)
or low folate concentration (O.Olmg/1)
PI (O.Olmg/1)
(ii) pre-incubation addition of BSS, or Am 114pM,
Ih prior to,
(iii) incubation 3h (^^^I)-UdR, O.SnCi
Results are given as mean (cpm) ± s.e. of lymphocyte 
cultures of 5 normal subjects.
The culture and pre-incubation conditions for each experiment 
are as indicated at the base of each column.
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The results show that as the medium concentration of
folate is reduced from 2 mg/1 to 0.01 ml/1, the
12 5incorporation of ( I)-UdR, after pre-incubation 
with BSS more than doubles, while after pre-incubâtion 
with aminopterin, there is no significant difference in 
incorporation into lymphocytes cultured in either medium 
This result is consistent with the hypothesis that the 
medium folate concentration has a marked effect on the 
de novo pathway's contribution to total thymidylate 
synthesis. The closeness of the extent of incorporation 
in the two media, after pre-incubation with aminopterin, 
could either reflect similar levels of DNA synthesis 
in these cultures irrespective of the incident folate 
levels or it could be due to coincident levels of enzyme 
activity at that particular time.
In order to determine the effect of variation of the
12 5medium folate concentration on acid-insoluble ( 1)-
UdR incorporation after pre-incubation with BSS or MTX 
during the course of PHA stimulated lymphocyte culture, 
determination of such incorporation was carried out at 
24, 48, 72 and 96 h after initiation of culture. The 
culture medium used was modified MEM (2) with a folate 
concentration of either 1.0 mg/1 or 0.01 mg/1. 
Determination of incorporation was carried out after a 
Ih pre-incubation with either BSS or MTX (110 pM) and 
the results are illustrated in Fig. 13.
Fig. 13 Effect of Variation of the Medium Folate
Concentration on Acid-insoluble Incorporation
of (^^^I)-UdR into PHA Stimulated Lymphocytes
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
stimulated lymphocyte cultures (2.5 x 10  ^ cells) was
determined at the times indicated, after;
(i) culture in modified MEM (2) of low folate
concentration (O.Olmg/1) and PI (l.Omg/1) (0/D )
or high folate concentration (l.Omg/1) and
PI (l.Omg/1) (#/■ )
(ii) pre-incubation with BSS (0/#) or MTX ilOpM (Q / #  ), 
Ih prior to ;
(iii) incubation 3h (^^^I)-UdR, 0.5pCi
Results are given as mean (cpm) ± s.e. of lymphocyte 
cultures of 4 control subjects.
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The results show that in modified MEM (2) with a high
folate concentration (1 mg/1) and after pre-incubation
with either BSS or MTX, incorporation follows a
similar pattern to that observed in complete MEM
after pre-incubation with either BSS or aminopterin,
Fig. 11. In modified MEM (2) with a low folate
concentration (0.01 mg/1) however, a different pattern
of incorporation is apparent. While incorporation
after pre-incubation with MTX is essentially
comparable to that in high folate medium, though the
extent of incorporation at 18h is reduced and the
12 5decline thereafter less marked, ( I)-UdR 
incorporation after pre-incubation with, BSS is 
greater in low folate medium and continues to 
increase up to 96 h. This is consistent with the 
result illustrated in Fig. 12 and indicates that 
the respective contribution of the de novo and 
salvage pathways to thymidylate synthesis is 
influenced by the medium folate concentration.
3.3.3. Effect of Pre-incubation with UdR on Acid- 
insoluble Incorporation of C^^^D-UdR or(^H)-TdR into PHA 
Stimulated Lymphocytes
The addition of UdR to PHA stimulated lymphocyte
cultures prior to determination of acid-insoluble
incorporation of radio-labelled thymidine results
in reduced incorporation relative to control cultures
to which no UdR has been added. A similar effect was
12 5observed on acid-insoluble incorporation of ( I)- 
UdR into PHA stimulated lymphocytes cultured in 
complete MEM, Fig. 14.
Fig, 14 Effect of Pre-incubâtion with UDR on Acid
12 5insoluble Incorporation of ( I)-UdR into 
PHA Stimulated Lymphocytes
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA 
stimulated lymphocytes (2.5 x 10  ^ cells) was determined 
at 72h after;
(i) culture in complete MEM
(ii) pre-incubation addition of UdR, to specified 
concentration, Ih prior to;
(iii) incubation 3h (^^^l)-UdR, 0.5pCi
Results are given as mean (cpm) ± s.e. of lymphocyte 
cultures of 5 control subjects.
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The observation that this normal deoxyuridine 
suppression was impaired in stimulated lymphocyte 
cultures derived from patients with folate or 
vitamin 8^2 deficiency formed the basis of the UdR 
suppression test for determination of such a vitamin 
deficiency. The presumed rationale for such a test 
is discussed earlier in this report (1.4.5.) and also 
a rationale for the possible extension of this test 
to determination of a vitamin B6 deficiency.
In order to assess the validity of this test and also 
to determine whether or not (assuming the use of the 
test was justified) alcoholic liver disease subjects 
were vitamin B6 deficient relative to control subjects, 
experiments were conducted in which the effect of 
pre-incubation with UdR on subsequent radioactively 
labelled DNA precursor incorporation was determined 
in PHA stimulated lymphocyte cultures derived from 
control, alcoholic non-liver disease and alcoholic liver 
disease subjects.
Results of studies of lymphocytes of control and 
alcoholic liver disease subjects cultured in complete 
MEM are shown in table 12. There was no statistically 
significant difference in UdR suppression between 
lymphocytes of control and alcoholic liver disease subjects
Table 12 Effect of Pre-incubation with UdR on Acid-
insoluble Incorporation of (^^^I)-UdR into PHA
Stimulated Lymphocytes Cultured in Complete MEM
Medium MEM Complete
Alcoholic
Subjects Control Liver Disease
preincuba­
tion BSS UdR BSS UdR
cpm % cpm % cpm % cpm %
1 17147 100 1980 11.5 11524 100 299 2 . 3
2 14695 100 1183 8.1 32358 100 1323 4.1
3 12393 100 63 0 . 5 20161 100 1694 8.4
4 7958 100 772 9.7 30106 100 2489 8 . 3
5 6566 100 670 10.2 31628 100 2059 6 . 5
6 9564 100 467 4.9 13681 100 436 3 . 2
7 9409 100 449 4.8
8 7286 100 545 7 . 5
Mean 11387 100 856 7.5 19519 100 1162 5.6
s.e. 1668 270 1.7 3715 299 0.8
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5stimulated lymphocyte cultures (2.5 x 10 cells) of 
control and alcoholic liver disease (aid) subjects was 
determined at 7 2h after:
(I) culture in complete MEM (15% serum)
(II) pre-incubation addition of BSS or UdR 2.7 mM,
Ih prior to;
(III) incubation 3h, (^^^I)-UdR, 0.5 pCi
Results are given as the mean of duplicate analyses. 
Incorporation after pre-incubation with UdR is 
expressed as a % of incorporation in replicate cultures 
to which BSS had been added.
In view of the possible masking effect of medium 
pyridoxal on tests of vitamin B6 deficiency, experiments 
were also conducted in a basal BSS medium (table 14), 
and in modified MEM (2) with a low pyridoxal 
concentration and without pyridoxal (table 13 and 15). 
Also, in view of the role of vitamin B6 in de novo 
thymidylate synthesis and the effect of the medium 
folate concentration on incorporation of radioactively 
labelled DNA precursor, experiments were conducted 
in medium of both high (1.0 mg/1) and low (0.01 mg/1) 
folate concentration.
Incorporation was determined at 72 h after pre­
incubation with BSS, MTX (Am), or UdR and the results 
are presented in tables 13, 14 and 17. (The UdR 
suppression results of table 15 are expressed in 
percentage terms in table 17). Incorporation after 
pre-incubation with UdR was expressed as a percentage 
of incorporation in control cultures to which no UdR 
had been added and this gives the percentage UdR value 
suppression value for a particular subject. Group 
values are given as mean ± standard error of these 
individual results. Statistical analysis of these 
values (two sample student t-test) indicates that there 
is no significant difference between the effect of 
UdR on incorporation of (^^^I)-UdR or (3H)-TdR in 
lymphocytes of control subjects and lymphocytes of 
alcoholic non-liver disease and liver disease subjects 
irrespective of the culture medium used. The results of
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Table (17) Effect of preincubation with UdR on acid-insoluble 
incorporation of (^^^I)-UdR into PHA stimulated lymphocytes
Medium MEM m(2)
fol l.Omg/1 
PI l.Omg/1
fol O.Olmg/1 
PI O.Olmg/1
fol. l.Omg/1 
0 PI
fol. O.Olmg/1 
0 PI
Incorpn. after pr 
incorporation in
eincubation with U 
control culture
dR expressed as % of
Sub]ects 
control
1 27 27 36 24
2 38 28 39 31
3 34 17 33 12
4 32 14 19 11
5 20 27 15 20
6 23 7 11 19
7 32 12 34 21
8 17 15 10 12
X 28 19 25 19
s.e. 3 3 4 2
anld
1 8 11 4 6
2 24 10 22 13
aid
3 18 15 24 20
4 33 19 17 20
X 20 14 17 15
s.e. 5 2 5 3
Culture conditions as for table (15)
Incorporation after preincubation with UdR is expressed as a % of incorporation 
in replicate cultures to which BSS had been added
biochemical analysis of serum samples and
histological analysis of liver biopsy samples of
the alcoholic subjects in Table 15 are presented
in Table 16. For the purpose of assessment of
functional vitamin B6 status in alcoholics, the
results of alcoholic non-liver disease and alcoholic
liver disease subjects presented in Table 15, were
combined in the analysis. It is apparent from the
results presented in Table 16 that the wide variation
12 5in acid-insoluble ( I)-UdR incorporation into PHA
stimulated lymphocyte cultures of different alcoholic 
subjects in Table 15 cannot be accounted for on the 
basis of variation in serum enzyme levels. The
question of inter-individual variation in acid- 
125insoluble ( I)-UdR incorporation into PHA stii 
lymphocytes is also discussed in section 4.2.2.
3.3.4. Effect of Pre-incubation Addition of the 
Vitamin Bg Antagonist 4-deoxypyridoxine on Acid- 
insoluble Incorporation of (^^^I)-UdR into PHA 
Stimulated Lymphocytes
Since the deoxyuridine suppression test did not 
discriminate between stimulated lymphocytes of control 
and alcoholic subjects, an alternative approach was 
adopted. This was based on the premise that 
lymphocytes of Bg deficient subjects would be more 
susceptible to the effect of a vitamin Bg antagonist 
than would lymphocytes of vitamin Bg replete subjects.
xo u .
This hypothesis was tested using the vitamin Bg
antagonist 4-deoxyp}Tidoxine (4-dPN). The effect of
pre-incubâtion addition of 4-dPN on acid-insoluble
12 5incorporation of ( I)-UdR into PHA stimulated 
lymphocytes of control and alcoholic liver disease 
subjects cultured in modified MEM is shown in Table 
18, In order to distinguish between the possible 
differential effect of such an antagonist on de novo 
and salvage thymidylate DNA synthesis, determination 
of incorporation was carried out after pre-incubation 
with BSS and aminopterin. The medium folate and 
pyridoxal concentrations were 0.01 mg/1.
The results indicate that 4-dPN, when added at the
pre-incubation stage to PHA stimulated lymphocytes
of control subjects does not significantly reduce 
12 5( I)-UdR incorporation either in the presence of
BSS or Am. However, when 4-dPN is added to PHA
stimulated lymphocytes of alcoholic liver disease
12 5subjects there is a significant reduction in ( I)- 
UdR incorporation in the presence of BSS (P< 0.01), 
but not after co-pre-incubation with Am.
When the effect of pre-incubation addition of 4-dPN 
12 5on ( I)-UdR incorporation into PHA stimulated 
lymphocytes of control subjects cultured in conditions 
of high or low folate concentration was studied, it 
was found that in high folate conditions incorporation 
was significantly reduced in the presence of BSS 
(p < 0.01) but not after co-pre-incubation with Am.
The results of this experiment, shown in Table 19 also
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Table 19
Effect of Pre-incubation with 4-dPM on Acid-insoluble 
Incorporation of C^^^)-UdR into PHA Stimulated 
Lymphocytes
Acid-insoluble C^^^D-UdR incorporation into PHA 
stimulated lymphocyte cultures (2.5 x 10  ^ cells) was 
determined at 72h, after;
(i) culture in modified MEM (2), folate and PI 
concentrations, as specified, and 15% autologous 
serum
(ii) pre-incubation addition of BSS, Am (114pM), UdR 
(2.7mM), 4-dPN (2.6mM)/BSS or 4-dPN (2.6mM)/Am
( llApM)
(iii) incubation 3h (^^^I)-UdR, G.SpCi.
Results are given as the mean of duplicate analyses. 
Incorporation after pre-incubation with UdR, 4-dPN/BSS 
and 4-dPN is expressed as a % of incorporation in replicate 
cultures to which BSS or Am had been added.
Medium MEMm folate (O.Olmg/1), PI (O.Dlmg/1) 15 % serum
Pre-inc'n BSS Am UdR % 4dPN/BSS % 4dPN/Am %
Subjects
Control
1 12204 20762 2513 21 12099 99 17618 87
2 10786 32020 2520 23 12021 111 18063 78
3 12766 28772 3217 25 13222 104 31354 109
4 10722 15592 1911 18 8618 80 13298 85
5 6245 17469 903 14 5808 93 15560 90
X 20 97 90
s.e. 1. g 5.3 5.2
Medium MEMm folate (2.0mg/l), PI (O.Dlmg/1) 15% serum
1 2864 17776 82 3 1827 64 18237 103
2 4883 25478 173 4 2299 47 22168 87
3 4189 26556 188 5 2787 67 29225 110
4 3050 14504 0 0 1275 42 12805 88
5 3247 22034 77 2 1591 49 17583 80
X 3 54 94
s.e. 0.9 4,9 5,5
Medium MEMm folate (O.Olmg/1), PI (2.0mg/l) 15% serum
1 10364 16629 2481 24 12023 116 18467 111
2 11733 25365 2155 18 10783 92 21214 84
3 11429 28593 3015 26 12572 110 27072 95
4 10395 158 53 2352 23 8357 80 13593 86
5 5413 18488 848 16 5171 96 18941 102
X 21 99 96
s.e. 1.9 6 . 4 5.0
indicate that this effect is independent of the 
pyridoxal concentration.
3.3.5. Effect of Culture in Medium without Pyridoxal 
(HCl) on Acid-insoluble Incorporation of (^^^I)-UdR 
into PHA Stimulated Lymphocytes
There were two particular questions of interest in
determining the effect of the absence of medium PI (HCl)
on PHA stimulated lymphocyte culture. One was to
assess the possible effect of a variation in the medium
PI (HCl) concentration on the relative contribution of
the de novo and salvage pathways to thymidylate DNA,
the second was to determine the sensitivity of
lymphocytes of normal and alcoholic liver disease
subjects to PHA stimulated culture in a vitamin Bg
deficient medium. The approach adopted in both
12 5questions was to determine acid-insoluble ( I)-UdR 
incorporation after pre-incubation with BSS and MTX. 
Cognisant of the possible masking effect of a high 
medium folate concentration, in reducing the possible 
effect of a vitamin Bg deficiency on serine hydroxy- 
methyltransferase activity, experiments were carried 
out in media of high and low folate concentration.
In order to determine the possible effect of the absence
of PI (HCl) during the course of PHA stimulated
12 5lymphocyte culture, determination of ( I)-UdR was 
carried out at 24, 48, 7 2 and 9 6 h.
The results of this experiment, illustrated in
Fig. 15, indicate that the absence of PI (HCl) has
12 5little effect on acid-insoluble ( I)-UdR incorporation 
at various times during PHA stimulated lymphocyte 
culture. This lack of effect of the absence of PI 
(HCl) is independent of the medium folate concentration 
and the pre-incubation addition of BSS and MTX. The 
results of an experiment directed at determination of 
the sensitivity of lymphocytes of alcoholic subjects 
to PHA stimulated culture in a vitamin Bg deficient 
medium are given in Table 15 and a comparison is 
presented in Table 20. Determination of incorporation 
was carried out at 7 2 h in lymphocytes cultured in 
medium of high or low folate concentration after pre­
incubation with BSS and MTX. The results indicate
that the absence of medium PI (HCl) does not have a
12 5statistically significant effect on ( I)-UdR 
incorporation in stimulated lymphocytes of normal or 
alcoholic subjects. This lack of effect is independent 
of the medium folate concentration and the pre-incubation 
addition of BSS or MTX.
3.3.6. Effect of Culture in Medium Containing 1-dPN 
on Acid-insoluble (^ ^^ :
Stimulated Lymphocytes
12 5 I)-UdR incorporation into PHA
In order to obtain cells with an unequivocal vitamin 
Be deficiency and also to establish conditions likely 
to allow discrimination between cells of different 
vitamin Bg status, experiments were carried out in 
which the effect of addition of the vitamin Bg antagonist 
1-dPN to the culture medium, prior to initiation of

Fig. 15 Effect of Culture in Medium Without PL
(HCl) on Acid-insoluble Incorporation of 
19 5( I)-UdR into PHA Stimulated Lymphocytes
19 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5
stimulated lymphocyte cultures (2.5 x 10 cells) was 
determined at the times indicated after;
(i) culture in modified MEM (2) with low folate with or
without PI i.e., fol G.Glmg/l PI l.Gmg/1 (0/1 I)
fol O.Glmg/1 PI O.Gmg/1 (#/##) 
or
with high folate with or without PI i.e.,
fol l.Omg/1 PI l.Omg/1 (0/D) 
fol l.Gmg/1 PI O.Gmg/1 (#/* )
(ii) pre-incubation addition of BSS (0/i) or MTX llGpM 
( D / B  ) Ih prior to;
19 5
(iii) incubation 3h ( I)-UdR, O.SpCi
Results are presented as mean (cpm) ± s.e. of incorporation 
into lymphocyte cultures of 4 control subjects after 
culture in medion of low folate ± PI and medium of high 
folate ± PI.
low folate high folate
45
40 I
in
o
35
m
30•H
■H
M
in
CN 20
m
o
10
24 48 72
period of culture (h)
96 24 48 72
period of culture (h)
96
Table 20 Effect of culture in medium without PI (HCl) 
on acid-insoluble incorporation of (^^^I)-UdR 
into PHA stimulated lymphocytes ________
Medium MEM m(2)
foll.Omg/1 (± PI l.Omg/1) fol. O.Olmg/1 (± PI O.Olmg/1)
Preincubn. BSS MTX BSS MTX
Percentage (125 I)-UdR incorporation in 9 PI mediiim cf. ®
PI medium cultures
Subjects
control
1 123 70 106 104
2 136 100 102 102
3 46 72 105 79
81 96 111 129
5 50 53 129 101
5 71 53 222 210
7 116 92 342 151
8 207 181 295 199
X 105 95 176 136
s.e. 18 13 34 17
anld
1 62 34 80 89
2 107 155 112 81
aid
3 51 75 80 98
4 80 72 96 86
X 75 84 92 89
s.e. 12 25 8 4
Culture conditions as for table (15)
Incorporation after culture in medium without PI (HCl) is expressed as a % 
of incorporation in replicate cultures in which PI (HCl) was present
PHA stimulated lymphocyte culture, was determined.
In Fig, 16 the result of an experiment in which acid- 
125insoluble ( I)-UdR incorporation was determined at
24, 48, 72 and 96 h in stimulated lymphocytes cultured
in the presence or absence of 4-dPN, is shown. The
basal medium used was complete MEM and incorporation
was determined after pre-incubation with BSS and MTX.
The results of this experiment indicate that 4-dPN,
when added prior to initiation of culture, results
12 5in a marked reduction in ( I)-UdR incorporation 
throughout the subsequent course of PHA stimulation.
This reduction in incorporation is of similar 
magnitude after pre-incubation with either BSS or 
MTX.
The sensitivity of PHA stimulated lymphocytes of
normal and alcoholic liver disease subjects to culture
in medium containing 4-dPN was assessed by determination
12 5of acid-insoluble ( I)-UdR incorporation into 72h
PHA stimulated lymphocytes. The results of this
experiment are presented in Table 21; (a) control
subjects and (b) alcoholic liver disease subjects.
The media used was modified MEM with a folate
concentration of 0.01 mg/1. The effect of culture
in the presence of 4-dPN was determined in medium
containing pyridoxal (1.0 mg/1) and in medium without
12 5pyridoxal. Determination of acid-insoluble ( I)- 
UdR incorporation was carried out after pre-incubation 
with BSS, MTX or 5-fu, The use of 5-fluorouracil 
the reduction product of which, 5-fluoro-2’-deoxyuridine 
5'-phosphate, is an inhibitor of thymidylate synthetase,

Fig. 16 Effect of Culture in Medium Containing 
4-dPN on Acid-insoluble Incorporation 
of (^^^I)-UdR into PHA Stimulated 
Lymphocytes
12 5Acid-insoluble ( )-UdR incorporation (cpm) into
5
PHA stimulated lymphocyte cultures (2.5 x 10 cells) 
was determined at the times indicated after;
(i) culture in modified MEM (2) with folate
l.Omg/1, PI l.Omg/1, without H-dPN (O / □  )
or with folate l.Omg/1, PI l.Omg/1, 4-dPN 
500mg/l (# / m  )
(ii) pre-incubation addition of BSS (0/#) or MTX 
llOpM (D/SI) Ih prior to;
(iii) incubation, 3h (^^^I)-UdR, O.SpCi
Individual results were expressed as a % of acid- 
125insoluble ( I)-UdR incorporation (cpm) in 
comparable lymphocytes cultured in medium free of
4-dPN, after pre-incubation with BSS, at 72h.
Group results are given as mean % (cpm) ± s.e. of 
lymphocyte cultures of 4 control subjects.
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Table 21 Sensitivity of Acid-insoluble (^^^I)-UdR
Incorporation into PHA Stimulated Lymphocytes
of Control and Alcoholic Liver Disease Subjects
to Initial Culture Medium Addition of 4-dPN
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA 
stimulated lymphocyte cultures (2.5 x 10  ^ cells) of 
normal (control) subjects (a) and alcoholic liver disease 
(aid) subjects (b) was determined at 72h after;
(i) culture in modified MEM (2) with low folate 
O.Olmg/1 and high PI l.Omg/1 and with or without
4-dPN (500mg/l) or with low folate O.Olmg/1, 
without PI and with or without 1-dPN (500mg/l)
(ii) pre-incubation addition of BSS, or MTX (llOpM) or
5-fu (l.OmM) prior to;
(iii) incubation 3h, ( I)-UdR, 0.5pCi
Results are given as the mean of duplicate analyses. 
Incorporation into lymphocytes cultured in the presence 
of 4-dPN is expressed as a % of incorporation into 
lymphocytes cultured in medium free of 4-dPN.
Table 21
(a)
Medium MEMm low fol / hig h PI
?rs-inc'n 3SS MTX 5-fu
Medium ^dPN - + % - % - %
Subjects
Conrrol
1 31945 20289 55 46057 42412 92 4 2'8 9 6 3 5670 33
2 23722 18177 77 31365 2 53 80 31 3 8 5 4 1 31100 81
3 32685 31983 98 35832 39983 110 50300 47205 73
u 31576 135 72 59 31040 27522 39 37085 23404 53
X 75 93 75
s.e. 3 . 7 6 .1
Medium MEMm low fol / without PL
1 283<ï3 93 57 33 43405 28875 67 3 58 14 23374 5 5
2 26724 15598 58 31719 22296 70 41338 30863 75
3 3 8 774 32879 35 44910 41341 92 52229 43899 71
35230 18864 52 33198 17270 52 37344 14347 38
X 57 70 5 2
s.e. 10 , 7 8 . 3 3 . 3
(b)
Medium ME'Mm low fol / high PI
Pre-inc'n 3SS MTX 5-fu
Medium 4dPM - + % - f % - + %
Subjects
aid
1 4901 1556 32 7811 2543 33 14265 -6269 44
2 22240 9893 44 16767 12822 75 30090 25831 39
3 16870 10151 50 1^589 1022 5 70 21518 9342 ^3
4- 33587 11806 35 38596 4 3 58 2 113 40338 15620 41
X 43 73 5 4
S . e . 6 . 3 15 . 4 11.5
Medium MEMm low fol/without PI
1 3 55 5 2551 7 5 3 35 5 3 3 6 7 ^0 5 346 30^0 -18
2 20902 13189 63 23^22 14125 60 31385 20367 54
3 15214 5451 40 18555 5485 34 19781 18 313 93
4 33172 3 5338 107 39317 ^2108 107 39650 10436 25
X 71 60
S . e . 14.0 15 . 5 1^ . 1
provides an alternative means of inhibiting de novo 
thymidylate synthesis (Paul, 1975).
Analysis of the results indicates that there is no 
consistent difference between stimulated lymphocytes 
of normal and alcoholic liver disease subjects in 
their response to culture in medium containing 4~dPN.
When the effect of 4-dPN on PHA stimulated lymphocyte
culture in high folate conditions (1.0 mg/1) was
determined, similar results were obtained and these
are presented in Table 22. These results also
indicate that the effect of 4-dPN in reduction of 
12 5( I)-UdR incorporation is similar in medium with 
or without pyridoxal and after pre-incubation with 
either BSS or MTX.
The effect of increasing the medium PI (HCl)
12 5concentration on acid-insoluble ( I)-UdR incor­
poration into PHA stimulated lymphocytes cultured in 
the presence of 4-dPN is shown in Fig. 17. Increasing 
the medium pyridoxal concentration to a level of 
10 mg/1 was found to have little influence on the 
effect of 4-dPN in lymphocytes of either control or 
alcoholic liver disease subjects.
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3.3.7. Effect of Variation of Cell Culture Medium
12 5Composition on Acid-insoluble ( I)-UdR Incorporation 
into PHA Stimulated Lymphocytes
The experiments reported in this section were directed
at characterisation of a selective medium for assessment
of vitamin B6 status in PHA stimulated lymphocytes,
of alcoholic liver disease subjects. The results of
12 5a comparison of acid-insoluble ( I)-UdR incorporation
into PHA stimulated lymphocytes cultured in modified
MEM (2) or basal BSS medium are shown in Fig. 18,
and the effect of variation of cell culture medium
12 5composition on acid-insoluble ( I)-UdR incorporation 
into PHA stimulated lymphocytes is shown in Fig. 19.

12 5
Fig. 18 Comparison of Acid-insoluble ( I)-UdR 
Incorporation into PHA Stimulated 
Lymphocytes Cultured in Modified MEM (2) or 
Basal BSS Medium
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5stimulated lymphocyte cultures (2.5 x 10 cells) was 
determined at 72h after;
(i) culture in modified MEM(2) or basal BSS medium 
(15% autologous serum)
(ii) pre-incubation addition of BSS (50pl), Am 
(O.llM-mM), UdR (2.7mM), 4dPN (2.6mM) or Am 
(0.114mM)/4dPN (2.6mM). 1 h prior to;
(iii) incubation 3h (^^^I)-UdR 0,5uCi
Results are presented as mean (cpm) ± s.e. of incorporation 
into lymphocyte cultures of 2 aid subjects.
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Fig. 19 Effect of Variation of Cell Culture Medium
Composition on Acid-insoluble (^^^I)-UdR
Incorporation into PHA Stimulated Lymphocytes
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA 
stimulated lymphocyte cultures (2.5 x 10  ^ cells) was 
determined at 72h after;
(i) culture in basal BSS medium with MEM vitamin and 
MEM amino acid additives as specified. Where 
added, MEM vitamins and amino acids were present 
at the same concentration as in MEM. (10% 
autologous serum)
(ii) pre-incubation addition of BSS or MTX (llOpM) Ih 
prior to;
19 5
(iii) incubation, 3h ( I)-UdR, 0.5 uCi
Incorporation into lymphocytes cultured in various media 
and after pre-incubation with BSS or MTX was expressed 
as a % of incorporation into lymphocytes cultured in 
basal BSS medium plus MEM vitamins and amino acids and 
after pre-incubation with MTX.
Group results are given as mean % (cpm) ± s.e. of 
lymphocyte cultures of 4 control subjects and 3 alcoholic 
liver disease subjects. The culture and pre-incubation 
conditions for each experiment are indicated at the base 
of the figure.
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Section 3.1.
Characterisation of the Effects of Vitamin B6
Antagonists on PHA Stimulation of Lymphocytes
3.1.1. Effect of Culture in Medium Containing the
Vitamin B6 Antagonist Isonicotinic Acid Hydrazide
12 5on Acid-insoluble Incorporation of ( I)-UdR 
into PHA Stimulated Lymphocytes
The appropriate use of specific metabolic inhibitors 
in biochemical investigations has provided much useful 
information and insight into a number of areas of 
metabolism. Although the advantages of their use 
usually outweigh the disadvantages, it is necessary 
to apply due circumspection to interpretation of 
results of experiments based on their use. The 
principal assumption in a consideration of the effect 
of an inhibitor is its specificity. In particular it 
is assumed that the effects observed due to the use of 
an inhibitor result from inhibition of the target 
activity and are not due to a non-specific effect. A 
wide variety of compounds are known to interfere at one 
or another point with the metabolism of vitamin B6.
In principle, such antagonists might exert their effects 
by interfering at any of the several points of importance 
in utilisation of vitamin B6 itself, i.e., in the 
absorption of the vitamin, in its transformation to PEP 
or by conversion to an analogue of PEP that could compete 
with the latter for combination with various apoenzymes. 
Demonstration that a particular inhibitor acts in one 
of these ways does not, however, eliminate the 
possibility that it also acts in another.
In considering 1-dPN as a specific vitamin B6 antagonist 
it is not possible to exclude a non-specific effect 
also resulting in a reduction of DNA synthesis, but 
its widespread employment by other investigators does
justify its use in this study. Further confirmation of 
the validity of its use is gained from a comparison of 
the effects of 4-dPN with the effects of an alternative 
vitamin B6 antagonist isonicotinic acid hydrazide (INK). 
This compound is one of a number of carbonyl reagents 
which are potent inhibitors of pyridoxal kinase and thus 
interfere with formation of PLP. The active inhibitors 
in this case are the condensation products of the 
carbonyl reagents with pyridoxal (Greenberg, 19 70).
The results of such a comparison are shown in Fig. 2 0
and indicate that the effect of INH in reducing acid-
125insoluble incorporation of ( l)-UdR into PHA 
stimulated lymphocytes is similar to that of 4-dPN.
3.4.2. Effect of Pre-incubation with MTX and 5-fu on
12 5Subsequent Acid-insoluble ( l)-UdR incorporation 
into PHA Stimulated Lymphocytes
The use of MTX and 5-fu in experimental determination of 
the respective de novo and salvage pathways’ contribution 
to total thymidylate synthesis has been mentioned 
previously (sections 3.3.1. and 3.3,6.). Both these 
inhibitors, by their effect on de novo thymidylate 
synthesis, increase acid-insoluble (^^^l)-UdR incorpora­
tion into PHA stimulated lymphocytes. However, the 
increase in incorporation caused by 5-fu is greater 
than that caused by MTX. The reason for this difference 
is partly apparent from a consideration of the different 
modes of action of these two inhibitors.

Fig. 20 Effect of Culture in Medium Containing the 
Vitamin B8 Antagonist Isonicotinic Acid 
Hydrazide on Acid-insoluble Incorporation 
of (^^^l)-UdR into PHA Stimulated Lymphocytes
12 5Acid-insoluble ( l)-UdR incorporation (cpm) into PHA
5
stimulated lymphocyte cultures (2.5. x 10 cells) was 
determined at 7 2h after;
(i) culture in complete MEM with no addition
or added INH 
(500mg/l)
or added 4-dPN 
(5G0mg/l)
(ii) pre-incubation addition of BSS or MTX (llOpM)
15 min.
prior to;
(iii) pre-incubation addition of BSS or UdR (2.7mM)
Ih prior to;
(iv) incubation 3h (^^^I)-UdR, O.SpCi
Incorporation into lymphocytes cultured in the presence 
of INH and 4-dPN and after various pre-incubation 
additions was expressed as a % of incorporation into 
lymphocytes cultured in complete MEM with no addition and 
after pre-incubation with BSS and MTX.
Group results are given as mean % (cpm) ± s.e. of 
lymphocyte cultures of 4 control subjects.
The culture and pre-incubation conditions for each 
experiment are as indicated at the base of each column.
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Methotrexate inhibits dihydrofolate reductase and 
therefore disrupts the regeneration of active on- 
carbon units necessary for méthylation of dUMP by 
thymidylate synthetase. 5-fluorouracil, however, 
after conversion to 5-fdUMP, inhibits thymidylate 
synthetase directly. Therefore, it is likely that 
in the presence of methotrexate, de novo thymidylate 
synthesis will continue until the available pool of 
active one-carbon units is exhausted whereas in the 
presence of 5-fluorouracil inhibition of de novo 
thymidylate synthesis is more direct and is independent 
of the size of the active one-carbon folate pool.
Several factors can be expected to influence the size of
the active one-carbon folate pool. Of particular
interest in this study is the effect of vitamin B6
deficiency and the medium folate concentration. The
effect of variation of these factors on the difference
12 5in acid-insoluble ( I)-UdR incorporation into PHA
stimulated lymphocytes pretreated with MTX and 5-fu is
shown in Fig. 21. The results indicate that the
12 5greatest difference in ( I)-UdR incorporation after 
pre-incubation with MTX and 5-fu occurs in PHA stimulated 
lymphocytes cultured in a high folate medium and that this 
difference is reduced either by culture in medium 
containing 1-dPN or in medium with a low folate 
concentration. Statistical analysis of these results, 
as presented in Table 23, confirms this interpretation.
(P < 0.01) .

Fig. 21 Effect of Pre-incubation with MTX and 5-fu on
12 5Subsequent Acid-insoluble ( I)-UdR Incor­
poration into PHA Stimulated Lymphocytes
12 5
Acid-insoluble ( I)-UdR incorporation (cpm) into PHA 
stimulated lymphocyte cultures (2.5 x 10  ^ cells) was 
determined at 7 2h after;
(i) culture in modified MEM(2)with a folate 1.0 mg/1,
PI l,Omg/l
and with or without 1-dPN 
(500mg/l)
or with a folate O.Olmg/1, 
without PI,
and with or without l-dPN 
(500mg/l)
(ii) pre-incubation addition of BSS, MTX (llOpM or 
5-fu (l.OmM) Ih prior to
(iii) incubation 3h (^^^I)-UdR, O.SpCi
Incorporation into lymphocytes cultured in various media 
and after pre-incubation addition of BSS, MTX or 5-fu 
was expressed as a% of incorporation into lymphocytes 
cultured in MEMm (fol/Pl l.Omg/1) without 1-dPN and 
after pre-incubation with MTX.
Group results are given as mean % (cpm) ± s.e. of 
lymphocyte cultures of 4 control subjects.
The culture and pre-incubation conditions for each 
experiment are as indicated at the base of each column.
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3.4.3. Effect of Prior Addition of MTX and 5-fu on UdR
12 5Suppression of Acid-insoluble ( I)-UdR Incorporation 
into PHA Stimulated Lymphocytes
In section 1.4.5. the possible use of the UdR suppression
test as a means of determining the efficiency of the de
novo thymidylate pathway, in the presence of a vitamin B6
or folate deficiency, was described. In section 3.3.3.
the results of experiments in which the UdR suppression
effect was determined in PHA stimulated lymphocytes of
both control and alcoholic subjects are presented. These
experiments utilised medium of high and low folate
concentration, with and without pyridoxal HCl, and the
results indicated that there were no significant differences
12 5in UdR suppression of ( I)-UdR incorporation into PHA 
stimulated lymphocytes of control or alcoholic subjects, 
irrespective of the culture medium.
A possible interpretation of these results would be that 
the lack of difference in the UdR suppression test 
indicates that there is no difference in the efficiency 
of the de novo thymidylate pathway in stimulated 
lymphocytes of control and alcoholic subjects cultured 
in these various conditions. However, in view of the 
doubts raised concerning the validity of this test, it 
seemed desirable to test its validity by an alternative 
approach.
Since MTX and 5-fu inhibit de novo thymidylate synthesis
and thus mimic the effect of folate deficiency it was
decided to determine the effect of pre-treatment with
these two inhibitors on subsequent UdR suppression of 
12 5( I)-UdR, incorporation into PHA stimulated lymphocytes.
As previously indicated the principal site of action 
of each of these inhibitors is different; MTX inhibits 
generation of Hi|F from HgF whereas 5-fdUMP, derived from 
5-fu inhibits thymidylate synthetase. However, the 
overall effect of each is that subsequently added UdR 
would not be efficiently converted to dTMP and dTTP and 
could not therefore result in feedback inhibition of 
thymidine kinase.
The effect of prior addition of MTX and 5-fluorouracil
12 5on UdR suppression of acid-insoluble ( I)-UdR incor­
poration into PHA stimulated lymphocytes was determined 
in medium of high er low folate concentration (Table 24) 
and in the presence and absence of 4-dPN (Figs. 2 2 and 
2 3 ) .
3.4,4. Effect of Pre-incubation Addition of formate on 
Acid-insoluble (^^^I)-UdR Incorporation into PHA 
Stimulated Lymphocytes
From the results of previous experiments concerning the 
effect of vitamin B6 deficiency and variation of the medium 
folate concentration on the respective contribution of 
the de novo and salvage pathways to total thymidylate 
synthesis, it was apparent that while vitamin B6 deficiency 
(as induced by 4-dPN) reduced overall DNA synthesis, but 
did not alter the relative contribution of the de novo 
pathway to total thymidylate synthesis, an increase in the 
medium folate concentration from O.Olmg/1 to lmg/1 
significantly reduced the salvage contribution but 
did not affect total thymidylate incorporation.
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•FIG. T2. Effect of prior addition of MTX and 5-fu on UdR suppression 
of acid-insoluble (^^^I)-UdR incorporation into PHA stimulated 
lymphocytes cultured in the presence and absence of 4 - d P N ______
Acid-insoluble (^^^I)-UdR incorporation (cpm) into PHA stimulated 
lymphocyte cultures (2.5 x 10^ cells) was determined at 72h after;
(i) culture in modified MEM (2) with folate concentration of 
O.Olmg/1 without PI and with or without h-dPN (500mg.l)
(ii) pre-preincubation addition of BSS, MTX (llOpM) or 5-fu (l.OmM) 
15 min. prior to;
(iii) preincubation addition of BSS or UdR (2.7mM)
Ih prior to ;
(iv) incubation 3h (^^^I)-UdR, 0.5pCi
Incorporation into lymphocyte cultures was expressed as a % of 
incorporation into comparable lymphocytes cultured in medium without 
4-dPN and after preincubation with BSS.
Results are given as mean % (cpm) ± s.e. of lymphocyte cultures of 
2 control subjects.
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Fig. 23 Effect of Prior Addition of MTX and 5-fu on
19 5UdR Suppression on Acid-insoluble ( I)- 
UdR incorporation into PHA Stimulated 
Lymphocytes Cultured in the Presence and 
Absence of H-dPN
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5
stimulated lymphocyte cultures (2.5 x 10 cells) was 
determined at 7 2h after;
(i) culture in modified MEM (2) with a folate concen­
tration of l.Omg/1 without PI and with or without 
4-dPN (5G0mg/l)
(ii) pre-incubation addition of BSS, MTX (llOpM) or 5- 
fu (l.OmM) 15 min. prior to;
(iii) pre-incubation addition of BSS or UdR (2.7mM) Ih 
prior to;
(iv) incubation, 3h (^^^I)-UdR, 0,5pCi
Incorporation into lymphocyte cultures was expressed as a % 
of incorporation into comparable lymphocytes cultured in 
medium without 4-dPN and after pre-incubation with BSS.
Results are given as mean % (cpm) ± s.e. of lymphocyte 
cultures of 5 control subjects.
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These results indicated that whereas an increase in
the folate concentration increased the contribution of
the de novo thymidylate pathway, a decrease in vitamin
B6 concentration had no effect. Efficient operation
of the de novo pathway is dependent on availability of
5, 10 methylene H^F. This is formed from H^F and a
carbon source such as serine by the PLP dependent enzyme
serine hydroxymethyltransferase. Formation of 5, 10
methylene H^F therefore requires H^F, a source of one-
carbon units and PLP. The influence of the medium
folate concentration and the lack of influence of vitamin
B6 deficiency on de novo thymidylate synthesis has
previously been shown (3.3.2. and 3.3.5.). In this
experiment the effect of variation in supply of one-
carbon units was investigated. As formate has been
shown to be a source of thymine methyl groups in
various cell types (Blakely, 1969), it was decided to
determine the effect of pre-incubation addition of
12 5formate on acid-insoluble ( I)-UdR incorporation into 
PHA stimulated lymphocytes.
In Fig. 2 4 the results of an experiment in which the
effect of formate was determined in stimulated lymphocytes
cultured in medium of high and low folate concentration
and in the presence and absence of 4-dPN are illustrated.
In figs. 25 and 26, the effect of pre-incubation
12 5addition of formate on ( I)-UdR incorporation was 
determined after prior addition of MTX and 5-fu. Again, 
medium of high and low folate concentration with and 
without 4-dPN was used.

Fig. 24 Effect of Pre-incubation with Formate on
12 5Acid-insoluble ( I)-UdR Incorporation into 
PHA Stimulated Lymphocytes Cultured in Medium 
of High and Low Folate Concentration and in 
the Presence and Absence of 4-dPN
19 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5
stimulated lymphocyte cultures (2.5 x 10 cells) was 
determined at 72h after;
(i) culture in modified MEM(2) with a folate/Pl
concentration of l.Omg/1 and with or 
without 4-dPN (5G0mg/l) or with a folate 
concentration of O.Olmg/1, without PI and 
with or without 4-dPN (500mg/l)
(ii) pre-incubation addition of BSS, formate (4mM), 
MTX (llOpM) or 5-fu (l.OmM), Ih prior to;
(iii) incubation 3h (^^^I)-UdR, O.SpCi
Incorporation into lymphocyte cultures was expressed as 
a % of incorporation into comparable lymphocytes cultured 
in MEM (fol/Pl, l.Omg/1) without 4-dPN and after pre­
incubation with MTX.
Results are given as mean % (cpm) ± s.e. of lymphocyte 
cultures of 4 control subjects.
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Fig. 25 Effect of Prior Addition of MTX and 5-fu, and 
Pre-incubation with Formate, on Acid-insoluble 
(^2 5i)-udR Incorporation into PHA Stimulated 
Lymphocytes Cultured in Low Folate Medium
Acid-insoluble (^^^I)-UdR incorporation into PHA
5
stimulated lymphocyte cultures (2.5 x 10 cells) was
determined at 7 2h after;
(i) culture in modified MEM (2) with a folate 
concentration of O.Olmg/1 without PI and with 
or without 4-dPN (500mg/l)
(ii) pre-preincubation with BSS, MTX (llOpM) or 5-fu 
(l.OmM) 15 min, prior to;
(iii) pre-incubation with BSS or formate (4mM) Ih 
prior to;
(iv) incubation, 3h (^^^I)-UdR, 0.5pCi
Incorporation into lymphocyte cultures was expressed as 
a % of incorporation into comparable lymphocytes cultured 
in MEMm (folate O.Olmg/1) without 4-dPN and after successive 
pre-incubation with MTX and BSS.
Results are given as mean % (cpm) ± s.e. of lymphocyte 
cultures of 2 control subjects.
180
160
140
120
100
o 80
•H
60
•H
40
LO£N
20
BSS^rmpreincub’n BSS Ëbrm 3SS form
prepreincub ' n BSS MTX 5-fu BSS 5-fuMTX
ffiMm low fol MEMm low fol 4dPN

Fig. 28 Effect of Prior Addition of MTX and 5-fu,
and Pne-incubâtion with Formate on Acid- 
125insoluble ( I)-UdR Incorporation into 
PHA Stimulated Lymphocytes Cultured in 
High Folate Medium
Acid-insoluble (^^^I)-UdR incorporation into PHA
stimulated lymphocyte cultures (2.5 x 10  ^ cells) was
determined at 7 2h after;
(i) culture in modified MEM (2) with a folate 
concentration of l.Omg/1 without PI and with 
or without 4-dPN (500mg/l)
(ii) pre-preincubation with BSS, MTX (llOpM) or 5-fu 
(l.OmM) 15 min. prior to;
(iii) pre-incubation with BSS or formate (4mM) Ih 
prior to;
19 5
(iv) incubation, 3h, ( I)-UdR, 0.5pCi
Incorporation into lymphocyte cultures was expressed as a % 
of incorporation into comparable lymphocytes cultured in 
MEMm (folate, l.Omg/1) without 4-dPN and after successive 
pre-incubation with MTX and BSS.
Results are given as the mean % (cpm)± s.e. of lymphocyte 
cultures of 2 control subjects.
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3.4.5. Incorporation of ( I)-UdR and 3-( C)-
Serine into PHA Stimulated Lymphocytes
Determination of the rate of DNA synthesis using a
12 5salvage pathway substrate such as C I)-UdR is
independent of direct involvement of PLP dependent
enzymes. In order to confirm that observed changes
12 5in acid-insoluble ( I)-UdR incorporation do in fact
reflect changes in total DNA synthesis and the
respective contributions of salvage and de novo pathways
to thymidylate synthesis, it is necessary to carry out
parallel experiments in which incorporation of a de novo
pathway substrate into DNA is determined. Such
experiments are also necessary in order to characterise
more directly the effect of vitamin B6 deficiency on
DNA synthesis. Since a major source of the methyl group
14of thymine is carbon-3 of serine, 3-( C)-serine was
used to label DNA via the de novo pathway. Incorporation 
14of 3-( C)-serine label into DNA is dependent on both 
folate coenzymes and the PLP dependent enzyme, serine 
hydroxymethyltransferase, therefore one might expect such 
incorporation to be sensitive both to the medium folate 
concentration and to vitamin B6 status.
From a consideration of the various metabolic pathways
14in which serine is involved it is apparent that 3-( O -
serine label would be incorporated into a number of
different cellular components including DNA, protein,
lipid etc. Since the principal component of interest is
14DNA, the extent of 3-( C)-serine incorporation into a 
DNA extract of PHA stimulated lymphocytes was determined.
i  i l
The pathway of incorporation of 3-( C)-serine label
into DNA is via transfer of the labelled carbon to
Hj^ F to form 5, 10 methylene H^F. This step requires
the PLP dependent enzyme serine hydroxymethyltransferase.
The labelled carbon on 5, 10 methylene H^F may then be
incorporated into DNA via purine synthesis or via
méthylation of dUMP in de novo thymidylate synthesis.
14Thus incorporation of 3-C C)-serine label into a DNA 
extract is not absolutely specific for de novo 
thymidylate synthesis. This is not a serious limitation 
however 5 as such incorporation would still be dependent 
on vitamin B6 requiring enzyme activity, would still be 
expected to be sensitive to vitamin B6 deficiency and 
would still be expected to reflect the effect of vitamin 
B6 deficiency on DNA synthesis and cell growth.
In this experiment, acid-insoluble incorporation of the
12 5salvage thymidylate pathway, substrate analogue, ( I)-
UdR, into PHA stimulated lymphocytes is compared with
14incorporation of 3-( C)-serine label into a DNA extract 
of similarly cultured PHA stimulated lymphocytes. 
Determination of incorporation was carried out at 24, 48,
7 2 and 9 6h in lymphocytes cultured in modified MEM.
The results are illustrated in Fig. 27, low folate 
conditions, and in Fig. 28, high folate conditions.
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Fig. 27 Incorporation of ( I)-UdR and 3( C)-serine 
label into PHA Stimulated Lymphocytes Cultured 
in Medium of Low Folate Concentration
12 5Acid-insoluble C I)-UdR incorporation (cpm) into PHA
5
stimulated lymphocyte cultures (2.5 x 10 cells) and
14incorporation of 3-( C)-serine label into a DNA extract 
of lymphocyte cultures derived from the same subject was 
determined at the times indicated, after;
(i) culture in modified MEM (2) with a folate concen­
tration of O.Olmg/1, (PI, l,Omg/l).
125
(ii) for determination of ( l)-UdR incorporation; pre­
incubation with BSS (0) or MTX, llOpM (□),
14and for determination of 3-( C)-serine incorpor­
ation: pre-incubation with BSS (tt).
(iii) incubation, 3h (^^^I)-UdR, 0.5pCi
1 4or incubation 3h 3-( C)-serine, 0.25pCi
12 5Results are presented as mean (cpm) ± s.e. of ( I)-UdR
14incorporation or mean (cpm)± s.e. of 3-( C)-serine incor­
poration, in lymphocyte cultures of 2 control subjects.
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Fig. 28 Incorporation of ( I)-UdR and 3-( C)-serine
Label into PHA Stimulated Lymphocytes Cultured
in Medium of High Folate Concentration
12 5Acid-insoluble ( l)-UdR incorporation (cpm) into PHA
5
stimulated lymphocyte cultures (2.5 x 10 cells) and
14incorporation of 3-( C)-serine label into a DNA extract 
of lymphocyte cultures derived from the same subject was 
determined at the times indicated, after;
(i) culture in modified MEM (2) with a folate concentration 
of l.Omg/1, (PI l.Omg/1),
12 5(ii) for determination of ( I)-UdR incorporation: pre- 
incubation with BSS (0), or MTX, llOpM. (D).
1 4 .and for determination of 3-( C)-serine incorporation: 
pre-incubation with BSS (M ).
(iii) incubation 3h, (^^^l)-UdR, 0.5pCi
■i ii
or incubation 3h, 3-( C)-serine, 0.25pCi
12 5Results are presented as mean cpm ± s.e. of ( I)-UdR
14incorporation or mean cpm ± s.e. of 3-( C)-serine incor­
poration in lymphocyte cultures of 2 control subjects.
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3.4.6. Effect of Variation of the Medium Folate
Concentration and Pre-incubation with MTX and 5-fu
14on Incorporation of 3-( C)-serine label into a 
DNA Extract of PHA Stimulated Lymphocytes
In this experiment the effect of culture in medium of 
both high and low folate concentration, and pre-incuba­
tion with MTX and 5-fu, on subsequent incorporation of 
1 u3-( C)-serine label into a DNA extract of PHA
stimulated lymphocytes was determined. Determination
of incorporation was carried out 72h after initiation
of culture and the results are illustrated in Fig. 29
The results indicate that in a low folate medium,
14incorporation of 3-( C)-serine label into a DNA
extract is reduced relative to incorporation into
lymphocytes cultured in high folate medium. The
results also indicate that pre-incubation with MTX
14or 5-fu reduces 3-( C)-serine label incorporation 
into DNA and that this effect is independent of the 
medium folate concentration.
3.4.7. Effect of Variation of the Medium Folate
Concentration and Pre-incubation with MTX and UdR
14on Incorporation of 3-( C)-serine Label into a DNA 
Extract of PHA Stimulated Lymphocytes
In this experiment the effect of culture in medium of 
both high and low folate concentration, and pre-incuba­
tion with MTX and UdR, on subsequent incorporation of 
3 - ( -serine label into a DNA extract of PHA 
stimulated lymphocytes was determined. Determination 
of incorporation was carried out 72h after initiation 
of culture and the results are illustrated in Fig. 30. 
As in the previous experiment (3.4.6.), incorporation

Fig. 29 Effect of Variation of the Medium Folate
Concentration and Pre-incubâtion with MTX
14and 5-fu on Incorporation of 3-( C)- 
serine label into a DNA Extract of PHA 
Stimulated Lymphocytes
14Incorporation of 3-( C)-serine label into a DNA extract
5
of PHA stimulated lymphocyte cultures (2.5 x 10 cells) 
was determined at 7 2h after;
(i) culture in modified MEM (2) with a folate concentra­
tion of l.Omg/1. (PI l.Omg/1) or O.Olmg/1,
(PI l.Omg/1).
(ii) pre-incubation addition of BSS, MTX (llOpM) or 
5-fu (1.OmM).
1 U(iii) incubation 3h, 3-( C)-serine, 0.25pCi
14Results are presented as mean cpm ± s.e. of 3-( C)-serine 
label incorporation into a DNA extract of lymphocyte cultures 
of 4 control subjects.
3 r
CO
■H
-U
ftJ
&
oCJ
c
o
5
6
preinc’n BSS MTX 5-fu BSS MTX 5-fu
culture MEMm high fol MEMm low fol

Fig. 30 Effect of Variation of the Medium Folate
Concentration, and pre-incubation with MTX and
14UdR, on Incorporation of 3-( C)-serine label 
into a DNA Extract of PHA Stimulated Lymphocytes
14Incorporation of 3-( C)-serine label into a DNA extract
5of PHA stimulated lymphocyte cultures (2.5 x 10 cells) 
was determined at 72h after;
(i) culture in modified MEM (2) with a folate 
concentration of l.Omg/1, (PI l.Omg/1) or 
O.Olmg/1 (PI l.Omg/1)
(ii) pre-incubation addition of BSS, MTX (llOpM) or 
UdR (2.7mM)
1 4(iii) incubation, 3h 3-( O-serine, 0.25pCi
14Results are presented as mean cpm ± s.e, of 3-( C)- 
serine label incorporation into a DNA extract of 
lymphocyte cultures of 2 control subjects.
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1 uof 3-( C)-serine label into a DNA extract of PHA
stimulated lymphocytes cultured in a low folate
medium is reduced relative to that of incorporation
into comparable lymphocytes cultured in a high
folate medium. Similarly incorporation into lymphocytes
cultured in either medium is reduced by pre-incubation
with MTX. Pre-incubation with UdR however increases 
1 4 .3-( C)-serine label incorporation, relative to 
incorporation into lymphocytes pre-incubated with BSS.
As before this effect occurs in lymphocytes cultured 
in medium of high or low folate concentration.
3.4.8. Effect of Addition of MTX and 5-fu Followed by
14Pre-incubation with UdR on Incorporation of 3-( C)- 
serine label into a DNA Extract of PHA Stimulated
Lymphocytes
Several possible mechanisms may be proposed to account
14for the observed increase in 3-( C)-serine label 
incorporation into a DNA extract of PHA stimulated 
lymphocytes after pre-incubation with UdR. If it is 
assumed that addition of UdR does not cause an increase 
in the actual rate of DNA synthesis, and if it is 
further assumed that only local effects are involved 
then the most obvious implication is that pre-incubation 
addition of UdR results in a change in the relative 
contributions of the de novo and salvage pathways to 
thymidylate synthesis. Such a change could result from 
either an alleviation of a restriction in de novo 
synthesis, at the level of dUMP, or inhibition of 
salvage thymidylate synthesis, probably at the level 
of thymidine kinase. The possibility that the de novo 
thymidylate pathway was limited by availability of
dUMP and not by the availability of the folate co- 
enzyme, 5, 10, methylene was investigated in
the following experiment by using MTX and 5-fu to 
produce a de facto folate deficiency.
After 15 min. pre-pre-incubation with BSS, MTX or
5-fu, PHA stimulated lymphocyte cultures were pre-
incubated with either BSS or UdR for a period of Ih
14-prior to incubation with 3-( C)-serine and determination 
of radioactive label incorporation into extracted DNA.
The results of this experiment are illustrated in 
Fig. 31. It is apparent from these results that 
limitation of folate coenzyme availability (MTX) is 
almost as effective as inhibition of thymidylate
synthetase (5-fu) in preventing a UdR dependent 
14increase in 3-( C)-serine label incorporation : 
a DNA extract of PHA stimulated lymphocytes.
3.4.9. Effect of Culture in Medium Containing 4-dPN
14on Incorporation of 3-( C)-serine label into a 
DNA Extract of PHA Stimulated Lymphocytes
In this experiment, the effect of culture in the presence
14of 4-dPN on incorporation of 3-( C)-serine label into
a DNA extract of PHA stimulated lymphocytes was
determined. The basal culture medium used was
modified MEM with either a high (l.Omg/1) or low (O.Olmg/1)
folate concentration. Determination of incorporation
was carried out at 20, 48, 72 and 96h of culture
14after incubation with 3-( C)-serine (0.25pCi) for 3h.
The results, illustrated in Fig. 32, indicate that
14culture in the presence of 4-dPN reduces 3-( C)-serine

by Pre-incubâtion with UdR, on Incorporation
of 1 43-( C)“serine label into a DNA Extract of
PHA Stimulated Lymphocytes 
14Incorporation of 3-( C)-serine label into a DNA extract
5
of PHA stimulated lymphocyte cultures (2.5 x 10 cells) 
was determined at 7 2h after;
(i) culture in complete MEM
(ii) pre-preincubation addition of BSS, MTX (llOpM),
or 5-fu (l.OmM) 15 min. prior to;
(iii) pre-incubation addition of BSS or UdR (2.7mM)
Ih prior to;
1 4(iv) incubation, 3h 3-( C)-serine, 0.25pCi
14Results are presented as mean cpm ± s.e, of 3-( C)-serine 
label incorporation into a DNA extract of lymphocyte 
cultures of 4 control subjects.
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Fig. 32 Effect of Culture in Medium Containing 4-dPN
14on Incorporation of 3-( C)-serine label int 
a DNA Extract of PHA Stimulated Lymphocytes
14Incorporation of 3-( C)-serine label into a DNA extract 
of PHA stimulated lymphocyte cultures (2.5 x 10  ^ cells) 
was determined at the times indicated, after;
(i) culture in modified MEM (2) with folate l.Omg/1, 
without PI and with (#) or without (0) 4-dPN,
5 0 0mg/l
or with folate O.Olmg/1, without PI
and with ( 0  ) or without (Q) 4-dPN. 500mg/l
1 4
(ii) incubation, 3h, 3-( C)-serine, 0.25pCi
14Results are presented as mean cpm ±s.e. of 3-( C)-serine 
label incorporation into a DNA extract of lymphocyte 
cultures of 4 control subjects.
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label incorporation into a DNA extract of PHA 
stimulated lymphocytes throughout the course of 
culture and that the effect on incorporation into 
lymphocytes cultured in low folate medium is of 
similar magnitude to the effect on incorporation 
into lymphocytes cultured in high folate medium.
143.4.10. Incorporation of ( C)-formate label into 
a DNA Extract of PHA Stimulated Lymphocytes
An alternative method of labelling DNA via the de novo
14thymidylate pathway is to make use of ( C)-formate.
14Using ( C)-formate, labelling of the active one- 
carbon folate pool can occur independently of vitamin 
B6 requiring enzymes but thereafter distribution of 
radioactive label is likely to be similar to
distribution of one-carbon metabolites labelled from
14 143-( C)-serine. Thus ( C)-formate label would be
incorporated into protein, via formation of serine from
glycine, and DNA, via formation of labelled thymidylate
from dUMP. Labelling of the purine ring structure at
carbons 2 and 8, and méthylation of other bases would
14also contribute to labelling of DNA by ( C)-formate.
14Therefore, although incorporation of ( C)-formate into
a DNA extract of PHA stimulated lymphocytes is not
absolutely specific for labelling of DNA via the de novo
thymidylate pathway, it does provide an alternative 
14to use of 3-( C)-serine, which is independent of 
vitamin B6 requiring enzymes and which would therefore 
be expected to reflect DNA synthesis and cell growth 
independently of a direct effect of vitamin B6 
deficiency on DNA synthesis.
In this experiment, the effect of pre-incubation with
BSS, MTX, 5-fu, formate and UdR on subsequent incor- 
14poration of ( C)-formate label, into a DNA extract
of PHA stimulated lymphocytes cultured in modified
MEM containing folate and pyridoxal (l.Omg/1), was
determined. The results, illustrated in Fig. 33,
are comparable with results of similar experiments 
14where 3-( C)-serine label was used, (3.4,7.). 
Principally, pre-incubation with MTX and 5-fu results in 
a reduction of incorporation, and pre-incubation with 
UdR results in an increase in incorporation, relative 
to incorporation into lymphocyte cultures pre­
incubated with BSS.
3.4.11. Effect of Presence of Non-essential amino
12 5acids on Acid-insoluble Incorporation of ( I)-UdR 
into PHA Stimulated Lymphocytes Cultured in Medium 
Containing 4-dPN
The possible causes of vitamin B6 deficiency and the 
likely effects of vitamin B6 deficiency in particular 
circumstances have previously been discussed (1.2.3.). 
Due to the increased rate of cell growth in PHA 
stimulated lymphocytes and the known involvement of 
PLP in de novo thymidylate synthesis, it had been 
imagined that one of the primary effects of vitamin B6 
deficiency in such circumstances would be a restriction 
of DNA synthesis and particularly of de novo thymidylate 
synthesis. However, the process of PHA stimulation 
is accompanied by a variety of other biochemical 
activities which could equally be susceptible to the 
effects of vitamin B6 deficiency and which would also

14Fig. 33 Incorporation of ( C)-formate label into a
DNA Extract of PHA Stimulated Lymphocytes
14Incorporation of ( C)-formate label into a DNA extract
5
of PHA stimulated lymphocyte cultures (2.5 x 10 cells) 
was determined at 7 2h after;
(i) culture in modified MEM (2) with a folate/Pl 
concentration of l.Omg/1
(ii) pre-incubation addition of BSS, MTX (llOpM), 5-fu 
(l.OmM), formate (4mM) or UdR (2.7mM), Ih prior to;
14(iii) incubation, 3h, ( C)-formate, l.OpCi
Results are presented as mean cpm (of duplicate analyses) 
14of ( C)-formate incorporation into a DNA extract of 
lymphocyte cultures of one control subject.
oX
ul
CM
co
•H
(Ü
yA
O
ü
C
■H
CD
4J
e
!4
0  
m
1
u
CN
I
IU
preinc cond BSS iMTC 5-fu form UdR
medium MEÜ4m fol, Pi l.Omg/1
result in a restriction in cell growth and DNA 
synthesis, though not specifically at the level of 
inhibition of de novo thymidylate synthesis.
Among the many processes dependent on vitamin B6 co- 
enzymes, in addition to formation of 5,10,methylene 
H^F, are the incerconversion of numerous amino acids 
and the synthesis of delta-aminolaevulinic acid.
Thus it is conceivable that a vitamin B6 deficiency 
could be primarily expressed through inhibition of 
protein or porphyrin synthesis, and also that such an 
effect could be alleviated by exogenous supply of the 
appropriate vitamin B6 dependent metabolite.
In these experiments, the possibility that the growth
restriction caused by culture in the presence of 4-dPN
could be alleviated by addition to the medium of non-
essential amino acids, including glycine and serine,
was investigated. In Fig. 34, the results of an
experiment in which the effect of non-essential amino
acids to PHA stimulated lymphocytes cultured in
modified MEM, of high folate concentration, with or
without pyridoxal and in the presence or absence of
4-dPN, was determined. Acid-insoluble incorporation 
12 5of C I)-UdR was used as an index of cell growth and
the analysis was carried out at 7 2h after pre-
incubation with either BSS or MTX. In Fig. 35, the
results of a similar experiment are illustrated. Here
the medium used was complete MEM, as above, the effect
of addition of non-essential amino acids to the initial
12 5culture medium, on acid-insoluble incorporation of ( I) 
UdR into PHA stimulated lymphocytes cultured in the

Fig. 34 Effect of Presence of Non-essential amino-
acids on Acid-insoluble Incorporation of
-tT4-------------------------- -----------
( I)-UdR into PHA Stimulated Lymphocytes
Cultured in Medium Containing 4-dPN.
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5
stimulated lymphocyte cultures (2.5 x 10 cells) was 
determined at 7 2h after;
(i) culture in modified MEM (2); the composition of 
the medium used in each experiment was as indi­
cated at the base of each column. The concentra­
tion of the medium components was as follows:
folate (l.Omg/1), PI (l.Omg/1), non-essential 
amino acids (1 x MEM)* and 4-dPN (50 0mg/l).
(ii) pre-incubation addition of BSS or MTX (llOpM),
Ih prior to ;
(iii) incubation, 3h, (^^^I)-UdR, 0.5pCi
Results are presented as mean (cpm) ± s.e. of incorporation 
in lymphocyte cultures of 4 control subjects.
* MEM non-essential amino acids were added at a final 
medium concentration of; alanine (8.9mg/l), asparagine 
(15mg/l), aspartate (13.3mg/l), glutamate (14.7mg/l), 
glycine (7.5mg/l) proline (11.5mg/l) and serine 
(10.5mg/l).
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Fig. 3 5 Effect of Presence of Non-essential amino
acids on Acid-insoluble Incorporation of 
1 9  5( I)-UdR into PHA Stimulated Lymphocyte; 
CuItured in Medium Containing 4-dPN
12 5Acid-insoluble ( I)-UdR incorporation (cpm) into PHA
5stimulated lymphocytes (2.5 x 10 cells) was determined at
72h after;
(i) culture in complete MEM; the composition of the 
medium used in each experiment was as indicated 
at the base of each column. The concentration of 
the medium components was as follows; non-essential 
amino acids (1 x MEM)* and 4-dPN (50 0mg/l)
(ii) pre-incubation addition of BSS, MTX (llOpM), 5-fu
(l.OmM) or UdR (2.7mM), Ih prior to;
(iii) incubation, 3h, (^^^I)-UdR, 0.5pCI
Incorporation into lymphocyte cultures was expressed as a % 
of incorporation into comparable lymphocytes cultured in 
complete MEM without non-essential amino acids or 4-dPN 
and after pre-incubâtion with MTX.
Results are given as the mean % (cpm) ± s.e. of lymphocyte 
cultures of 4 control subjects.
*MEM non-essential amino acids were added at a final medium 
concentration of; alanine (8.9mg/l), asparagine (15mg/l) 
aspartate (13.3mg/l), glutamate (14.7mg/l), glycine 
(7.5mg/l), proline (11.5mg/l) and serine (10.5mg/l).
160
140
(n
I—I
120
X
in
CN
§
-H4J(0
y
uc
■H
I
100
80
60
in
CN
40
20
p r e i n c  n BSS MTX 5 f u  ;]dR BSS OTX Be u [JdR BSS MTX S fu (JdR BSS OTX Bfu JdR
m e d iu m 4dP N 4dP N
n o n  e s s e n t i a l  a m in o  a c i d s
MEM c o m p le t e
X X y .
presence and absence of 4~dPN, was determined at 72h.
In this case however, the effect of pre-incubation 
addition of BSS, MTX, 5-fu and UdR was determined.
The results of these experiments indicate that the
medium presence of non-essential amino acids has little
12 5effect on acid-insoluble incorporation of C I)-UdR 
into PHA stimulated lymphocytes cultured in medium 
with or without pyridoxal and with or without 4-dPN.
3.4.12. Effect of Culture in Medium Containing 4-dPN
14on Acid-insoluble Incorporation of ( C)-leucine Label 
into PHA Stimulated Lymphocytes
The principal method used in this study to estimate cell
growth and DNA synthesis in stimulated lymphocyte cultures
12 5has been based on acid-insoluble incorporation of ( I)- 
UdR. Such a determination has been shown to provide a 
reasonably accurate index of the rate of lymphocyte DNA 
synthesis, and, since DNA synthesis is an integral part 
of the cell cycle, of cell growth. This method has been 
used both to evaluate the cell growth response to PHA 
in lymphocytes of normal and alcoholic liver disease 
subjects and also to investigate the effect of various 
medium components and other reagents on this response.
Since increased protein synthesis is one of the major 
biochemical changes accompanying PHA stimulation it was 
decided to investigate the effect of 4-dPN induced 
vitamin B6 deficiency on protein synthesis in PHA 
stimulated lymphocytes. From this it was hoped to 
establish the relationship between the effect of 
4-dPN on protein and DNA synthesis and also the
respective value of alternative methods of assessing 
cell growth response to PHA.
In this experiment acid-insoluble incorporation of 
14( C)-leucine label incorporation into PHA stimulated 
lymphocytes cultured in complete MEM with or without 
added 4-dPN was determined at 7 2h after pre-incubation 
with BSS, MTX or UdR. The results, illustrated in 
Fig. 36, indicate that 4-dPN reduces protein synthesis 
by about 50%. This is similar to the effect of 4-dPN 
on DNA synthesis.
3.4.13. Effect of Presence of Hemin on Acid-insoluble
19 5Incorporation of ( I)-UdR into PHA Stimulated 
Lymphocytes Cultured in Medium Containing 4-dPN
Vitamin B6 deficiency has been implicated in inhibition
of porphyrin synthesis, and hence haematopoiesis, as a
result of both reduced availability of glycine and reduced
delta-aminolaevulinic acid synthetase activity. As in
(3.4.11) it is conceivable that such inhibition could be
alleviated by exogenous supply of the appropriate vitamin
B6 dependent metabolite.
In this experiment, such a possibility was investigated
by carrying out a PHA stimulated lymphocyte culture in
modified MEM (fol, l.Omg/1, PI, O.Omg/l) with added BSS,
4-dPN, hemin, or 4-dPN/hemin. After 67h of culture, Ih
pre-incubation with BSS, MTX or 5-fu and 3h incubation 
12 5with ( I)-UdR (0.5pCi), acid-insoluble incorporation 
of radioactive label into cultures was determined.
The results of this experiment illustrated in Fig. 37, 
indicate that addition of hemin to cultures containing
4-dPN, does not markedly relieve the effect of 4-dPN,

Fig. 36. Effect of Culture in Medium Containing 4-dPN
14on Acid-insoluble Incorporation of ( C)- 
leucine label into PHA Stimulated Lymphocytes
14Acid-insoluble ( C)-leucine incorporation (cpm) into
5
PHA stimulated lymphocyte cultures (2.5 x 10 cells) 
was determined at 72h after;
(i) culture in complete MEM with or without 4-dPN 
(5 0 0mg/l)
(ii) pre-incubation addition of BSS, MTX (llOpM) or
5-fu (l.OmM) Ih prior to;
"I u
(iii) incubation, 3h, ( C)-leucine, l.OpCi
Results are presented as mean (cpm) ± s.e. of incorpora­
tion into lymphocyte cultures of 4 control subjects.
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Fig. 3 7 Effect of Presence of Hemin on Acid-
125insoluble Incorporation of ( I)-UdR into 
PHA Stimulated Lymphocytes Cultured in 
Medium Containing 4-dPN
Acid-insoluble (^^^I)-UdR incorporation (cpm) into PHA 
stimulated lymphocyte cultures (2.5 x lO^cells) was 
determined at 7 2h after;
(i) culture in modified MEM (2) with a folate 
concentration of l.Omg/1, without PI and with 
added 4-dPN (500mg/l), hemin (G.lmM) or 1-dPN 
(50Qmg/l) and hemin (O.lmg/1)
(ii) pre-incubation addition of BSS, MTX (llOpM) or
5-fu (l.OmM) Ih prior to;
1 9 R
(iii) incubation 3h ( I)-UdR, O.SpCi.
Incorporation into lymphocyte cultures was expressed as a 
% of incorporation into comparable lymphocytes cultured 
in modified MEM with no addition and after pre­
incubation with MTX.
Results are presented as the mean % (cpm) ± s.e. of 
lymphocyte cultures of 2 control subjects.
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particularly when the effect of addition of hemin alone
12 5to cultures on subsequent ( I)-UdR incorporation is 
considered.
CHAPTER 4
DISCUSSION
Section 4. 1.
Preliminary Studies
4.1.1. Ascorbic Acid Status
The results reported in section 3.1.1. suggest that 
ascorbic acid levels in alcoholic liver disease subjects 
are lower than those observed in control subjects.
This is consistent with previous reports, e.g.,
O'Keene, Russell and Goldberg, ( 1972 ); Beattie and 
Sherlock, (1976). The cause of lower ascorbic status 
in alcoholic liver disease is partly low dietary intake 
but the effects of alcohol may also be a factor 
(O'Keene et al 1972 ). The functional consequences of 
low ascorbate status may include interference with 
hepatic drug metabolism (Beattie and Sherlock, 1976); 
Zannoni, Flynn and Lynch, 19 72) and anaemia (Goldberg, 
1963). There is insufficient data in the present study 
to assess the relationship between low ascorbate status 
and the incidence of alcoholic liver disease.
The effect of reduced ascorbate status of alcoholic 
liver disease subjects on hepatic drug metabolism was 
considered in this study by comparing SAA levels with 
the rate of clearance of the drug antipyrine.
Antipyrine clearance was assessed by determination of 
the serum half-life (t^) and the results are illustrated 
in Table 6. The results indicate there is no significant 
correlation between SAA level and antipyrine t^.
Of eleven subjects with prolonged antipyrine tj (greater 
than 2 3 h) six had a low SAA level and five had a normal 
SAA level (greater than 20 mmol/1). A similar pattern of 
results was observed when LAA levels were considered.
As seven of the eleven alcoholic liver disease subjects 
with prolonged antipyrine ti had cirrhosis and as the 
severity of liver disease is known to be a major 
determinant of serum antipyrine ti (Branch et al,
19 73) it is likely that in the present series the 
severity of the liver disease obscures any relationship 
between ascorbate status and drug metabolism. Beattie 
and Sherlock (19 76) also noted that prolonged antipyrine 
tj can occur in the presence of normal ascorbate status. 
This suggests that ascorbate status is only one of 
several factors determining antipyrine clearance.
4.1.2. Pyridoxal Phosphate Status
The results reported in section 3.1.2. indicate that 
serum PLP levels in alcoholic liver disease subjects are 
not significantly lower than in control subjects. This 
contrasts with published reports by Lumeng and Li (1974), 
and Labadarios, et al (1977), which suggest that serum 
PLP levels are significantly lower in both alcoholic 
and alcoholic liver disease subjects than in control 
subjects. The reasons for the failure to detect a 
reduced vitamin B6 status in alcoholic liver disease 
subjects in this study may include the small sample 
population size and the wide variation in serum PLP 
values observed in this sample. For example, the serum 
PLP level of subject number 11 (Table 3) was 30 ng/ml. 
This suggests that release of vitamin B6 from damaged 
liver tissue may, in some cases, result in serum PLP 
values which do not necessarily indicate the true 
tissue vitamin B6 status. Such an effect of high serum
levels of vitamin B6 due to liver damage has been 
reported by Rossouw, et al (1978). The association of 
high serum levels of vitamin B12 and diminished hepatic 
levels has been observed in cases of liver disease 
(Sherlock, 1963) and reports of high serum B12 levels 
in alcoholic liver disease subjects have been reviewed 
by Bonjour (1979). These observations suggest that in 
some cases, usually dependent on the type, severity and 
stage of liver disease, serum levels of a vitamin 
cannot be considered indicative of tissue levels.
Measurement of cellular and serum transaminase activities 
in the absence and presence of added PLP has been 
suggested as a means of assessing vitamin B6 status 
and of providing information on the state of deficiency 
or the degree of depletion of vitamin B6 reserves 
(Sauberlich, 1972). The results reported in section 3.1.3 
indicate that there is no statistically significant 
correlation between serum PLP levels and the degree of 
stimulation of AST activity by addition of PLP. A 
negative correlation might have been expected if low 
serum PLP levels accompanied low PLP saturation of 
serum AST and therefore a high degree of stimulation 
of AST activity in the presence of added PLP. The 
lack of any apparent correlation between these two 
measures of B6 status in this study may be due to 
the confounding effect of the wide range of AST 
activity observed, the serum half-life of AST and the 
effect of liver damage on serum PLP levels and AST 
activity. To avoid these confounding effects it may
be more appropriate to assess PLP stimulation of AST 
activity in erythrocytes (Sauberlich, 1972).
Although the results of the studies reported here do not 
provide evidence of reduced vitamin B6 status in 
alcoholics, perhaps because of the low number and type 
of subject, it is clear from the studies reviewed by 
Bonjour (1980) that there is a high incidence of low 
circulating levels of vitamin B6 in alcoholics.
However, other than evidence of sideroblastic anaemia 
(Hines and Cowan, 19 70) there are few reports of overt 
clinical manifestations of vitamin B6 deficiency. 
Therefore, to investigate whether or not the suspected 
vitamin B6 deficiency of alcoholic liver disease is 
functionally significant it seems appropriate to assess 
vitamin B6 status by a more functionally relevant method
4.1.3. Genetic Markers
The results presented in sections 3.1.4. and 3.1.5. 
suggest that there is no difference in the distribution 
of fast and slow acetylator or alpha-l-antitrypsin 
phenotypes in the alcoholic or control populations 
studied. To establish with a greater degree of 
confidence whether or not such a difference does exist 
would require analysis of a much larger sample of the 
alcoholic population. Although there were no apparent 
sex differences in the results reported here, there was 
insufficient data to draw any conclusions.
4.1.4. Vitamin B12 Metabolism
This study was concerned with characterisation of 
several aspects of vitamin B12 metabolism and in 
particular the observation of raised serum vitamin B12 
levels in liver disease (Hines, 1969). Preliminary 
studies by the department of Nuclear Medicine,
Southern General Hospital suggested that intestinal 
vitamin B12 absorption remained normal in alcoholic 
liver disease subjects and the results of determinations 
of serum vitamin B12 levels in alcoholic liver disease 
subjects carried out by the Department of Haematology, 
Southern General Hospital were consistent with but did 
not confirm, the observation of raised serum vitamin 
B12 levels in these subjects. The most accepted 
explanation for raised serum vitamin B12 levels in 
alcoholic liver disease subjects is release of vitamin 
B12 from hepatic stores (Chanarin, 1982). It was 
expected that an increase in serum vitamin B12 levels 
would be accompanied by alteration of levels of serum 
vitamin B12 binding proteins and the object of this 
study, the results of which are presented in section
3.1.6. was to characterise these changes.
There appear to be three main types of vitamin B12 
binding protein in serum, known as transcobalamins I,
II and III (TO I, II & III) although some authors prefer 
the classification of TO II and R binders (TO I & III), 
(England et al, 1973). As the physiological role of 
each of these vitamin B12 binding proteins has not 
been established and since the main functional distinction
appears to be between TCII and. TC I & III, this 
classification is adopted here. The prime role of TC II 
in vitamin B12 transport is illustrated by the 
appearance of severe megaloblastic anaemia in infants 
lacking this protein (Hakami et al, 1971). Neither 
the role nor the source of TC I and III have been 
established although England (1973) considers that 
all the transcobalamins are involved in vitamin B12 
transport and the association of high TC I levels 
with disorders of granulocyte proliferation suggests 
that bone marrow is a major source (Herbert, 1968).
The physiological significance of the raised TC I 
and III levels in alcoholic liver disease subjects 
observed in this study (Table 5) is difficult to assess. 
A possible explanation is that the higher levels of 
TC I and III in serum from these subjects is indicative 
of release of vitamin B 12 binding proteins from 
damaged liver tissue which are, or behave similarly 
to TC I and III. However, Retief Vandenplas and Visser 
(1969), do not report increased unsaturated TC I levels 
in liver disease. Therefore, further studies are 
required to confirm the existence of raised TC I and 
III levels in alcoholic liver disease subjects, to 
establish the identity of these proteins and to 
assess their physiological significance.
4.1.5. Liver Cell Suspension and Vitamin B6 
Deficient Rat Studies
The background and objectives of these studies are 
described in sections 1.3.3. and 1.4.3. The methods 
used are described in sections 2.2.9,, 2.2.10 and 
2.2.11. and the practical difficulties which were 
encountered and which prevented satisfactory results 
being obtained are described in section 3.1.8.
Section 4.2.
Preliminary PHA Stimulated Lymphocyte Studies
4.2.1. Acid-insoluble (^^^I)-UdR Incorporation
into PHA Stimulated Lymphocytes
12 5The results of determination of acid-insoluble ( I)-
UdR incorporation into PHA stimulated lymphocytes at
different times after initiation of culture (Fig. 9),
show that for the first 2 4 h there is little incorporation
The rate of increase of incorporation then increases to
a maxima between 48 and 72 h and subsequently declines.
12 5This pattern of ( I)-UdR incorporation is similar to 
the pattern of (^H)-TdR incorporation observed by Cooper, 
Barkham and Hale (1963).
The results presented in Table 7 show the sensitivity of
12 5acid-insoluble ( I)-UdR incorporation in PHA stimulated
lymphocyte cultures to variation of serum concentration
and cell number. It is apparent that increasing the
serum concentration from 10 to 20% results in a marked 
12 5increase in ( I)-UdR incorporation. This indicates
that serum concentration may be a limiting factor in
PHA stimulation and suggests a possible approach to
discrimination between serum of different subjects.
Increasing the cell concentration from 2.5 x 10 cells
to 1.0 X 10  ^ cells also results in an increase in (^^^I)-
UdR incorporation though the percentage increase in 
12 5( I)-UdR incorporation is smaller than the percentage
increase in cell number. A further increase in cell
number, to 2,0 x 10^ cells, results in a decrease in 
12 5( I)-UdR to a level comparable to that where the
5
cell concentration is 2.5 x 10 cells.
4.2.2. Inter-individual Variation in Acid-insoluble 
12 5( I)-UdR Incorporation into PHA Stimulated Lymphocytes
12 5Inter-individual variation in acid-insoluble ( I)-
UdR incorporation into PHA stimulated lymphocyte
cultures of control subjects is shown in Table 8 and
of alcoholic liver disease subjects in Table 9.
It is apparent that in both alcoholic liver disease and
control subjects there is considerable variation in acid- 
125insoluble ( I)-UdR incorporation into PHA stimulated
lymphocyte cultures. Such variation has also been
observed by other authors, e.g.. Das and Herbert (19 78)
12 5report a range of ( I)-UdR incorporation in PHA
stimulated lymphocyte cultures of seven folate/vitamin
B12 deficient subjects of 9251 cpm to 46958 cpm and
Metz et al (1968) report results in which the range of
(3H) TdR incorporation in bone marrow cells of five
normal subjects was 4200 cpm to 45,500 cpm and in five
vitamin B12 deficient subjects 9710 cpm to 83,680 cpm.
The results of comparison of serum enzyme levels and
12 5other indicators of liver damage with ( I)-UdR
incorporation in PHA stimulated lymphocyte cultures of
alcoholic liver disease subjects suggests that there
12 5is no simple relationship between ( I)-UdR incorporation 
and the extent of liver damage.
Since similar numbers of cells are used in cultures of
lymphocytes of different subjects, the variable
12 5incorporation of ( l)-UdR would also be apparent if
12 5the results were expressed in terms of ( I)-UdR per 
unit (ug) DNA of the cultured cells. This is because 
incorporation of radiolabelled nucleotide precursor
depends on the proportion of DNA synthesising cells
in the lymphocyte culture which is known to vary
considerably in different normal subjects and patients
with disturbed haemopoiesis (Ling and Kay, 1975).
Because of this variability, relating the amount of
12 5incorporation of ( I)-UdR to the total number of
cells in the cultures or the DNA content may be
misleading. However, the comparison of the uptake 
12 5of ( I)-UdR may be made more meaningful by 
providing an internal control in the cell culture 
from each individual subject and expressing the 
experimental result relative to that of the control 
(Das, Manusellis and Herbert, 1980). This was the 
approach adopted in this study.
4.2.3. Relationship between Serum PLP Concentration
'IOC
and Acid-insoluble ( I)-UdR Incorporation into PHA 
Stimulated Lymphocytes of Alcoholic Liver Disease Subjects
A principal objective of the PHA stimulated lymphocyte
studies was to develop a functional assay of vitamin
B6 status independent of reliance on determination
of serum levels of vitamin B6. The commonly used
methods for the determination of serum PLP, e.g.,
using tyrosine apodecarboxylase, have been criticised
because of incomplete extraction of PLP from serum
proteins (Srivastava and Beutler, 19 73), and it is
also possible that abnormal release of vitamin B6 and
vitamin B6 dependent enzymes from damaged liver tissue,
raised serum alkaline phosphatase levels and altered
serum albumin levels could affect serum PLP levels
and result in a false estimate of vitamin B6 status.
Nevertheless, it was of interest to compare the
results of determinations of serum PLP concentrations
12 5with acid-insoluble incorporation of ( l)-UdR in
PHA stimulated lymphocyte cultures of alcoholic liver
disease subjects. However, it is apparent from the
analysis of such a comparison (Table 10) that there
is no simple relationship between serum PLP
12 5concentration and acid-insoluble ( I)-UdR incor­
poration. Other problems inherent in such a comparison 
are the possible effects of medium pyridoxine, the
presumed folate sparing effect of a vitamin B6
12 5deficiency and consequent increase in ( l)~UdR
incorporation and the possibility that reliance on a
12 5simple measurement of ( I)-UdR incorporation, 
without reference to an internal control may be 
misleading.
4.2.4. Absence of PHA Stimulated Lymphocyte Response
in Advanced Alcoholic Cirrhosis
The absence of a PHA stimulated lymphocyte response in 
a patient with advanced alcoholic cirrhosis is reported 
in section 3.2.6. Such cases have been documented by 
other authors, e.g., Hsu and Leevy (19 71); Young,
Dudley and Van der Weyden, (1979). Hsu and Leevy (1971) 
considered that this effect might result from toxic 
effects of unmetabolised products, abnormal protein 
produced by the diseased liver, the increase in 
immunoregulatory humoral factor in response to stimuli 
such as hypergammaglobulinaemia or inactivation of PHA 
by anti-PHA proteins in the cirrhotic serum. Young, 
et al (1979) presented evidence that the suppression 
of lymphocyte transformation was not due to nutrient 
deficiencies in the serum, increased serum thymidine 
phosphorylase levels or interference with lymphocyte- 
mitogen interaction. Young, et al (19 79) also reported 
that inhibition was most marked in serum from patients 
with alcoholic hepatitis and that it correlated with 
bilirubin and AST levels. These observations suggest 
that hepatocyte damage is the principal determinant 
of serum inhibition of the PHA stimulated lymphocyte 
response and that the in-vivo significance of this 
phenomenon may be related to the observed impaired 
immunological response in alcoholic cirrhosis 
(Berenyi, Straus and Cruz, 1974).
4.2.5. Effect of Culture in a Pyridoxine Deficient
12 5culture medium on Acid-insoluble ( I)-UdR 
Incorporation into PHA Stimulated Lymphocytes
As a result of the experiments reported in section
3.2.7. it was concluded that the observed effects 
of culture in modified MEM (1) could not be attributed 
to the absence of pyridoxine in this medium and were 
more likely to be due to some non-specific medium 
variable. All PHA stimulated experiments reported in 
other sections used complete MEM, modified MEM (2) or 
basal BSS medium and where necessary included appropriate 
controls for the effect of different media on the PHA 
stimulated lymphocyte response.
4.2.6. Effect of Ethanol on Acid-insoluble (^^^I)-UdR 
Incorporation into PHA Stimulated Lymphocytes
When the effect of ethanol on acid-insoluble (^^^I)-UdR
incorporation into PHA stimulated lymphocytes was
investigated, Section 3.2.8., Fig. 10, it was found
that whether ethanol was added at the start of culture
12 5or 1 h prior to determination of ( I)-UdR incorporation,
concentrations of absolute ethanol up to 1% v/v had
little effect whereas a concentration of 5% v/v had
12 5a significant inhibitory effect, reducing ( I)-UdR
to less than 10% of that in comparable control cultures.
12 5
This inhibitory effect of ethanol on ( I)-UdR 
incorporation in lymphocytes may be compared with the 
cytotoxic effect of ethanol reported by Walker et al 
(1974). These workers reported that after a period of
3 days' exposure to different concentrations of 
ethanol, a significant cytotoxic effect on fibroblast 
and liver cells in stationary culture was apparent 
at an ethanol concentration of 0.2 5% v/v. At a 
1% v/v ethanol concentration, the percentage of 
surviving liver cells was 7 5% and of fibroblast cells, 
90%. Other acute effects of ethanol have also been 
investigated, e.g., Parker et al (1979) reported 
that acute high doses of ethanol in dogs, (3g ethanol/ 
kg body weight) lowered plasma PLP . While it is not 
possible to extrapolate these results to the in-vivo 
clinical situation, it is apparent that in addition 
to the long term metabolic effects of ethanol ingestion, 
it is possible that there are significant acute effects 
on plasma PLP, cell viability and DNA synthesis.
Section 4. 3.
Development of a Functional Assay for 
Determination of Vitamin B6 Status in 
Alcoholic Subjects
4.3.1. Effect of Variation of the Medium Folate
Concentration
In view of the demonstrable effect of variation of 
the medium folate concentration on the relative 
contributions of the de novo and salvage pathways 
to total thymidylate synthesis, it is surprising 
that little cognisance of this fact is noted in 
many studies of DNA synthesis. For example, in a 
study of the adaptation of thymidine utilisation to 
changing rates of DNA synthesis in the cell cycle 
(Miller, et al, 1979), the culture medium used was 
MEM which has a folate concentration of 1.0 mg/1. 
Under such conditions most of the DNA-thymine is 
derived from the de novo pathway and it is unlikely 
that the physiological role of the salvage pathway 
can be properly assessed under such conditions.
Since this project is concerned with the relationship
between vitamin B6 deficiency and inhibition of cell
growth, and with the effect of vitamin B6 deficiency
on de novo thymidylate synthesis, the influence of
the medium folate concentration on certain aspects
of DNA synthesis was of particular significance.
In this study, folate status was varied by altering
the medium folate concentration and the effect of
such variation on the relative contribution of de
novo thymidylate synthesis to DNA was determined by
12 5comparing rates of incorporation of ( I)-UdR into 
PHA stimulated lymphocyte cultures in the presence 
and absence of Am or MTX. The basis of this method
has previously been discussed (3.3.1.) and a 
similar method has also been described by Miller 
et al (1979), and Siegers et al (1974).
The effects of variation of the medium folate
12 5concentration on parameters of ( I)-UdR incor­
poration into PHA stimulated lymphocytes, as
observed in this study, may be summarised as follows:
12 5There is an inverse relationship between ( )1-
UdR incorporation into DNA and folate status, such 
that in low folate conditions, (O.Olmg/1), incor­
poration is high and in high folate conditions 
(l.Omg/1), incorporation is low. This effect is 
apparent from the results illustrated in Figs.
12. and 13. Using Am or MTX to inhibit the de 
12 5novo pathway ( I)-UdR incorporation into DNA 
is similar in both high and low folate conditions. 
Fig. 12.
These results indicate that in high folate conditions 
the contribution of the de novo thymidylate pathway 
to DNA synthesis is high relative to that in low 
folate conditions and that the rate of DNA synthesis 
in comparable PHA stimulated lymphocyte cultures is 
similar in both high and low folate conditions.
In studies of lymphocytes of megaloblastic anaemic
subjects, due to folate deficiency, it was found
3that the incorporation of ( H)-TdR into DNA was 
significantly greater than that of incorporation 
into lymphocytes of normal subjects (Das and Hoff- 
brand, 1970). Originally this was thought not to be
due to increased DNA synthesis in the folate
deficient lymphocytes but later studies using 
3( H)-TTP incorporation into isolated megaloblastic 
nuclei compared with similar nuclei treated with 
folate in vitro suggested that this increased ( H)- 
TdR incorporation into megaloblastic PHA stimulated 
lymphocytes was due to increased DNA synthesis and 
not just the result of an increased specific 
radioactivity of the dTTP pool due to inhibition 
of de novo synthesis and an increase in thymidine 
kinase activity (Hooton and Hoffbrand, 1977).
However, in the conditions used in this study where
the folate concentration is at least O.Olmg/1, folate
12 5deficiency is obviated and changes in ( I)-UdR 
incorporation cannot be attributed to compensatory 
increases in DNA synthesis. Therefore, although 
variation of the folate concentration within the range 
0.01 “ 2mg/l, is likely to result in some degree of 
adaptation of the de novo and salvage thymidylate 
pathways to the folate status, such adaptation is not 
likely to invalidate the use of Am or MTX in assessing 
the relative contributions of the de novo and salvage 
pathways to DNA-thymine synthesis.
Interest in the effect of variation of folate status
12 5on parameters of ( I)-UdR incorporation into DNA, 
stems from the possible parallels in the effect of 
vitamin B6 deficiency and folate deficiency on de novo 
thymidylate synthesis. As the effects of variation
125of folate status on ( I)-UdR incorporation are
clearly demonstrable, such effects, attributable 
to variation in vitamin B6 status, would provide 
clear evidence of the functional effect of vitamin 
B6 deficiency and also provide a means of assessing 
vitamin B6 status.
If a vitamin B6 deficiency occurs, but not at the 
level of a reduction in the de novo contribution to 
DNA-thymine, then the relative contributions of the 
de novo and salvage pathways to DNA thymine will 
not alter but a reduction in total DNA synthesis would 
be expected. The effect of variation of the medium 
folate concentration on this reduction would depend 
on the extent to which folate status either ameliorated 
or exacerbated the effect of vitamin B6 deficiency.
1.3.2. Use of the UdR Suppression Test 
The use of the UdR suppression test to assess folate 
and vitamin B6 status in PHA stimulated lymphocytes, 
its presumed basis and certain reservations concern­
ing its validity have been discussed (1.4.5.). The 
rationale for the extension of this test to assessment 
of vitamin B6 status is that if a vitamin B5 deficiency 
exists, or is produced as a result of PHA stimulation 
of lymphocytes in a pyridoxal deplete culture medium 
and if the primary effect of a vitamin B6 deficiency 
is to reduce the active one-carbon folate pool, then 
similar changes to those effected by culture in 
folate deficient conditions will be observed.
The results shown in Fig. 14 and Tables 12, 13, 14 
and 15 demonstrate the basic phenomenon that 
incorporation of labelled thymidine (or an analogue) 
is reduced by prior treatment of cultures with UdR. 
However, these results do not indicate that there is 
a functionally significant vitamin B6 dependent 
difference between lymphocytes of control and alcoholic 
subjects. Furthermore, there is no apparent trend in 
the results which suggests such a difference exists.
A variety of conditions including use of medium of 
high or low folate concentration with or without 
pyridoxal were used in these experiments.
The magnitude of the differences observed between 
normal and folate deficient subjects in UdR suppression 
tests is of the order of 3 0% (Wickramasinghe and 
Longland, 1974; Das and Herbert, 1978). The magni­
tude of the differences observed between serum PLP 
levels of normal and vitamin B6 deficient subjects 
is also of the order of 30% (Lumeng and Li, 1974; 
Labadarios et al, 1977; Bonjour, 1980). Differences 
of such magnitude were not observed in the present 
study. Because of the inter-individual variability 
observed in the present study, determination of 
significant differences of a smaller size would 
require study of larger groups.
12 5Reduction of ( I)-UdR incorporation by pre­
incubation with UdR is consistent with the hypothesis 
that exogenous non-radioactive UdR leads to the intra­
cellular formation of non-radioactive dTMP which 
dilutes the pool of radioactive dTMP (or (^^^I)-dUMP)
12 5arising from TdR (or ( D-UdR) and reduces 
labelling of DNA. The absence of a reduced UdR 
suppression effect in the lymphocyte cultures of 
the alcoholic subjects suggests that conversion of 
dUMP to dTMP is not reduced in lymphocyte cultures 
of these subjects. This indicates that these 
subjects are not vitamin B6 or folate deficient. 
However, alternative hypotheses are also consistent 
with these results and for this reason experiments 
were carried out to further characterise this effect 
(4.4.2.).
Other investigations have also examined the UdR 
suppression test in alcoholic liver disease though 
not specifically with regard to vitamin B6 deficiency 
These studies also reported negative or inconclusive 
results, e.g., in a study of 17 alcoholic liver 
disease subjects with macrocytosis, results of UdR 
suppression tests could not be related to folate 
status as some had a normal UdR suppression test and 
low red cell folate status while others exhibited 
the reverse (Belaiche, Cattan and Zittoun, 1978).
In a study of 16 alcoholic or chronic liver disease 
subjects, UdR suppression tests on bone marrow 
aspirates were all normal despite macrocytosis being 
present in each case (Wickramasinghe and Longland,
19 74). Part of the reason for the apparent incon­
sistencies in these results may be the existence 
of indirect folate deficiency in primarily iron 
deficient subjects who despite apparently normal
folate status exhibited abnormal UdR suppression 
results (Das et al, 1978). Das and Herbert (1978) 
consider that the persistence of an abnormal UdR 
suppression result in a group of patients with past 
deficiency of folate and vitamin B12, up to 84 days 
after vitamin therapy, suggests that circulating 
unstimulated lymphocytes do not incorporate appreciable 
amounts of vitamin B12 or folate and therefore that 
results of studies on such lymphocytes reflect the 
vitamin status of the patient when the lymphocytes were 
generated. One consequence of this is that the recent 
history of the subject is of less importance than the 
underlying disease. It has been suggested that the 
existence of macrocytosis and megaloblastosis 
reversible by alcohol withdrawal but not by treatment 
with folate demonstrates that these effects result 
from the direct action of alcohol on the developing 
haematopoietic cells and not, in the first instance, 
to accompanying folate deficiency (Sullivan and Herbert, 
1964; Wu et al, 1975). It is possible therefore that 
reports of vitamin B6 deficiency dependent changes 
are attributable to the effects of alcohol and 
liver disease rather than on a priori vitamin B6 
deficiency.
4.3.3. Effect of Pyridoxal Deficient Medium 
The most direct approach to determination of the 
cellular requirement for a particular nutrient, 
and the effects of a specific deficiency, is to 
culture cells in deficient medium and to observe 
the subsequent effects on specific areas of cellular 
metabolism. This was the approach adopted in this 
study.
The results shown in Fig. 15 suggest that the absence
of pyridoxal from the culture medium has little
effect on (^^^I)-UdR incorporation during 96h PHA
12 5stimulated lymphocyte culture. The pattern of ( I)-
UdR incorporation in both low folate and high folate 
medium is similar to that shown in Fig. 13. The results 
do not suggest that the absence of pyridoxal 
increases salvage thymidylate incorporation. Such 
an effect was observed in low folate conditions. 
Therefore, there was no evidence that variation of 
medium pyridoxal concentration affected the relative 
contribution of the de novo and salvage pathways to 
total thymidylate synthesis. Furthermore, there was 
no evidence that high folate conditions potentiated 
the effects of vitamin B6 deficiency resulting from 
lack of medium pyridoxal. When the effect of culture 
in medium without pyridoxal was compared in lymphocytes 
of control and alcoholic subjects. Table 20, it was 
found that there was no statistically significant 
differences between these two groups of subjects in 
their sensitivity to such culture conditions.
Several factors may account for this result. If the 
test system is valid, the most direct conclusion is 
that alcoholic subjects are not vitamin B6 deficient 
relative to normal subjects. However, before such a 
conclusion can be accepted, several other possible 
explanations must be investigated. One possibility 
is that the conditions are insufficiently exacting 
to result in vitamin B6 deficiency and so discriminate 
between cultures of subjects differing in vitamin B6 
status. For example, the presence of MEM amino- 
acids may decrease the requirement for PLP dependent 
activities such as decarboxylation and transamination 
and therefore the requirement for medium pyridoxal 
to sustain normal DNA synthesis. Other possibilities 
are that a longer period than 7 2h is required to 
produce vitamin B6 deficiency or that PLP is more 
tightly bound to PLP dependent enzymes involved in 
DNA synthesis than to other PLP dependent enzymes.
Such variation in the effect of absence of pyridoxine 
from cell culture medium on the activity of vitamin 
B6 dependent enzymes has been observed by Lipson et 
al (1980). These investigators found that activity 
of pyridoxine kinase remained constant during all 
depletion and repletion experiments while that of 
aspartate aminotransferase fell to a mean of 50% of 
control values.
As the results of experiments with lymphocytes 
cultured in various media with or without pyridoxal 
did not demonstrate an effect of vitamin B6 status 
on acid-insoluble incorporation of radioactively
labelled DNA precursor, it was decided to 
investigate the effect of a vitamin B6 antagonist.
It was felt that this approach would increase the 
sensitivity of the model system, facilitate the 
detection of a difference in functional vitamin B6 
status if it existed and reduce the possible 
confounding effect of the relatively short culture 
period. Another factor which determined that these 
studies be extended at this stage, rather than 
consolidated, was the limited availability of 
suitable alcoholic liver disease subjects for 
inclusion in the study. This also determined, 
through the study, that a large number of 
observations and investigations be carried out 
on a relatively small group of subjects.
4.3.4. Effect of 4-dPN
Use of pyridoxal deficient medium did not, during
96h PHA stimulated lymphocyte culture, have a
significant effect on DNA synthesis as determined by 
12 5( I)-UdR incorporation. Nor did use of such media 
discriminate between lymphocytes of control and possibly 
vitamin B6 deficient alcoholic subjects. To exclude 
the possibility that this lack of difference was due 
to insensitivity of the test and also to assess the 
effect of vitamin B6 deficiency on DNA synthesis and 
cell growth, the use of more exacting vitamin B6 
requiring conditions was investigated. The method 
adopted to attain such conditions was use of the 
vitamin B6 antagonist 4-deoxypyridoxine. The effect 
of this antagonist was investigated in two ways.
Firstly, by addition of 4-dPN to cultures Ih prior
12 5to determination of ( I)-UdR incorporation, and 
secondly, by addition of 4-dPN to cell culture medium 
at start of culture.
12 5In Table 18, the sensitivity of ( I)-UdR incor­
poration, in the presence of BSS and Am to 4-deoxy- 
pyridoxine was determined in stimulated lymphocytes 
of control and alcoholic liver disease subjects
cultured in low folate and low pyridoxal conditions.
12 5The extent of suppression of ( I)-UdR incorporation 
by UdR was also determined.
In the sample group of control subjects, 4-dPN did
12 5not reduce either salvage incorporation ( ( 1)-
UdR incorporation in the presence of BSS) or total
12 5DNA synthesis ( ( I)-UdR incorporation in the 
presence of Am). However, in the sample group of 
alcoholic liver disease subjects, 4-dPN resulted in 
a significant reduction of salvage incorporation but 
not of total DNA synthesis. This result seems 
difficult to account for. If 4-dPN caused a vitamin 
B6 deficiency at the level of de novo thymidylate 
synthesis one would expect a relative increase in 
salvage incorporation comparable to that observed in 
low folate conditions, and total DNA synthesis would 
be either reduced or unaffected. If 4-dPN caused a 
vitamin B6 deficiency which did not specifically 
limit serine hydroxymethyltransferase activity but 
did result in a reduction of cell growth, and DNA 
synthesis, then one would expect a decrease in both 
salvage incorporation and total DNA synthesis. This 
is perhaps the most likely explanation for the results
reported here as there is a significant decrease in 
salvage incorporation (24%) and an apparent (14%) 
decrease in total DNA synthesis. UdR suppression 
was also determined and again no significant 
difference was found between lymphocyte cultures of 
normal and alcoholic liver disease subjects in this 
respect. A tentative conclusion therefore, is that 
there is a significant difference in the sensitivity 
of lymphocyte cultures of control and alcoholic liver 
disease subjects to variation in vitamin B6 supply. 
However, the sample size is small and such a result 
requires confirmation before a firm conclusion can be 
stated.
To further characterise the effect of pre-incubation
addition of 4-dPN, this experiment was repeated in
medium of high or low folate and high or low pyridoxal
concentration in PHA stimulated lymphocyte cultures of
control subjects (Table 19). It was found that in low
folate medium (O.Olmg/1), irrespective of the pyridoxal
concentration (O.Olmg/1 of 2.0 mg.l), pre-incubation
addition of 4-dPN did not significantly affect either
salvage incorporation or total DNA synthesis.
However, when the folate concentration was increased
to 2.0mg/l, it was found that 4-dPN significantly
reduced salvage incorporation (P < 0.01) but had no
significant effect on total DNA synthesis. Again,
this result seems difficult to interpret. With regard
to the earlier discussion in this section, of the
12 5likely effect on ( I)-UdR incorporation of a vitamin 
B6 deficiency inhibiting de novo thymidylate synthesis,
and the high medium folate conditions (2.0mg/l), 
it is unlikely that the effect of 4-dPN seen here 
is due to reduced serine hydroxymethyltransferase 
activity. Furthermore, there is no significant 
reduction in total DNA synthesis. This result 
indicates that in high folate conditions, 4-dPN 
specifically reduces salvage incorporation.
The UdR suppression effect was also determined in 
this experiment. It was found that in low folate 
conditions, irrespective of the pyridoxal 
concentration, UdR reduced salvage incorporation to 
20% of that in control conditions, while in high 
folate conditions (2.0mg/l) UdR reduced salvage 
incorporation to 3% of that in control cultures.
While the enhanced UdR suppression effect in high 
folate conditions is consistent with the conventional 
rationale for UdR suppression (1.4.5.), the specific 
sensitivity of salvage incorporation to the effect of
4-dPN in high folate conditions is less readily explained
12 5As total DNA synthesis, ( I)-UdR incorporation in 
the presence of Am, is unaffected, this effect cannot 
be attributed to a specific effect on thymidine kinase 
activity, and this implies that in high folate 
conditions, 4-dPN actually increases the de novo 
contribution to thymidylate synthesis, resulting in 
a reduction of salvage incorporation. A rationale 
for this apparently anomalous result might be that 
excess folate corrects a vitamin B6 deficiency in 
one area of metabolism, thereby exacerbating its 
effects on another area of metabolism. This
explanation implies that high folate conditions 
potentiate the effect of vitamin B6 deficiency 
as induced by 4-dPN. An alternative explanation 
however, is that in high folate conditions, salvage 
incorporation is very much reduced relative to 
that in low folate conditions and this factor alone 
enhances the sensitivity of such incorporation to 
reduction by UdR or 4-dPN.
The effect of culture in medium containing 4-dPN
12 5on acid-insoluble incorporation of ( I)-UdR into 
PHA stimulated lymphocytes at various times during 
the course of culture is shown in Fig. 16. These 
results show that culture in medium containing 4- 
dPN results in a significant reduction of DNA 
synthesis in PHA stimulated lymphocytes. There is 
no evidence of a differential effect on incorpora­
tion after pre-incubation with BSS compared with 
incorporation after pre-incubation with MTX and 
this indicates that vitamin B6 deficiency, as 
induced by 4-dPN, although reducing total DNA 
synthesis does not affect the respective contribu­
tions of the de novo and salvage pathways to 
thymidylate synthesis. However, the medium folate 
concentration in this experiment was 1.0 mg/1 and 
this might mask the effect of a vitamin B6 deficiency 
operating at such a level.
Therefore, in contrast to use of pyridoxal deficient 
medium and pre-incubation addition of 4-dPN, the 
inclusion of 4-dPN in the initial culture medium does 
result in a significant reduction in subsequent DNA 
synthesis, which, subject to the qualifications
regarding the specificity of inhibitors, may be
attributed to the effects of an induced vitamin B6
deficiency. Attainment of such conditions offered
a further approach to assessment of relative vitamin
B6 status in different population groups. The basis
of this approach was that sensitivity of PHA
stimulated lymphocyte cultures derived from different
subjects, to 4-dPN, would vary according to the
cellular and serum vitamin B6 status of the donor.
The results of an investigation of this possibility
are presented in Table 21. The cell culture medium
used was modified MEM of low folate concentration,
12 5with or without pyridoxal. Acid-insoluble ( I)-
UdR incorporation was determined at 72h after pre­
incubation with either BSS, MTX or 5-fu, in PHA 
stimulated lymphocyte cultures of both control and 
alcoholic liver disease subjects. Low folate medium 
was used to avoid the possible effect of excess folate 
correcting a vitamin B6 deficiency at the level of 
serine hydroxymethyltransferase activity. 5-fu was 
used because of its inhibitory action on thymidylate 
synthetase. Such inhibition has a similar effect to 
that of antifolates in 'uncoupling' de novo thymidylate 
synthesis and thus permitting discrimination between 
de novo and salvage thymidylate synthesis. 5-fu is 
converted to the nucleotide 5-fdUMP which is the 
active inhibitor of thymidylate synthesis. As the 
fluorine atom is similar to that of hydrogen, 5-fdUMP 
competes with dUMP but the 5-position cannot be 
methylated and thus de novo thymidylate synthesis is 
inhibited.
Although 5-fdUMP does not become incorporated into 
DNA, the corresponding riboside is incorporated into 
RNA, disrupting the activity of this macromolecule. 
5-fdUMP also inhibits orotic acid metabolism and the 
incorporation of phosphate into DNA (Hurst, 1980).
In addition to these multiple biochemical effects, it 
is likely that in its conversion to an active inhibitor,
5-fu will compete with TdR, or an analogue of TdR, for 
uptake and phosphorylation. These considerations 
preclude the use of 5-fu in precise quantitative 
studies of DNA synthesis. However, its major effect, 
particularly in short term studies is inhibition of 
thymidylate synthetase and therefore its use in these 
circumstances is justifiable.
Although the results in Table 21 show considerable 
variation, it is possible to derive some valid 
conclusions from them. Firstly, it is apparent that 
in PHA stimulated lymphocyte cultures derived from 
either control or alcoholic liver disease subjects, 
inclusion of 4-dPN in the initial culture medium 
results in a significant reduction of DNA synthesis, 
and hence, cell growth. However, there is no 
consistent pattern of significant differences between 
the extent of this reduction, in cultures derived 
from control or alcoholic liver disease subjects. 
Similarly, the presence or absence of pyridoxal in 
the culture medium does not appear to significantly 
influence the effect of 4-dPN, and even in low folate 
conditions, it is apparent that vitamin B6 deficiency, 
as induced by 4-dPN, does not have a differential
effect on de novo and salvage thymidylate synthesis 
comparable to that of folate deficiency.
The validity of these conclusions is strengthened
by analysis of the results presented in Table 22.
These results, obtained using lymphocytes cultured
in high folate medium, confirm the limited influence
of medium pyridoxal in reducing the effect of 4-dPN
and the lack of a differential effect on de novo
and salvage thymidylate synthesis. The influence of
the medium pyridoxal concentration on the effect of
12 54-dPN on acid-insoluble ( I)-UdR incorporation into 
PHA stimulated lymphocyte cultures derived from 
control subjects was further investigated (Fig. 17).
It was apparent from the results shown in Tables 21 
and 22 that pyridoxal at a concentration of l.Omg/1 had 
little influence on the effect of 4-dPN and this lack 
of influence is also apparent from Fig. 17 where an 
increase in the pyridoxal concentration to lOmg/1 is 
also shown to be ineffective in modulating the effect 
of 4-dPN,
A possible reason for the apparent lack of differential 
effect of 4-dPN on de novo and salvage thymidylate 
synthesis has been described by Coburn and Mahuren 
(1976). In a study of the in-vivo metabolism of
4-dPN in rat and man these authors reported that in 
contrast to in-vitro studies where conversion of 4- 
dPN to 4dPN-phosphate resulted in competitive 
inhibition of PLP enzymes, this did not appear to 
take place in-vivo, nor were PLP concentrations 
reduced. The authors suggest that under some 
conditions the main effect of deoxypyridoxine may
zby .
be inhibition of vitamin B6 transport. Subsequently 
Coburn et al (1980) presented further evidence that 
the in-vivo effect of 4-dPN may involve more than 
simple competitive inhibition of PLP enzymes. The 
authors suggest that inhibition of PLP enzymes was 
very selective and that vitamin B6 may exert regulatory 
effects independently of its enzyme cofactor role.
4.3.5. Effect of Variation of Cell Culture 
Medium Composition
It had been noted (section 3.2.2.) that increasing the
proportion of serum in the cell culture medium resulted
12 5in an increase in acid-insoluble ( I)-UdR incorporation
into PHA stimulated lymphocytes. This observation
suggested that it,might be possible, by altering the
medium composition, to characterise a medium which could
be used to assess the nutritional status of serum and
lymphocytes of alcoholic liver disease subjects (4.2.1.).
The results shown in Fig. 18 indicate that when a 15%
serum concentration is used, there is little difference
12 5between acid-insoluble ( I)-UdR incorporation into
PHA stimulated lymphocyte cultures of two alcoholic
liver disease subjects cultured in either modified
MEM (2) or basal BSS medium. Similarly, the results
shown in Fig. 34 indicate that the medium presence of
non-essential amino acids has little effect on acid-
125insoluble incorporation of ( I)-UdR into PHA
stimulated lymphocyte cultures. However, when the
serum concentration used is 10%, the addition of MEM
amino acids to a basal BSS medium results in a
12 5significant increase in acid-insoluble ( I)-UdR 
incorporation into PHA stimulated lymphocyte cultures.
These results are illustrated in Fig. 19. It is also
12 5apparent from Fig. 19 that a similar pattern of ( I)-
UdR incorporation is observed in both the alcoholic
liver disease and control subjects studied. The effect
of addition of MEM vitamins to the basal BSS medium on 
12 5( I)-UdR incorporation is much less than the effect of
addition of amino acids. However, it is interesting to
note that in the BSS plus MEM amino acid medium (^^^I)-
UdR incorporation (after pre-incubation with BSS) is
higher than in the BSS plus MEM vitamins/amino acids
medium. This observation is consistent with the effect
12 5of folate concentration of ( I)-UdR incorporation 
observed in other experiments, e.g., Fig. 12.
These experiments illustrate certain aspects of the
effect of serum concentration and medium composition 
12 5on ( I)-UdR incorporation into PHA stimulated
lymphocyte cultures. Although no discriminatory
effect of culture of lymphocytes of different subjects
in different media was apparent in the results
presented here, it is feasible that in nutritionally
deficient subjects, use of such selective media could
be used to assess nutritional status. However, in these
12 5studies, the principal determinants of ( l)-UdR 
incorporation were the serum concentration and the 
presence of MEM amino acids. As such studies could 
not be considered to assess vitamin B6 status 
specifically, they were not pursued in the present 
study.
Section 4.4.
Characterisation of the Effects of
Vitamin B6 Antagonists on PHA Stimulation
of Lymphocytes
z / z .
4.4.1. Use of Vitamin B6 Antagonists 
A large number of substances as well as several useful 
drugs react with PLP requiring enzymes. For example, 
one of the drugs used in the treatment of tuberculosis, 
isonicotinic acid hydrazide (isoniazid) inhibits 
pyridoxal kinase, the enzyme that converts pyridoxal 
to PLP. Inhibition is believed to be mediated by the 
reaction of the drug and pyridoxal to form a hydrazone 
which blocks the enzyme. The rationale of the therapeutic 
use of this drug is that since the content of pyridoxal 
kinase in mycobacteria is low, its blockage effectively 
inhibits growth. However, patients on long-term 
isoniazid therapy sometimes develop symptoms of vitamin 
B6 deficiency.
Phosphorylation of 4-deoxypyridoxine by pyridoxal kinase 
is thought to produce an antagonistic analogue of PLP 
and administration of this substance induces death in 
chicks, and, during tests in man of the potential anti­
cancer effects of 4-dPN, it was shown to cause 
convulsions and other symptoms of vitamin B6 deficiency. 
Other substances with known vitamin B6 antagonist 
activity include cycloserine, the L-isomer of which 
inhibits many PLP enzymes and is toxic to humans 
and, the substituted cysteine derivative, L-penicillamine 
which causes convulsions and low glutamate decarboxylase 
levels in the brain (Metzler, 1977).
From a consideration of the known involvement of PLP 
in enzyme activity in a variety of metabolic systems 
it can be appreciated that a deficiency of this coenzyme 
might result in a metabolic block in a number of areas
of metabolism. In the whole animal this will result 
in a variety of effects such as anaemia, nervous 
system dysfunction and skin complaints. It is 
unlikely that these symptoms can be attributed to a 
unique enzyme lesion but it is possible that one 
effect is associated with a limiting metabolic 
block which when relieved would alleviate the most 
serious defect.
Various studies in man and other animals have looked 
at the effects of various vitamin B6 antagonists 
on a number of areas of metabolism. For example: 
Carbidopa, which is a hydrazine derivative of the 
amino acid L-dopa, selectively inhibits the enzyme 
aromatic L-amino acid decarboxylase in peripheral 
tissues, and this makes it a useful adjunct in the 
treatment of Parkinson's disease. However, studies 
in rats suggest that large doses of carbidopa can, 
by depleting tissues of PLP, cause potentially un­
desirable non-specific changes in PLP dependent 
enzymes, though coadministration of pyridoxine with 
carbidopa can maintain tissue PLP levels and protect 
against such enzyme changes without reducing the 
effectiveness of carbidopa (Airoldi, et al, 1978).
Sideroblastic, pyridoxine responsive, anaemia, 
associated with alcoholism and isoniazid (INH) therapy 
has been attributed to a block in heme synthesis.
In cell culture studies using murine erythroleukemia 
cells (MELC) and mouse fetal liver cells CMFLC), 
treatment with hemin overcome the inhibitory effect 
of INH and thus the vitamin B6 antagonist effect in
this case could be primarily attributed to 
inhibition of delta-aminolaevulinic acid synthetase 
(Hoffman & Ross, 1980).
In studies of the effect of acute alcohol ingestion 
on plasma PLP in dogs it was demonstrated that acute 
high doses of alcohol lower plasma PLP accumulation 
from precursor pyridoxine (Parker et al, 19 79).
Although it is not possible to extrapolate this result 
to the human circumstances of long-term alcohol intake, 
it is apparent that alcohol, or a metabolite of 
alcohol, may have a specific effect on PLP dependent 
enzymes as well as a more direct effect on haematopoiesis 
(Wu et al, 1975; Sullivan and Herbert, 1964).
These studies illustrate some of the factors which 
determine the effects of alcohol and vitamin B6 deficiency 
on cellular metabolism. This complexity is further 
illustrated by the description of cases where 
impairment in reticulocyte globin synthesis, due to 
alcohol, was correctable by addition of haem and by 
other cases where abnormal haem synthesis was corrected 
by pyridoxine but not by delta-aminolaevulinic acid 
(Solomon and Hillman, 1979 a). Thus alcohol may well 
impair haem synthesis by a direct toxic effect only 
correctable by alcohol withdrawal, by other effects 
correctable by administration of pyridoxine and by a 
specific effect requiring treatment with the appropriate 
vitamin B6 dependent metabolite.
In this study, the incidence of vitamin B6 deficiency 
in alcoholic liver disease subjects as well as the 
effect of vitamin B6 deficiency on cellular metabolism
z. / O .
has been investigated using the vitamin B6 antagonist
I
4 -deoxypyridoxine. In view of the various effects of 
different vitamin B6 antagonists, it was of interest to 
compare the effect of 4-dPN with that of another 
vitamin B6 antagonist, INH. The results of such a 
comparison are shown in Fig. 20. These results suggest 
that the overall effect of each of these vitamin B6 
antagonists on DNA synthesis in PHA stimulated 
lymphocyte cultures of control subjects is similar, 
and that neither has a differential effect on salvage 
or de novo thymidylate synthesis.
These results also indicate that the use of vitamin B6
antagonists represents a useful cell culture model
system for investigating vitamin B6 deficiency.
From the effect of 4-dPN and INH on DNA synthesis
12 5(acid-insoluble C I)-UdR incorporation) in PHA
stimulated lymphocyte cultures it is clear that cells 
cultured in such conditions have impaired ability to 
function and replicate and so it would be of interest 
to determine whether the biochemical abnormalities of 
such chronically exposed cells could be reversed by 
addition of exogenous hemin or other vitamin B6 
dependent metabolite.
4.4.2, Characterisation of UdR Suppression 
In view of the reported value of the UdR suppression test 
in determining folate and vitamin B12 status 
(Wickramasinghe and Longland, 1974), its potential 
use in determining vitamin B6 status and also because 
of the uncertainty surrounding its biochemical basis 
(Beck, 1975), it was of interest to further 
characterise this test. The approach adopted was
to determine the effect of UdR on (^^^l)-UdR
14 . 143-( C)-serine and ( C)-formate incorporation into
PHA stimulated lymphocyte cultured in medium of high
or low folate concentration after pre-incubation with
BSS, MTX or 5-fu. Such an approach allows assessment
of UdR suppression in conditions of different folate
status, i.e. In low folate medium (0.01 mg/1), the
folate status is comparable to that in serum and in
high folate medium (1.0 mg/1), folate is in excess of
normal physiological levels (Lundquist , 19 75).
Treatment with MTX may be considered to induce folate
deficient conditions. In cell cultures treated with
5-fu the de novo thymidylate pathway is inhibited at
the level of thymidylate synthetase and pre-
pre-incubation with BSS represents a control of normal
UdR suppression.
In all the experiments discussed in this section it is 
realised that competitive and metabolic relationships 
are not capable of precise interpretation when applied 
to such a complex system as the living cell, where the 
interrelation of metabolite and inhibitor can be affected 
by transport phenomena at membranes, pool size, equilibria
between products of consecutive reactions and so on. 
Nevertheless, it is possible to deduce certain qualitative 
information from analysis of such experiments.
Prior to determination of the effect of UdR, the
effect of pre-incubation with MTX and 5-fu on
12 5subsequent acid-insoluble ( I)-UdR incorporation into
PHA stimulated lymphocytes was determined. These results
are illustrated in Fig. 21 and Table 23 and are
consistent with the hypothesis that differences in 
12 5( I)-UdR incorporation into PHA stimulated lymphocytes
after pre-incubation with MTX and 5-fu reflect changes
in the size of the active one-carbon folate pool
available for de novo thymidylate synthesis. The
results presented in Fig. 21 show that the difference
12 5between acid-insoluble ( I)-UdR incorporation after 
pre-incubation with MTX and 5'fu is much greater in 
high folate conditions than in low folate conditions.
This is consistent with a greater one-carbon folate 
pool in high folate conditions.
If this principle was established it would provide 
an indirect, but functional, means of estimating the 
relative size of the active one-carbon folate pool 
under different conditions. These results indicate 
that the size of an active one-carbon folate pool is 
affected by vitamin B6 deficiency, as induced by 4-dPN, 
and by varying the medium folate condition. As 4-dPN 
has not been shown to have a specific effect on de novo 
thymidylate synthesis in other experiments reported in 
this study, it is unlikely that the apparent effect of
4-dPN on the active one-carbon folate pool observed
here is due to specific inhibition of serine hydroxy­
methyltransf erase . However, substantiation of this 
hypothesis would require further characterisation of 
various aspects of the observations. In particular 
it would be necessary to determine changes in this 
parameter throughout the course of PHA stimulated 
lymphocyte culture and to exclude the influence of 
indirect effects of both inhibitors. It would also 
be important to ensure that the level of each inhibitor 
present was such that each target enzyme was inhibited 
to a similar extent.
When the effect of UdR on acid-insoluble incorporation 
12 5of ( I)-UdR into PHA stimulated lymphocytes, cultured 
in medium of high or low folate concentration and in 
the presence or absence of 4-dPN, after pre- 
pre-incubation with MTX and 5-fu was considered 
(Table 24 and Figs. 22 and 23), it was apparent that 
the extent of UdR suppression was not significantly 
effected by the presence of MTX or 5-fu.
The principal conclusion from this result is that since
the de novo thymidylate pathway is inhibited by the
presence of either MTX or 5-fu, the major part of the
UdR suppression effect must be mediated independently
of the de novo pathway. This conclusion conflicts
with the hypothesis that UdR suppression is mediated
by feedback inhibition of thymidine kinase due to
increased de novo synthesis of dTTP from dUMP (Herbert
et al, 1973). It is therefore probable that the major
part of the UdR suppression effect can be attributed
to competitive substrate inhibition of thymidine kinase
12 5the salvage pathway enzyme necessary for ( I)-UdR
incorporation, by added UdR. Evidence for such a
hypothesis can be adduced from the data of Cleaver
(196 7) concerning the substrate specificity of
thymidine kinase. From this data it is apparent
that UdR is 67% as effective as substrate of TK
as is TdR, and therefore it is likely that this
factor alone will account for significant suppr- 
12 5ession of ( l)-UdR incorporation by added UdR.
( (I)-UdR is 93% as effective a substrate of TK as 
is TdR.) Another observation which is inconsistent 
with UdR suppression being mediated by feedback 
inhibition of TK by dTTP is the finding that dTTP 
levels are not unequivocally raised in UdR treated, 
normal or folate deficient cells (Ganeshaguru and 
Hoffbrand, 1978).
To account for the observation that the UdR supp­
ression effect is different in normal and folate 
deficient cells, and can therefore be used to 
discriminate between such cells, it is necessary to
consider what other factors might affect the
12 5sensitivity of ( I)-UdR incorporation to UdR.
12 5As it is known that ( I)-UdR incorporation is 
dependent on TK, this question is primarily concerned 
with what factors might affect TK activity. From 
results of experiments discussed earlier in this 
report (e .g.4.3.1.)it is clear that a major factor 
affecting the relative contribution of the de novo 
and salvage pathways to thymidylate synthesis, and 
hence TK activity, is the medium folate concentration
In low folate conditions TK activityC ( ^I)-UdR
incorporation) is high, whereas in high folate
12 5conditions TK activity ( ( I)-UdR incorporation)
is low, and in both high and low folate conditions,
in the presence of MTX TK activity ( (^^^I)-UdR
incorporation) is similar, (Fig. 12). As expected
12 5the effectof UdR is dependent on the level of ( I)- 
UdR incorporation and where this is low, as in high 
folate conditions, UdR suppression will be more
12 5effective than in low folate conditions where ( I)-
UdR incorporation is high. In the results of experiments
reported here e.g.. Figs. 2 2 and 23, where the folate
concentration is either 0.01 mg/1 or 1.0 mg/1, the
12 5absolute level of ( I)-UdR incorporation in the 
presence of UdR is higher in high folate conditions 
than in low folate conditions, though the percentage 
UdR suppression is of similar magnitude in both high 
and low, folate conditions.
This result, in common with the observed effect of 
12 5MTX on ( I)-UdR incorporation in high and low folate 
conditions indicates that TK activity is adapted to 
cellular folate status. If consideration of these 
circumstances is extended to folate deficient conditions, 
it is likely that the degree of adaptation to thymidine 
utilisation will be greater,that TK activity will be 
higher and that this would account for the reduced 
extent of UdR suppression in such conditions. Further 
evidence for such adaptation can be adduced from a 
report of a three fold increase in thymidine kinase
activity in extracts of peripheral blood lymphocytes 
of cobalamin or folate deficient patients (Ellims,
Hayman and Van der Weyden, 19 79).
Interest in characterisation of the UdR suppression 
test stemmed not only from its potential use in 
evaluating vitamin B6 status but also from the 
information it would provide concerning the possible 
effect of vitamin B6 deficiency on de novo thymidylate 
synthesis. It was postulated that such an effect 
would be mediated by inhibition of serine hydroxy­
methyltransf erase with a consequent reduction of active 
one-carbon folate units available for de novo thymidylate 
synthesis.
However, as it does not appear that the UdR suppression 
effect is primarily mediated via thymidylate synthetase, 
it was not possible to use the UdR suppression effect 
to assess the effect of vitamin B6 deficiency on de novo 
thymidylate synthesis.
Determining the effect of pre-incubation addition of
12 5formate on acid-insoluble ( I)-UdR incorporation into 
PHA stimulated lymphocytes (3.4.4.), offered an 
alternative means of assessing the role of the de novo 
thymidylate pathway. As 5,10-methylene tetrahydro- 
folate can be formed from formate and H^P, independently 
of any PLP requiring enzyme (Blakley, 1969) it is 
likely that an exogenous supply of formate would relieve 
a restriction in 5,10 me H^F availability due to a 
vitamin B6 deficiency. If a vitamin B6 deficiency did 
result in inhibition of serine hydroxymethyltransferase 
and this inhibition was relieved by addition of formate,
the expected result would be a reduction in 
12 5C I)-UdR incorporation. The results of experiments
directed at determination of such an effect are
illustrated in Figs. 24, 25 and 26. These results
indicate that formate does not significantly affect 
12 5( I)-UdR incorporation in high or low folate 
conditions, in the presence or absence of 4-dPN, or 
after pre-preincubation with either BSS, MTX or 
5-fu. These experiments therefore give further 
indication that vitamin B6 deficiency does not 
specifically inhibit 5,10 me synthesis from
serine and H^F.
14The effect of UdR on incorporation of 3-( C)-serine 
1 4and ( C)-formate label into a DNA extract of PHA
stimulated lymphocyte cultures is illustrated in
Figs. 30, 31 and 33. These results indicate that
14incorporation of 3-( C)-serine is increased by
pre-incubation with UdR in both high and low folate
14conditions,( Fig. 30) that incorporation of ( C)-
formate is also increased by pre-incubation with UdR
in complete MEM (Fig. 33) and that this effect of UdR 
14on 3-( C)-serine incorporation is inhibited by pre­
preincubation with MTX or 5-fu (Fig. 31). It is 
apparent from these results that UdR increases 
incorporation of de novo thymidylate precursors into 
DNA but these experiments do not discriminate 
between such an effect being mediated by stimulation 
of de novo thymidylate synthesis or by inhibition of 
salvage thymidylate synthesis.
During this project a number of reports concerning 
the biochemical basis of the UdR suppression test 
have been published. One report (Van de Weyden,
19 79), which recognises the competition of UdR and 
TdR as substrates for thymidine kinase but not the 
likely effect of adaptation to TdR utilisation or 
raised TK levels in folate deficient cells, concludes 
that; reduced deoxyuridylate conversion to (deoxy)- 
thymidylate by thymidylate synthetase accounts for 
the UdR suppression effect. A further report (Hayman 
and Van der Weyden, 1980) describes the use of PHA 
stimulated normal human peripheral blood lymphocytes 
cultured in folate depleted medium as an in vitro 
model for megaloblastic haematopoiesis. This was 
considered an appropriate system for analysis of 
biochemical events accompanying megaloblastic 
maturation and the biochemical basis of the UdR 
suppression test as it allowed a convenient means 
of obtaining deficient cells while avoiding the 
uncertain specificity involved in the use of 
metabolic inhibitors such as MTX or 5-fu. A study 
by Pelliniemi and Beck (198 0) used PHA stimulated 
lymphocytes cultured in RPMl 1640 medium, which has 
a folate concentration of 1.0 mg/1, and MTX and 
5-fUdR as inhibitors of thymidylate synthetase, to 
investigate the biochemical basis of the UdR suppression 
test. These authors also noted the significance of 
UdR as a competitive substrate inhibitor of TK and 
reports of raised levels of TK in megaloblastic cells 
and concluded that exogenous deoxyuridine has multiple
effects on (sH)-TdR incorporation which must be 
considered in interpretation of deoxyuridine 
suppression test results.
4.4.3. Use of de novo Thymidylate Precursors
Interest in the use of de novo thymidylate precursors
in PHA stimulated lymphocyte studies stemmed from the
realisation that this would provide an alternative
approach to assessing the effect of vitamin B6
deficiency on cell growth and DNA synthesis. This
12 5approach complements studies using ( I)-UdR and 
also provides further information on aspects of 
de novo thymidylate synthesis.
In Figs. 27 and 28, the results of a determination
12 5of both acid-insoluble ( I)-UdR incorporation, and 
143-( C)-serine incorporation into a DNA extract,
of PHA stimulated lymphocytes at various times during
96h of culture in medium of either high (1.0 mg/1) or
low (0.01 mg/1) folate concentration are presented.
From these results it is apparent that the pattern 
12 5of ( I)-UdR incorporation after pre-incubation with
either BSS or MTX, in both high and low folate medium
is similar to that previously observed in Fig. 13.
14Incorporation of 3-( C)-serine label into a DNA
extract of replicate PHA stimulated lymphocyte cultures
is shown to increase linearly throughout the course
of culture in both high and low folate conditions.
14This pattern of 3-( C)-serine label incorporation 
is consistent with the expected de novo contribution 
to thymidylate synthesis as determined from the
incorporation of a salvage precursor in the presence 
and absence of an inhibitor of endogenous production 
of thymidine phosphates. This result therefore 
substantiates the use of such inhibitors in determin­
ation of rates of DNA synthesis.
The effect of culture in high and low folate condit­
ions and pre-incubation addition of MTX and 5-fu on
14incorporation of 3-( C)-serine label into a DNA
extract of PHA stimulated lymphocyte cultures was
further examined in Fig. 29. It was apparent from
these results that at a corresponding period during
14culture, incorporation of 3-( C)-serine label is
reduced in low folate medium compared to culture in
high folate conditions. As results of other experiments
e.g., Fig. 12 indicate that total DNA synthesis is
similar in both high and low folate conditions, this
result further supports the concept of adaptation of
de novo thymidylate synthesis to the prevailing folate
status. It was also apparent from Fig. 2 9 that
pre-incubation addition of MTX or 5-fu results in
14appreciable inhibition of 3-( C)-serine label
incorporation. This inhibition of incorporation
of de novo thymidylate precursor is also evident
from analysis of the results presented in Figs. 30,
31 and 33. In Fig. 33 where the radioactive label 
14used is ( C)-formate this inhibition is even more
14marked. It is considered that sensitivity of 3-( C)-
14serine incorporation or ( C)-formate incorporation 
to the effect of MTX or 5-fu is reduced by the 
incomplete specificity of such labelling for DNA- 
thymine. To exclude such non-specific labelling.
i.e., of purines and méthylation, it would be necessary 
to carry out further purification. This might 
involve further hydrolysis to liberate the bases, 
separation of bases using a chromatographic technique 
and quantitation of radioactive label incorporation 
into specific bases (Wolberg, 1969). As this degree 
of resolution was not considered necessary for these 
experiments, this purification was not carried out. 
Similar considerations would also apply to other 
aspects of these experiments where de novo thymidylate 
incorporation per se is considered rather than total
DNA synthesis and cell growth. The difference in the
14 . 14sensitivity of 3-( C)-serine and ( C)-formate label
to MTX and 5-fu may be attributed to differences in
their metabolism. This might indicate that carbon-3
of serine is a preferred source of one-carbon units
compared with formate but this is not substantiated
by the work of Wolberg (19 71) which indicates that
these sources are incorporated to similar extents.
The effect of UdR and the effect of sequential
1 4treatment with MTX or 5-fu and UdR on 3-( C)-serine
incorporation into a DNA extract of PHA stimulated
lymphocyte cultures (Figs. 3 0 and 31), has previously
been discussed (4.4.2.). The observation that the
14effect of UdR in increasing 3-( C)-serine incorpor­
ation is not further enhanced either in low folate 
conditions (Fig, 30) or in folate deficient conditions 
(as induced by MTX) (Fig. 31) indicates that stimulation 
of de novo thymidylate synthesis by addition of
exogenous UdR, as suggested by Van der Weyden (1979), 
is independent of the folate status and this supports 
the hypothesis that the effect of UdR is primarily 
mediated via inhibition of thymidine kinase. This 
result also indicates that de novo thymidylate 
synthesis is not restricted by the dUMP supply.
As previous experiments, the results of which are 
illustrated in Figs. 24, 25 and 26, indicated that de 
novo thymidylate synthesis was not limited by the 
availability of one-carbon metabolites, as supplied 
by exogenous formate, it is apparent that the 
availability of H^-folate coenzyme represents an 
important control element in de novo thymidylate 
synthesis. This conclusion is substantiated by the 
lack of effect of variation of pyridoxal status 
which contrasts with the marked influence of folate 
status on the relative contribution of the de novo 
thymidylate pathway to DNA .synthesis.
The result of an experiment directed at determination
of the effect of culture in medium containing 4-dPN
14on incorporation of 3-( C)-serine label into a DNA
extract of PHA stimulated lymphocytes is shown in
14Fig. 32. The reduction in incorporation of 3-( C)-
serine label is seen to be similar to the reduction 
12 5in ( I)-UdR incorporation caused by 4-dPN, (Fig. 16)
and is also independent of the medium folate
concentration. In other experiments, not reported
here, it was further demonstrated that, as with
12 5studies using ( I)-UdR, the presence or absence of
14medium pyridoxal (1.0 mg/1) did not affect 3-( C)-
serine incorporation into a DNA extract of PHA 
stimulated lymphocytes and nor did it affect the 
reduction in incorporation caused by 4-dPN.
The lack of influence of low or high medium folate 
concentration and the presence or absence of pyridoxal 
on the effect of 4-dPN is consistent with the results 
of previous experiments and confirms that sensitivity 
to vitamin B6 deficiency, as induced by 4-dPN is 
neither potentiated nor mitigated by variation of 
folate status. These observations also substantiate 
the previously advanced contention that vitamin B6 
deficiency does not specifically affect de novo 
thymidylate synthesis.
Formate has also been shown to be a precursor of DNA-
thymine. For example, Blakley (1969) has cited
reports that formate is incorporated into the methyl
group of DNA-thymine by rabbit bone marrow in vitro
and that each incorporation is considerably increased
when UdR or CdR is present in the suspending medium
and is decreased by the inhibitor aminopterin.
And, Wolberg, (19 71), has shown that incorporation 
1 4of ( C)-formate label into DNA-thymine of PHA
stimulated lymphocytes is similar to incorporation 
14of 3-( C)-serine label under comparable conditions.
14The results of determination of ( C)-formate 
incorporation into a DNA extract of
PHA stimulated lymphocytes presented here (Fig, 33) 
also show this pattern of incorporation, is reduced 
after pre-incubation with MTX or 5-fu and is increased
after pre-incubation with UdR, In other experiments, 
not reported here, incorporation was also shown to be 
reduced after culture in low folate conditions.
The results of these experiments indicate that
14 14incorporation of 3-( C)-serine or C C)-formate label
into a DNA extract of PHA stimulated lymphocyte
cultures, primarily via the de novo thymidylate pathway
12 5is a reciprocal reflection of ( I)-UdR incorporation
into an acid-insoluble residue of comparable cultures
and these results further demonstrate that the primary
lesion in vitamin B6 deficiency, in these conditions,
is unlikely to be that of a restriction in serine
hydroxymethyltransferase activity. Because the use 
14 .of 3-( C)-serine label incorporation into a DNA
extract of PHA stimulated lymphocytes provides a means
of determining DNA synthesis independently of salvage
incorporation, and therefore represents a more direct,
functional means of determination of vitamin B6
deficiency, these results also support the validity
12 5of methods based on the use of ( I)-UdR incorporation, 
via the complementary salvage pathway, to assess the 
effect of vitamin B6 deficiency on DNA synthesis and 
cell growth.
4.4.4. Effect of Medium Addition of Non-essential
Amino Acids
Interest in the possible effect of additional, non- 
essential amino acids on the effect of vitamin B6 
deficiency as induced by 4-dPN arose from observations, 
reported by Axelrod (1971) that the effect of 4-dPN 
in inhibiting antibody synthesis could be partially
reversed by glycine or serine supplementation, serine 
being much more effective than glycine on a molar 
basis. The results of experiments in this study 
directed at determination of the effect of medium 
addition of non-essential amino acids, including 
glycine and serine, on vitamin B6 deficiency as 
induced by 4-dPN are illustrated in Fig. 35.
These results indicate that medium supplementation 
with non-essential amino acids does not effect
12 5either an increase or a decrease in subsequent ( I)-
UdR incorporation irrespective of presence or absence 
of 4-dPN and pre-incubation with BSS, MTX, 5-fu or 
UdR. This suggests that the presence or absence of 
non-essential amino acids has no effect on vitamin B6 
deficiency as it affects DNA synthesis and cell growth.
The possible effect of vitamin B6 deficiency on synthesis
of specific cell products or specific proteins such as
immunoglobulins was not considered in this project
though it is conceivable that such a deficiency could
have a differential effect on the synthesis of such
products. If such a differential effect did arise it
is possible that it could be detected by the
application of an appropriate technique, particularly
in the early stages of the vitamin B6 deficiency
process. In this study, however, it is apparent
that amino-acid supplementation does not affect 4-dPN
induced inhibition of cell growth as expressed in 
12 5reduced C I)-UdR incorporation.
The effect of supplementary serine and glycine on 
vitamin B6 deficiency in chicks was examined by 
Aboaysha and Kratzer (1980), These workers had 
previously demonstrated that glycine, but not serine 
depressed the growth of chicks when added to a diet 
marginal in folic acid. This was presumed to be due 
to the fact that folic acid is required for the 
interconversion of glycine and serine so that glycine 
toxicity was spared by the failure of serine to be 
converted to glycine in folate deficiency. Since PLP 
is also required for the interconversion of glycine 
and serine these workers then investigated the 
possibility that a vitamin B6 deficiency would act 
similarly to a folic acid deficiency in reducing the 
toxicity of glycine for young chicks. The results 
they in fact observed however, were that addition 
of serine to a diet containing isolated soybean 
protein caused growth depression with marginal levels 
of pyridoxine, and that this growth depression could 
be overcome by the addition of extra dietary pyridoxine 
Since serine appeared to be readily converted to 
glycine, and also from the results of other studies, 
these authors attributed the metabolic defect, in this 
instance of pyridoxine deficiency, to a block in the 
conversion of phosphatidylserine to phosphatidyl 
choline.
Since addition of non-essential amino-acids caused
12 5neither an increase nor a decrease in ( I)-UdR 
incorporation, there is no evidence in this study
that supplementary amino-acids either exacerbated or 
alleviated the effects of 4-dPN induced vitamin B6 
deficiency. This work again indicates a possible 
relationship between the effects of folate and 
vitamin B6 deficiency and reaffirms the complexity 
of the interrelationships involved in this area of 
metabolism.
4.4.5. Protein Synthesis in Stimulated Lymphocytes
In this project, the principal means of assessing the
effect of 4-dPN induced vitamin B6 deficiency on cell
12 5growth has involved the use of ( I)-UdR incorpora­
tion to estimate the rate of DNA synthesis. In view 
of the possible differential effect of vitamin B6 
deficiency on protein and DNA synthesis, the 
relationship between protein synthesis and the 
physiological role of lymphocytes, and the association 
of increased protein synthesis with PHA stimulation, 
it was of interest to establish whether or not the 
4-dPN induced reduction in cell growth, as evidenced 
in reduced DNA synthesis, was reflected to a similar 
extent in reduced protein synthesis.
The results of an experiment in which the effect of
culture in medium containing 4-dPN on acid-insoluble 
14( C)-leucine incorporation into PHA stimulated 
lymphocytes was determined are presented in Fig. 36. 
These results indicate that the effect of 4-dPN on 
protein synthesis in 72h PHA stimulated lymphocytes 
is comparable to the effect on DNA synthesis under 
similar conditions, and therefore substantiate the 
validity of the methods used in so far as DNA synthesis 
is considered to equate with cell growth capacity.
4.4.6. Effect of Medium Addition of Hemin 
It is known that deprivation of vitamin B6 from 
animals causes disorders of erythropoiesis 
characterised by hypochromic, microcytic, anaemia, 
elevation of serum iron with increased saturation 
of iron binding capacity, erythroid hyperplasia in 
the bone marrow and increased iron storage in body 
tissues (Soloman and Hillman, 1979b). The clinical 
condition is sideroblastic or pyridoxine-responsive 
anaemia and the primary lesion has been attributed 
to a block in heme synthesis. The role of PLP in 
heme synthesis is that of a cofactor for delta- 
aminolaevulinic acid synthetase; the enzyme which 
catalyses the condensation of succinyl CoA and 
glycine to form delta-aminolaevulinic acid and 
which is believed to be the rate limiting enzyme in 
the heme synthetic pathway.
Other symptoms of vitamin B6 deficiency include 
glossitis, dermatitis, and neuropathy but in certain 
circumstances this may not develop (Aoki et al, 1979), 
and the principal lesion is that of a block in haem 
synthesis. Although quantitatively the highest body 
requirement for haem synthesis is in erythropoiesis, 
because haem is a constituent of a number of enzymes 
and is a cofactor in oxidative phosphorylation, an 
adequate supply of haem is required for cell viability 
in other cell types. In folate deficiency the primary 
lesion is considered to be a restriction of DNA 
synthesis and this effect is most marked in those 
tissues with the highest turnover, i.e., haematopoietic 
cells. Similarly in vitamin B6 deficiency affecting
haem synthesis, the greatest effect is likely to 
be on those tissues with the highest haem requirement, 
i.e., maturing red cells. However, depending on the 
degree of hyperplasia in other tissues, perhaps due 
to alcohol, other cell types could also be susceptible 
to the effects of vitamin B6 deficiency induced haem 
restriction.
The relationship of pyridoxine deficiency and 
inhibition of haem synthesis has also been investigated 
using the vitamin B6 antagonist INH and on erythroid 
cell culture system (Hoffman and Ross, 1980). The 
levels of INH used were such as to reduce the capacity 
of these cells to synthesise haem without significantly 
affecting their viability or their ability to replicate. 
This study offered a further example, albeit in a 
specialised cell type, of an instance where a vitamin 
B6 deficiency, in this case induced by 4-dPN, 
specifically reduced haem synthesis, and hence globin 
synthesis, but did not reduce overall protein synthesis. 
This study also presented evidence that exogenous haem 
could overcome the inhibitory effects of INH.
Evidence that exogenous haem * may be incorporated into 
haemoprotein of cells other than those of the erythroid 
type is presented in a report by Correia et al (1979). 
These workers presented evidence that exogenously 
supplied haem had been incorporated into the hepatic 
microsomal haemoprotein of rats and they also suggested 
that exogenously supplied haem readily gains access
* In this report haem is considered to be interchangeable 
with hemin (iron-protorphyrin - IX).
to an unassigned haem pool which provides haem for 
cytochrome P-450 formation.
These studies illustrate the potential value of using 
vitamin B6 antagonists to obtain a model, cell culture 
sytem for investigating the effects of vitamin B6 
deficiency. They also describe an instance where a 
biochemical abnormality arising from chronic exposure 
of cells to a vitamin B6 antagonist could be reversed 
by pyridoxal, exogenous hemin or other vitamin B6 
dependent metabolite.
In this project, the possibility that exogenous hemin 
could overcome the inhibitory effect of 4-dPN on DNA 
synthesis in PHA stimulated lymphocytes was investigated 
The results of this experiment are illustrated in 
Fig. 3 7 and these results indicate that, in this 
instance, exogenous hemin has only a limited influence 
on the effect of 4-dPN on DNA synthesis. A number of 
hypotheses may be proposed to account for this lack 
of influence; the most obvious inference is that in 
PHA stimulated lymphocytes the primary lesion in 4-dPN 
induced vitamin B6 deficiency is unrelated to a block 
in haem synthesis, but it is also possible that hemin 
is not incorporated into cells in this system or that 
although hemin corrects inhibition of haem synthesis 
caused by 4-dPN, other effects of vitamin B6 deficiency 
still result in inhibition of DNA synthesis.
zyb.
Section 4. 5
Conclusion
4.5.1. Preliminary Studies
The original purpose of this study was to investigate 
the clinical importance of nutritional deficiency and 
genetic markers in the aetiology and morbidity of 
alcoholic liver disease. The results of studies carried 
out for this purpose are described in section 3.1. and 
discussed in section 4.1. As it was apparent from these 
initial studies that this approach was unlikely to 
produce significant results it was decided to adopt an 
alternative approach.
4.5.2. Vitamin B6 Deficiency and the Stimulated Lymphocyte
In these studies acid-insoluble incorporation of 
12 5( I)-UdR was measured in stimulated lymphocyte cultures 
of alcoholic and control subjects. The conditions and 
period of labelling, described in section 2.2.16., 
were based on the methods described by Das and Herbert 
(1978); Herbert, Tisman, Go and Brenner (1973); Das and 
Hoffbrand (1970); Das,Herbert, Colman and Longo (1978);
Ling and Kay (19 75) and McCluskey (19 74). For a number 
of reasons discussed by Adams (1980) it is incorrect 
to equate acid-insoluble incorporation of a radioactively 
labelled precursor with the rate of DNA synthesis 
which means that acid-insoluble incorporation must be 
considered a relative rather than absolute index of 
DNA synthesis. However, it is apparent from Ling and 
Kay (1975) that by using carefully controlled and 
standard conditions a valid assessment of relative DNA
synthesis in PHA stimulated lymphocyte cultures 
of different subjects may be made by determination 
of acid-insoluble incorporation of an appropriately 
labelled DNA precursor.
One reason why acid-insoluble incorporation of 
radioactively labelled DNA precursor cannot be equated 
with the rate of DNA synthesis is that growth promoters 
affect pool sizes which in turn affect the specific 
activity of the DNA precursor pool. One approach to this 
problem is to measure the acid-soluble pool and apply an 
appropriate correction factor, Cowan and Leake (1979). 
However, certain findings indicate that use of this 
method in the experiments reported in this study may 
not necessarily provide a more accurate index of DNA 
synthesis. These include the reported compartmentation 
of nucleotide pools in PHA stimulated lymphocytes which 
are not uniformly labelled (Taheri, Wickremasinghe and 
Hoffbrand, 1981), the possible effect of variation in 
thymidine kinase activity (Hooton and Hoffbrand, 1977), 
and evidence that the thymidine triphosphate pool in 
PHA stimulated lymphocyte cultures derived from folate 
deficient subjects is not significantly different from 
that observed in normal cells (Ganeshaguru and Hoffbrand,
1978). This finding suggests that variation in the 
acid-soluble pool size in folate deficient and normal 
cells does not explain the variation in acid-insoluble 
incorporation observed in cultures of these cells.
From this it is reasonable to expect that similar 
considerations would apply to pyridoxal deficient cells. 
Validation of the method of estimation of DNA synthesis 
in this study is also provided by the results of
experiments in which the de novo thymidylate synthesis 
inhibitors MTX and 5-fu were used.
Most means of determination of vitamin B6 status 
depend on measurement of one or more of the forms of 
vitamin B6 in body fluids or tissues. A variety of 
techniques have been used and there is no generally 
agreed optimal method (Sauberlich et al, 19 72).
The range of results obtained from different 
investigators using the same method can vary considerably 
(Lumeng and Li,1974; Labadarios et al, 1977).
Although most agree that alcoholics have lower 
circulating levels of vitamin B6 than control subjects 
(Bonjour, 1980), such reduced levels were not observed 
in the present study (4.1.2.). Because of the technical 
(Srivastava and Beutler, 1973) and clinical limitations 
of direct measurement of vitamin B6 it was decided to 
attempt to assess the functional significance of the 
relative vitamin B6 deficiency observed in alcoholic 
liver disease subjects.
Several approaches were used to determine whether a 
functional vitamin B6 deficiency existed in lymphocytes 
of alcoholic subjects, or of control subjects cultured 
in medium free of pyridoxal or exposed to vitamin B6 
antagonists. Although a vitamin B6 deficiency might 
be expected to affect numerous enzymes in several 
areas of metabolism and to result in a variety of 
systemic and local disorders, the method of assessment 
of functional vitamin B6 deficiency adopted in this 
study was based on determination of DNA synthesis.
This method was used because inhibition of de novo 
thymidylate synthesis had been postulated as a primary 
site of action of vitamin B5 deficiency and because 
the principal interest was to determine the overall 
effect of vitamin B6 deficiency on cell growth.
The results of this study do not indicate that a 
functional vitamin B6 deficiency is present or is 
expressed in stimulated lymphocytes of alcoholic 
subjects, or in stimulated lymphocytes of control or 
alcoholic subjects cultured in medium free of exogenous 
pyridoxal or other PLP precursor. There was, however, 
a significant reduction in DNA synthesis in lymphocytes 
exposed to either of the vitamin B6 antagonists 4-dPN 
and INH. This latter observation formed the basis of 
using 4-dPN in PHA stimulated lymphocyte culture to 
study certain aspects of the effect of vitamin B6 
deficiency on DNA synthesis. The appropriateness of 
this approach has been demonstrated by a report 
describing the use of PHA stimulated lymphocytes 
cultured in folate depleted medium as an in vitro 
model for megaloblastic haematopoiesis (Van der Weyden,
1979) .
Several approaches were used to determine the effect 
of 4-dPN induced vitamin B6 deficiency on DNA synthesis 
and cell growth. The results of experiments involving 
the use of the inhibitors and metabolites MTX, 5-fu,
UdR, folate and formate, and the radioactivity labelled
12 5 14 14precursors ( )-UdR, 3-( C)-serine and ( C)-formate
indicated that 4-dPN induced vitamin B6 deficiency,
although it reduced overall DNA synthesis did not 
have a specific effect on de novo thymidylate 
synthesis. The results of experiments where the 
effect of UdR on incorporation of salvage and de 
novo thymidylate precursors into cells pre-treated 
with MTX or 5-fu was determined, indicated that 
the presumed basis of the UdR suppression test was 
suspect and that the major part of the UdR suppression 
phenomenon could be attributed to competitive 
substrate inhibition of thymidine kinase. Results 
of experiments where the effect of variation of the 
medium folate concentration on subsequent incorporation 
of thymidylate precursors in the presence and absence 
of inhibitors of de novo thymidylate synthesis 
indicated that the medium folate concentration is a 
critical factor in determining the degree of cellular 
adaptation to thymidine utilisation. It was considered 
that this would have a significant bearing on many 
experiments in which DNA synthesis is determined.
Experiments were carried out to determine the effect 
of addition of non-essential amino acids and hemin 
on the reduction of DNA synthesis caused by 4-dPN 
induced vitamin B6 deficiency. In each case no 
appreciable effect was observed.
Although these experiments demonstrated the potential 
value of the use of 4-dPN and PHA stimulated lymphocyte 
culture in investigating aspects of the cellular 
effects of vitamin B6 deficiency, it is considered 
that in order to exploit the advantages of this system 
fully it would be necessary to refine the methods used
and to perhaps restrict the study to analysis of 
more specific enzyme lesions rather than overall 
DNA synthesis.
4.5.3. Vitamin B6 Deficiency and Alcoholic Liver Disease
The principal aim of this project was to determine 
whether or not a functional difference existed between 
the vitamin B6 status of control and alcoholic liver 
disease subjects. While blood level studies have 
demonstrated that vitamin B6 levels are lower in 
alcoholic or alcoholic liver disease subjects than in 
control subjects (Bonjour, 1980), the clinical 
significance of this finding or its relevance to 
the pathogenesis of alcoholic liver disease has not 
been established. For example, Labadarios et al (1977) 
have presented evidence that plasma PLP is significantly 
lower than normal in patients with liver disease but 
that there is no significant difference in plasma PLP 
between patients with alcoholic liver disease and other 
forms of liver disease.
The approach used in this study to assess vitamin B6 
status and the functional significance of reduced 
vitamin B6 status employed peripheral blood lymphocytes 
from control and alcoholic subjects. Maximal vitamin 
B6 requiring conditions were created by culture in the 
presence of PHA and in medium free of pyridoxal.
Sensitivity of lymphocytes to culture in different 
folate concentrations and to the vitamin B6 antagonist
4-dPN was also determined. As DNA synthesis and 
cell growth was considered to be a possible determinant 
factor in the pathogenesis of alcoholic liver disease, 
determination of DNA synthesis was used to assess 
functional vitamin B6 status, and, as vitamin B6 
deficiency had been reported to have a specific effect 
on de novo thymidylate synthesis (Axelrod, 1971),
I
cultures were pre-incubated with MTX or 5 fu prior 
to incubation with a salvage thymidylate precursor, 
(^^^l)-UdR, to detect such an effect.
The results of experiments carried out in this study 
do not indicate that there is a marked difference in 
functional vitamin B6 status between the alcoholic and 
control subjects studied. However, as the sample size 
of the population studied was small it was not possible 
to exclude the possibility that a smaller though real 
difference did exist. Because of the lack of subjects 
sutiable for inclusion in the study, it was decided 
to concentrate on characterisation of the model system 
and on the effects of vitamin B6 antagonists. The 
failure to demonstrate a functionally significant 
lower vitamin B6 status in the alcoholic subjects 
surveyed in this study, the lack of overt clinical 
manifestations of vitamin B6 deficiency and the 
difficulty in distinguishing between the role of 
alcohol and the role of liver damage on vitamin B6 
metabolism emphasise the difficulty in assessing 
whether the reduced vitamin B6 levels observed in
alcoholics are a necessary accompaniment or pre­
condition for alcoholic liver disease. Soloman and 
Hillman (19 79) observed that alcohol ingestion per se 
did not appear to impair either pyridoxine kinase 
activity or PLP activity and that as the anaemia 
of alcoholism is often complicated by the simultaneous 
presence of folate deficiency, inflammation, active 
liver disease and major dietary deprivations, 
the influence of each of these factors on vitamin B6 
metabolism has yet to be determined.
4.5.4. Conclusions 
This study reports;
an approach to assessment of functional vitamin B6 
status
the use of PHA stimulated lymphocytes as a model system 
for study of cell growth
the use of a customised cell culture medium to
differentiate between lymphocytes of 
alcoholic and control subjects
the application of the UdR suppression effect to 
assessment of vitamin B5 status
an approach to characterisation of the effects of 
vitamin B6 antagonists
The results of this study suggest that;
vitamin B6 deficiency is not always of functional 
significance in the aetiology and morbidity of 
alcoholic liver disease
the primary lesion in 4-dPN induced vitamin B5
deficiency in the PHA stimulated lymphocyte is not 
at the level of de novo thymidylate synthesis
the use of the UdR suppression test is not a valid 
method of assessing folate status
the UdR suppression effect is mediated primarily by 
inhibition of thymidine kinase rather than 
stimulation of de novo thymidylate synthesis
the medium folate concentration has a significant 
influence on cellular adaptation to thymidine 
utilisation
low medium pyridoxal concentration does not result 
in increased salvage thymidylate incorporation.
4.5.5. Future Work
The work described in this project may be developed 
and extended in several ways. Certain experiments 
could be carried out to further characterise the 
methods used and results observed in the present study. 
For example, determination of acid-soluble pool sizes 
and thymidine kinase activity in PHA stimulated 
lymphocytes of different subjects cultured in different 
conditions. The availability of a larger population 
of subjects suitable for inclusion in the study would 
allow assessment of larger sample sizes and greater 
clinical and demographic standardisation of subjects.
If the lymphocyte cell population recovers from the 
effects of alcohol and nutritional deficiency quickly, 
the possible effect on vitamin B6 metabolism may be 
confounded. However, it has been suggested (Das and 
Herbert, 19 78) that the lymphocyte is a marker of 
past nutritional status rather than nutritional 
status at the time of collection of the blood sample.
This suggests that PHA stimulated lymphocyte studies 
can be used for retrospective diagnosis of vitamin 
deficiency and are not affected by recent changes in 
nutrition or alcohol intake.
With reference to alcoholic liver disease, the PHA 
stimulated lymphocyte system could be used to study 
other possible nutritional factors in the aetiology 
and morbidity of this condition and certain aspects 
of immunological and other abnormalities in the 
alcoholic liver diseased subject.
With reference to determination of vitamin B6 status 
and to characterisation of the effects of vitamin B6 
deficiency, there are a number of areas which could be 
investigated. For example, if use of the PHA stimulated 
lymphocyte system is retained, the actual vitamin B6 
deficiency induced lesions could be considered rather 
than the overall effect on protein or DNA synthesis.
Such a study could also be carried out in specialised 
cell culture systems such as Friend cells or cells 
derived from nerve or hepatic tissue where effects of 
vitamin B6 deficiency on specific protein synthesis 
or cell functions might more easily be determined.
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